Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

210604
Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 138,027 138,543 57,203 59,277 35,803 37,309
Marijuana 127,139 126,504 48,242 49,634 31,606 32,784
Cocaine 41,445 39,261 5,468 5,172 1,998 1,831
Crack 9,375 9,356 778 657 378 335
Heroin 5,696 6,252 745 902 431 513
Hallucinogens 44,087 43,949 6,010 7,133 1,915 1,761
LSD 27,528 28,123 2,470 2,637 580 649
PCP 5,516 6,141 73 95 * 24
Ecstasy 20,097 20,478 2,539 2,622 663 681
Inhalants 25,090 26,749 2,142 2,390 807 904
Methamphetamine 16,013 15,397 1,999 2,550 1,173 1,722
Misuse of Prescription Psychotherapeutics nr nr 16,304 16,073 5,337 5,278
Pain Relievers nr nr 9,724 9,254 2,819 2,536
Stimulants nr nr 4,929 5,092 1,566 1,493
Tranquilizers or Sedatives nr nr 5,895 6,205 1,958 2,196
Tranquilizers nr nr 5,220 5,460 1,781 1,891
Sedatives nr nr 1,098 1,240 304 481
Benzodiazepines -- -- 4,841 4,779 -- --
Opioids nr nr 10,065 9,490 3,101 2,885
Central Nervous System Stimulants nr nr 10,136 10,306 4,264 4,483
Illicit Drugs Other Than Marijuana2 nr nr 23,588 23,962 9,333 9,305
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 50.2 50.0 20.8 21.4 13.0 13.5
Marijuana 46.2 45.7 17.5 17.9 11.5 11.8
Cocaine 15.1 14.2 2.0 1.9 0.7 0.7
Crack 3.4 3.4 0.3 0.2 0.1 0.1
Heroin 2.1 2.3 0.3 0.3 0.2 0.2
Hallucinogens 16.0 15.9 2.2 2.6 0.7 0.6
LSD 10.0 10.2 0.9 1.0 0.2 0.2
PCP 2.0 2.2 0.0 0.0 * 0.0
Ecstasy 7.3 7.4 0.9 0.9 0.2 0.2
Inhalants 9.1 9.7 0.8 0.9 0.3 0.3
Methamphetamine 5.8 5.6 0.7 0.9 0.4 0.6
Misuse of Prescription Psychotherapeutics nr nr 5.9 5.8 1.9 1.9
Pain Relievers nr nr 3.5 3.3 1.0 0.9
Stimulants nr nr 1.8 1.8 0.6 0.5
Tranquilizers or Sedatives nr nr 2.1 2.2 0.7 0.8
Tranquilizers nr nr 1.9 2.0 0.6 0.7
Sedatives nr nr 0.4 0.4 0.1 0.2
Benzodiazepines -- -- 1.8 1.7 -- --
Opioids nr nr 3.7 3.4 1.1 1.0
Central Nervous System Stimulants nr nr 3.7 3.7 1.5 1.6
Illicit Drugs Other Than Marijuana2 nr nr 8.6 8.7 3.4 3.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 6,090 5,229 4,279 3,436 2,167 1,679
Marijuana 3,947 3,103 3,284 2,531 1,837 1,472
Cocaine 154 105 97 84 34 11
Crack 20 3 11 2 5 2
Heroin 21 * * * * *
Hallucinogens 615 563 440 370 152 80
LSD 392 317 279 219 68 27
PCP 41 7 21 * * *
Ecstasy 225 183 144 86 40 23
Inhalants 2,202 2,327 743 683 216 106
Methamphetamine 75 48 41 21 11 7
Misuse of Prescription Psychotherapeutics nr nr 1,062 688 329 169
Pain Relievers nr nr 567 396 165 96
Stimulants nr nr 430 288 123 72
Tranquilizers or Sedatives nr nr 436 226 121 26
Tranquilizers nr nr 392 196 112 25
Sedatives nr nr 82 35 29 1
Benzodiazepines -- -- 381 157 -- --
Opioids nr nr 567 396 165 96
Central Nervous System Stimulants nr nr 499 346 160 87
Illicit Drugs Other Than Marijuana2 nr nr 1,862 1,507 598 305
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 24.5 20.9 17.2 13.8 8.7 6.7
Marijuana 15.8 12.4 13.2 10.1 7.4 5.9
Cocaine 0.6 0.4 0.4 0.3 0.1 0.0
Crack 0.1 0.0 0.0 0.0 0.0 0.0
Heroin 0.1 * * * * *
Hallucinogens 2.5 2.3 1.8 1.5 0.6 0.3
LSD 1.6 1.3 1.1 0.9 0.3 0.1
PCP 0.2 0.0 0.1 * * *
Ecstasy 0.9 0.7 0.6 0.3 0.2 0.1
Inhalants 8.8 9.3 3.0 2.7 0.9 0.4
Methamphetamine 0.3 0.2 0.2 0.1 0.0 0.0
Misuse of Prescription Psychotherapeutics nr nr 4.3 2.8 1.3 0.7
Pain Relievers nr nr 2.3 1.6 0.7 0.4
Stimulants nr nr 1.7 1.2 0.5 0.3
Tranquilizers or Sedatives nr nr 1.8 0.9 0.5 0.1
Tranquilizers nr nr 1.6 0.8 0.5 0.1
Sedatives nr nr 0.3 0.1 0.1 0.0
Benzodiazepines -- -- 1.5 0.6 -- --
Opioids nr nr 2.3 1.6 0.7 0.4
Central Nervous System Stimulants nr nr 2.0 1.4 0.6 0.3
Illicit Drugs Other Than Marijuana2 nr nr 7.5 6.0 2.4 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 131,937 133,314 52,924 55,841 33,636 35,630
Marijuana 123,192 123,401 44,958 47,103 29,769 31,312
Cocaine 41,291 39,155 5,371 5,088 1,965 1,821
Crack 9,355 9,354 766 655 372 333
Heroin 5,675 6,251 745 902 431 513
Hallucinogens 43,472 43,386 5,571 6,763 1,763 1,681
LSD 27,137 27,806 2,191 2,418 512 622
PCP 5,475 6,134 52 95 * 24
Ecstasy 19,872 20,295 2,395 2,537 623 659
Inhalants 22,889 24,422 1,399 1,707 591 797
Methamphetamine 15,939 15,349 1,958 2,528 1,161 1,715
Misuse of Prescription Psychotherapeutics nr nr 15,242 15,385 5,008 5,108
Pain Relievers nr nr 9,158 8,858 2,654 2,440
Stimulants nr nr 4,499 4,804 1,443 1,421
Tranquilizers or Sedatives nr nr 5,459 5,979 1,837 2,170
Tranquilizers nr nr 4,829 5,264 1,669 1,866
Sedatives nr nr 1,016 1,205 275 480
Benzodiazepines -- -- 4,460 4,622 -- --
Opioids nr nr 9,499 9,094 2,936 2,789
Central Nervous System Stimulants nr nr 9,638 9,960 4,103 4,396
Illicit Drugs Other Than Marijuana2 nr nr 21,727 22,455 8,735 9,000
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 52.7 52.9 21.1 22.2 13.4 14.1
Marijuana 49.2 49.0 18.0 18.7 11.9 12.4
Cocaine 16.5 15.5 2.1 2.0 0.8 0.7
Crack 3.7 3.7 0.3 0.3 0.1 0.1
Heroin 2.3 2.5 0.3 0.4 0.2 0.2
Hallucinogens 17.4 17.2 2.2 2.7 0.7 0.7
LSD 10.8 11.0 0.9 1.0 0.2 0.2
PCP 2.2 2.4 0.0 0.0 * 0.0
Ecstasy 7.9 8.1 1.0 1.0 0.2 0.3
Inhalants 9.1 9.7 0.6 0.7 0.2 0.3
Methamphetamine 6.4 6.1 0.8 1.0 0.5 0.7
Misuse of Prescription Psychotherapeutics nr nr 6.1 6.1 2.0 2.0
Pain Relievers nr nr 3.7 3.5 1.1 1.0
Stimulants nr nr 1.8 1.9 0.6 0.6
Tranquilizers or Sedatives nr nr 2.2 2.4 0.7 0.9
Tranquilizers nr nr 1.9 2.1 0.7 0.7
Sedatives nr nr 0.4 0.5 0.1 0.2
Benzodiazepines -- -- 1.8 1.8 -- --
Opioids nr nr 3.8 3.6 1.2 1.1
Central Nervous System Stimulants nr nr 3.9 4.0 1.6 1.7
Illicit Drugs Other Than Marijuana2 nr nr 8.7 8.9 3.5 3.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 18,832 17,879 13,193 12,398 8,406 8,016
Marijuana 17,450 16,604 11,952 11,566 7,749 7,727
Cocaine 3,809 3,065 1,789 1,441 540 424
Crack 339 247 61 49 18 35
Heroin 389 226 87 62 38 26
Hallucinogens 5,597 5,269 2,425 2,446 625 645
LSD 3,368 3,284 1,202 1,254 260 273
PCP 249 167 30 63 8 *
Ecstasy 3,500 2,946 1,089 845 214 187
Inhalants 3,099 2,929 577 507 157 160
Methamphetamine 904 538 275 171 110 74
Misuse of Prescription Psychotherapeutics nr nr 3,868 3,193 1,145 764
Pain Relievers nr nr 1,754 1,361 420 288
Stimulants nr nr 1,951 1,616 587 267
Tranquilizers or Sedatives nr nr 1,409 1,237 365 371
Tranquilizers nr nr 1,313 1,108 337 357
Sedatives nr nr 175 251 44 78
Benzodiazepines -- -- 1,266 1,097 -- --
Opioids nr nr 1,776 1,376 439 296
Central Nervous System Stimulants nr nr 3,205 2,567 1,127 682
Illicit Drugs Other Than Marijuana2 nr nr 5,791 5,169 2,059 1,600
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 55.8 53.4 39.1 37.0 24.9 23.9
Marijuana 51.7 49.6 35.4 34.5 23.0 23.1
Cocaine 11.3 9.1 5.3 4.3 1.6 1.3
Crack 1.0 0.7 0.2 0.1 0.1 0.1
Heroin 1.2 0.7 0.3 0.2 0.1 0.1
Hallucinogens 16.6 15.7 7.2 7.3 1.9 1.9
LSD 10.0 9.8 3.6 3.7 0.8 0.8
PCP 0.7 0.5 0.1 0.2 0.0 *
Ecstasy 10.4 8.8 3.2 2.5 0.6 0.6
Inhalants 9.2 8.7 1.7 1.5 0.5 0.5
Methamphetamine 2.7 1.6 0.8 0.5 0.3 0.2
Misuse of Prescription Psychotherapeutics nr nr 11.5 9.5 3.4 2.3
Pain Relievers nr nr 5.2 4.1 1.2 0.9
Stimulants nr nr 5.8 4.8 1.7 0.8
Tranquilizers or Sedatives nr nr 4.2 3.7 1.1 1.1
Tranquilizers nr nr 3.9 3.3 1.0 1.1
Sedatives nr nr 0.5 0.7 0.1 0.2
Benzodiazepines -- -- 3.8 3.3 -- --
Opioids nr nr 5.3 4.1 1.3 0.9
Central Nervous System Stimulants nr nr 9.5 7.7 3.3 2.0
Illicit Drugs Other Than Marijuana2 nr nr 17.2 15.4 6.1 4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 113,104 115,435 39,731 43,443 25,231 27,614
Marijuana 105,742 106,797 33,007 35,537 22,020 23,585
Cocaine 37,483 36,091 3,582 3,646 1,425 1,396
Crack 9,016 9,107 706 606 355 298
Heroin 5,287 6,024 658 840 392 488
Hallucinogens 37,876 38,117 3,146 4,317 1,138 1,036
LSD 23,769 24,521 989 1,164 252 349
PCP 5,226 5,967 22 31 * 24
Ecstasy 16,372 17,348 1,306 1,692 409 472
Inhalants 19,790 21,493 822 1,200 434 637
Methamphetamine 15,034 14,811 1,682 2,358 1,051 1,641
Misuse of Prescription Psychotherapeutics nr nr 11,374 12,192 3,863 4,344
Pain Relievers nr nr 7,404 7,498 2,234 2,152
Stimulants nr nr 2,548 3,188 856 1,154
Tranquilizers or Sedatives nr nr 4,050 4,742 1,472 1,799
Tranquilizers nr nr 3,516 4,156 1,332 1,509
Sedatives nr nr 841 954 231 402
Benzodiazepines -- -- 3,194 3,526 -- --
Opioids nr nr 7,723 7,717 2,497 2,493
Central Nervous System Stimulants nr nr 6,433 7,393 2,976 3,714
Illicit Drugs Other Than Marijuana2 nr nr 15,936 17,286 6,676 7,400
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2019 and 2020
Drug Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
ILLICIT DRUGS1 52.2 52.8 18.3 19.9 11.6 12.6
Marijuana 48.8 48.9 15.2 16.3 10.2 10.8
Cocaine 17.3 16.5 1.7 1.7 0.7 0.6
Crack 4.2 4.2 0.3 0.3 0.2 0.1
Heroin 2.4 2.8 0.3 0.4 0.2 0.2
Hallucinogens 17.5 17.5 1.5 2.0 0.5 0.5
LSD 11.0 11.2 0.5 0.5 0.1 0.2
PCP 2.4 2.7 0.0 0.0 * 0.0
Ecstasy 7.6 7.9 0.6 0.8 0.2 0.2
Inhalants 9.1 9.8 0.4 0.5 0.2 0.3
Methamphetamine 6.9 6.8 0.8 1.1 0.5 0.8
Misuse of Prescription Psychotherapeutics nr nr 5.3 5.6 1.8 2.0
Pain Relievers nr nr 3.4 3.4 1.0 1.0
Stimulants nr nr 1.2 1.5 0.4 0.5
Tranquilizers or Sedatives nr nr 1.9 2.2 0.7 0.8
Tranquilizers nr nr 1.6 1.9 0.6 0.7
Sedatives nr nr 0.4 0.4 0.1 0.2
Benzodiazepines -- -- 1.5 1.6 -- --
Opioids nr nr 3.6 3.5 1.2 1.1
Central Nervous System Stimulants nr nr 3.0 3.4 1.4 1.7
Illicit Drugs Other Than Marijuana2 nr nr 7.4 7.9 3.1 3.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 138,027 138,543 57,203 59,277 35,803 37,309
12-20 12,323 10,691 9,116 7,486 5,137 4,208
21 or Older 125,704 127,852 48,087 51,791 30,666 33,101
12-17 6,090 5,229 4,279 3,436 2,167 1,679
12-13 1,041 941 582 442 214 76
14-15 1,970 1,780 1,313 1,209 622 599
16-17 3,080 2,507 2,384 1,785 1,331 1,004
18 or Older 131,937 133,314 52,924 55,841 33,636 35,630
18-25 18,832 17,879 13,193 12,398 8,406 8,016
18-20 6,233 5,463 4,837 4,051 2,970 2,529
21-25 12,599 12,416 8,356 8,347 5,436 5,487
26 or Older 113,104 115,435 39,731 43,443 25,231 27,614
26-49 59,083 58,674 26,092 27,784 16,479 18,165
26-29 11,523 10,746 6,690 6,234 4,419 4,177
30-34 13,677 13,638 6,520 6,967 4,056 4,508
35-39 12,847 13,127 5,338 6,053 3,337 3,914
40-44 10,694 10,448 3,887 4,323 2,337 2,926
45-49 10,342 10,714 3,657 4,207 2,330 2,641
50 or Older 54,021 56,762 13,639 15,660 8,752 9,449
50-54 11,391 11,192 3,108 3,624 2,024 2,302
55-59 12,209 12,248 3,498 3,797 2,203 2,187
60-64 12,176 12,056 3,303 3,955 2,281 2,419
65 or Older 18,245 21,266 3,730 4,284 2,243 2,541
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 50.2 50.0 20.8 21.4 13.0 13.5
12-20 32.4 28.6 23.9 20.0 13.5 11.2
21 or Older 53.0 53.4 20.3 21.6 12.9 13.8
12-17 24.5 20.9 17.2 13.8 8.7 6.7
12-13 12.7 11.1 7.1 5.2 2.6 0.9
14-15 23.2 20.6 15.5 14.0 7.3 6.9
16-17 37.3 31.8 28.9 22.6 16.1 12.7
18 or Older 52.7 52.9 21.1 22.2 13.4 14.1
18-25 55.8 53.4 39.1 37.0 24.9 23.9
18-20 47.3 43.9 36.7 32.6 22.6 20.3
21-25 61.3 59.0 40.6 39.6 26.4 26.1
26 or Older 52.2 52.8 18.3 19.9 11.6 12.6
26-49 58.3 57.8 25.8 27.4 16.3 17.9
26-29 63.8 60.3 37.1 35.0 24.5 23.5
30-34 61.4 60.0 29.3 30.7 18.2 19.8
35-39 60.0 58.8 24.9 27.1 15.6 17.5
40-44 55.5 53.9 20.2 22.3 12.1 15.1
45-49 51.1 55.5 18.1 21.8 11.5 13.7
50 or Older 46.9 48.6 11.8 13.4 7.6 8.1
50-54 55.3 56.2 15.1 18.2 9.8 11.6
55-59 57.4 56.9 16.4 17.6 10.4 10.2
60-64 59.2 57.7 16.1 18.9 11.1 11.6
65 or Older 34.5 39.0 7.1 7.9 4.2 4.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 127,139 126,504 48,242 49,634 31,606 32,784
12-20 9,580 8,003 7,696 6,325 4,626 3,952
21 or Older 117,559 118,501 40,546 43,310 26,981 28,832
12-17 3,947 3,103 3,284 2,531 1,837 1,472
12-13 253 158 201 111 84 32
14-15 1,165 1,031 992 897 527 517
16-17 2,528 1,914 2,091 1,523 1,227 923
18 or Older 123,192 123,401 44,958 47,103 29,769 31,312
18-25 17,450 16,604 11,952 11,566 7,749 7,727
18-20 5,633 4,900 4,412 3,794 2,788 2,480
21-25 11,817 11,704 7,539 7,773 4,961 5,247
26 or Older 105,742 106,797 33,007 35,537 22,020 23,585
26-49 55,315 54,599 22,016 23,445 14,559 15,950
26-29 10,906 10,105 5,958 5,420 4,026 3,787
30-34 12,842 12,750 5,562 5,924 3,627 4,028
35-39 12,077 12,385 4,451 5,214 2,932 3,561
40-44 9,922 9,864 3,134 3,611 2,023 2,478
45-49 9,568 9,496 2,911 3,276 1,951 2,097
50 or Older 50,427 52,198 10,990 12,091 7,461 7,635
50-54 10,707 9,961 2,562 2,789 1,695 1,995
55-59 11,394 11,409 2,867 2,870 1,906 1,580
60-64 11,664 11,474 2,891 3,140 2,024 2,024
65 or Older 16,662 19,354 2,670 3,292 1,836 2,035
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 46.2 45.7 17.5 17.9 11.5 11.8
12-20 25.2 21.4 20.2 16.9 12.1 10.6
21 or Older 49.6 49.5 17.1 18.1 11.4 12.0
12-17 15.8 12.4 13.2 10.1 7.4 5.9
12-13 3.1 1.9 2.5 1.3 1.0 0.4
14-15 13.7 11.9 11.7 10.4 6.2 6.0
16-17 30.6 24.3 25.3 19.3 14.9 11.7
18 or Older 49.2 49.0 18.0 18.7 11.9 12.4
18-25 51.7 49.6 35.4 34.5 23.0 23.1
18-20 42.8 39.4 33.5 30.5 21.2 19.9
21-25 57.5 55.6 36.7 36.9 24.1 24.9
26 or Older 48.8 48.9 15.2 16.3 10.2 10.8
26-49 54.6 53.8 21.7 23.1 14.4 15.7
26-29 60.4 56.7 33.0 30.4 22.3 21.3
30-34 57.7 56.1 25.0 26.1 16.3 17.7
35-39 56.4 55.5 20.8 23.4 13.7 16.0
40-44 51.5 50.9 16.3 18.6 10.5 12.8
45-49 47.2 49.2 14.4 17.0 9.6 10.9
50 or Older 43.7 44.7 9.5 10.3 6.5 6.5
50-54 51.9 50.0 12.4 14.0 8.2 10.0
55-59 53.6 53.0 13.5 13.3 9.0 7.3
60-64 56.7 54.9 14.0 15.0 9.8 9.7
65 or Older 31.5 35.5 5.1 6.0 3.5 3.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 41,445 39,261 5,468 5,172 1,998 1,831
12-20 925 558 529 357 161 95
21 or Older 40,520 38,703 4,939 4,815 1,838 1,736
12-17 154 105 97 84 34 11
12-13 12 8 12 4 * *
14-15 30 21 20 19 11 1
16-17 112 76 65 62 23 10
18 or Older 41,291 39,155 5,371 5,088 1,965 1,821
18-25 3,809 3,065 1,789 1,441 540 424
18-20 771 452 432 273 127 84
21-25 3,038 2,612 1,357 1,168 413 340
26 or Older 37,483 36,091 3,582 3,646 1,425 1,396
26-49 17,622 17,641 2,863 3,002 1,051 1,156
26-29 3,298 2,744 957 924 296 286
30-34 4,173 4,021 811 535 309 175
35-39 3,870 4,272 565 676 200 287
40-44 3,346 3,122 284 437 149 226
45-49 2,936 3,482 246 431 98 183
50 or Older 19,861 18,450 720 644 374 240
50-54 4,307 3,548 181 218 118 127
55-59 5,339 4,611 219 150 96 70
60-64 5,323 5,172 220 120 129 16
65 or Older 4,892 5,118 100 157 32 27
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 15.1 14.2 2.0 1.9 0.7 0.7
12-20 2.4 1.5 1.4 1.0 0.4 0.3
21 or Older 17.1 16.2 2.1 2.0 0.8 0.7
12-17 0.6 0.4 0.4 0.3 0.1 0.0
12-13 0.1 0.1 0.1 0.0 * *
14-15 0.4 0.2 0.2 0.2 0.1 0.0
16-17 1.4 1.0 0.8 0.8 0.3 0.1
18 or Older 16.5 15.5 2.1 2.0 0.8 0.7
18-25 11.3 9.1 5.3 4.3 1.6 1.3
18-20 5.9 3.6 3.3 2.2 1.0 0.7
21-25 14.8 12.4 6.6 5.5 2.0 1.6
26 or Older 17.3 16.5 1.7 1.7 0.7 0.6
26-49 17.4 17.4 2.8 3.0 1.0 1.1
26-29 18.3 15.4 5.3 5.2 1.6 1.6
30-34 18.7 17.7 3.6 2.4 1.4 0.8
35-39 18.1 19.1 2.6 3.0 0.9 1.3
40-44 17.4 16.1 1.5 2.3 0.8 1.2
45-49 14.5 18.0 1.2 2.2 0.5 0.9
50 or Older 17.2 15.8 0.6 0.6 0.3 0.2
50-54 20.9 17.8 0.9 1.1 0.6 0.6
55-59 25.1 21.4 1.0 0.7 0.5 0.3
60-64 25.9 24.7 1.1 0.6 0.6 0.1
65 or Older 9.3 9.4 0.2 0.3 0.1 0.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 9,375 9,356 778 657 378 335
12-20 71 46 27 25 10 25
21 or Older 9,304 9,311 751 632 368 310
12-17 20 3 11 2 5 2
12-13 * * * * * *
14-15 3 * * * * *
16-17 16 3 11 2 5 2
18 or Older 9,355 9,354 766 655 372 333
18-25 339 247 61 49 18 35
18-20 51 43 15 23 4 23
21-25 287 204 46 26 13 12
26 or Older 9,016 9,107 706 606 355 298
26-49 4,334 4,463 343 371 168 244
26-29 469 389 38 40 22 19
30-34 949 854 69 52 31 17
35-39 945 1,259 110 118 49 81
40-44 1,024 829 63 83 32 78
45-49 947 1,132 63 79 34 50
50 or Older 4,682 4,644 363 234 187 53
50-54 1,275 1,116 94 138 67 29
55-59 1,266 1,523 96 14 28 6
60-64 1,376 852 99 * 75 *
65 or Older 765 1,153 75 82 18 19
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 3.4 3.4 0.3 0.2 0.1 0.1
12-20 0.2 0.1 0.1 0.1 0.0 0.1
21 or Older 3.9 3.9 0.3 0.3 0.2 0.1
12-17 0.1 0.0 0.0 0.0 0.0 0.0
12-13 * * * * * *
14-15 0.0 * * * * *
16-17 0.2 0.0 0.1 0.0 0.1 0.0
18 or Older 3.7 3.7 0.3 0.3 0.1 0.1
18-25 1.0 0.7 0.2 0.1 0.1 0.1
18-20 0.4 0.3 0.1 0.2 0.0 0.2
21-25 1.4 1.0 0.2 0.1 0.1 0.1
26 or Older 4.2 4.2 0.3 0.3 0.2 0.1
26-49 4.3 4.4 0.3 0.4 0.2 0.2
26-29 2.6 2.2 0.2 0.2 0.1 0.1
30-34 4.3 3.8 0.3 0.2 0.1 0.1
35-39 4.4 5.6 0.5 0.5 0.2 0.4
40-44 5.3 4.3 0.3 0.4 0.2 0.4
45-49 4.7 5.9 0.3 0.4 0.2 0.3
50 or Older 4.1 4.0 0.3 0.2 0.2 0.0
50-54 6.2 5.6 0.5 0.7 0.3 0.1
55-59 6.0 7.1 0.5 0.1 0.1 0.0
60-64 6.7 4.1 0.5 * 0.4 *
65 or Older 1.4 2.1 0.1 0.2 0.0 0.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 44,087 43,949 6,010 7,133 1,915 1,761
12-20 1,999 1,823 1,271 1,202 360 358
21 or Older 42,088 42,126 4,739 5,931 1,554 1,404
12-17 615 563 440 370 152 80
12-13 50 24 29 14 17 6
14-15 175 161 125 130 50 19
16-17 390 378 285 227 85 55
18 or Older 43,472 43,386 5,571 6,763 1,763 1,681
18-25 5,597 5,269 2,425 2,446 625 645
18-20 1,385 1,260 831 831 208 278
21-25 4,212 4,010 1,593 1,614 416 368
26 or Older 37,876 38,117 3,146 4,317 1,138 1,036
26-49 21,719 21,938 2,742 3,757 1,002 979
26-29 4,398 3,815 1,023 1,142 358 308
30-34 5,101 5,020 878 988 326 159
35-39 4,857 4,825 396 770 157 298
40-44 4,086 3,957 268 460 89 124
45-49 3,277 4,321 178 397 71 90
50 or Older 16,157 16,178 404 560 136 57
50-54 3,312 3,274 114 303 29 11
55-59 3,927 3,353 129 17 51 17
60-64 4,240 4,545 52 81 6 *
65 or Older 4,678 5,006 109 160 51 29
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 16.0 15.9 2.2 2.6 0.7 0.6
12-20 5.3 4.9 3.3 3.2 0.9 1.0
21 or Older 17.7 17.6 2.0 2.5 0.7 0.6
12-17 2.5 2.3 1.8 1.5 0.6 0.3
12-13 0.6 0.3 0.4 0.2 0.2 0.1
14-15 2.1 1.9 1.5 1.5 0.6 0.2
16-17 4.7 4.8 3.4 2.9 1.0 0.7
18 or Older 17.4 17.2 2.2 2.7 0.7 0.7
18-25 16.6 15.7 7.2 7.3 1.9 1.9
18-20 10.5 10.1 6.3 6.7 1.6 2.2
21-25 20.5 19.0 7.7 7.7 2.0 1.7
26 or Older 17.5 17.5 1.5 2.0 0.5 0.5
26-49 21.4 21.6 2.7 3.7 1.0 1.0
26-29 24.4 21.4 5.7 6.4 2.0 1.7
30-34 22.9 22.1 3.9 4.4 1.5 0.7
35-39 22.7 21.6 1.8 3.4 0.7 1.3
40-44 21.2 20.4 1.4 2.4 0.5 0.6
45-49 16.2 22.4 0.9 2.1 0.3 0.5
50 or Older 14.0 13.8 0.3 0.5 0.1 0.0
50-54 16.1 16.4 0.6 1.5 0.1 0.1
55-59 18.5 15.6 0.6 0.1 0.2 0.1
60-64 20.6 21.7 0.3 0.4 0.0 *
65 or Older 8.9 9.2 0.2 0.3 0.1 0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 25,090 26,749 2,142 2,390 807 904
12-20 3,124 3,254 967 848 259 158
21 or Older 21,966 23,495 1,175 1,541 548 746
12-17 2,202 2,327 743 683 216 106
12-13 675 760 285 247 85 24
14-15 827 874 266 232 69 51
16-17 699 693 192 204 63 31
18 or Older 22,889 24,422 1,399 1,707 591 797
18-25 3,099 2,929 577 507 157 160
18-20 922 927 224 165 43 51
21-25 2,176 2,002 353 341 114 109
26 or Older 19,790 21,493 822 1,200 434 637
26-49 11,893 12,957 623 1,062 332 563
26-29 1,957 2,059 184 325 73 164
30-34 2,671 2,802 167 179 101 71
35-39 2,574 2,723 133 268 56 143
40-44 2,440 2,639 81 97 47 34
45-49 2,252 2,733 59 192 54 151
50 or Older 7,897 8,536 199 139 102 75
50-54 2,035 2,057 63 15 15 1
55-59 2,059 2,052 47 41 37 27
60-64 1,963 2,338 * 52 * 16
65 or Older 1,839 2,089 89 30 50 30
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 9.1 9.7 0.8 0.9 0.3 0.3
12-20 8.2 8.7 2.5 2.3 0.7 0.4
21 or Older 9.3 9.8 0.5 0.6 0.2 0.3
12-17 8.8 9.3 3.0 2.7 0.9 0.4
12-13 8.3 9.0 3.5 2.9 1.0 0.3
14-15 9.8 10.1 3.1 2.7 0.8 0.6
16-17 8.5 8.8 2.3 2.6 0.8 0.4
18 or Older 9.1 9.7 0.6 0.7 0.2 0.3
18-25 9.2 8.7 1.7 1.5 0.5 0.5
18-20 7.0 7.4 1.7 1.3 0.3 0.4
21-25 10.6 9.5 1.7 1.6 0.6 0.5
26 or Older 9.1 9.8 0.4 0.5 0.2 0.3
26-49 11.7 12.8 0.6 1.0 0.3 0.6
26-29 10.8 11.6 1.0 1.8 0.4 0.9
30-34 12.0 12.3 0.7 0.8 0.5 0.3
35-39 12.0 12.2 0.6 1.2 0.3 0.6
40-44 12.7 13.6 0.4 0.5 0.2 0.2
45-49 11.1 14.1 0.3 1.0 0.3 0.8
50 or Older 6.8 7.3 0.2 0.1 0.1 0.1
50-54 9.9 10.3 0.3 0.1 0.1 0.0
55-59 9.7 9.5 0.2 0.2 0.2 0.1
60-64 9.5 11.2 * 0.2 * 0.1
65 or Older 3.5 3.8 0.2 0.1 0.1 0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 16,013 15,397 1,999 2,550 1,173 1,722
12-20 242 125 115 60 34 34
21 or Older 15,771 15,273 1,884 2,490 1,139 1,688
12-17 75 48 41 21 11 7
12-13 12 1 9 1 3 1
14-15 16 6 9 4 5 4
16-17 47 40 24 16 3 2
18 or Older 15,939 15,349 1,958 2,528 1,161 1,715
18-25 904 538 275 171 110 74
18-20 167 77 74 38 23 27
21-25 737 462 202 133 88 47
26 or Older 15,034 14,811 1,682 2,358 1,051 1,641
26-49 7,727 8,215 1,262 1,549 800 1,107
26-29 1,001 1,002 238 260 139 151
30-34 1,619 1,679 312 233 164 179
35-39 1,779 2,102 318 512 211 334
40-44 1,800 1,588 228 273 162 238
45-49 1,528 1,844 165 270 124 204
50 or Older 7,307 6,597 420 809 251 534
50-54 1,549 1,175 159 202 81 134
55-59 1,687 1,577 102 227 83 90
60-64 1,934 1,966 99 102 73 79
65 or Older 2,137 1,879 60 278 14 231
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 5.8 5.6 0.7 0.9 0.4 0.6
12-20 0.6 0.3 0.3 0.2 0.1 0.1
21 or Older 6.7 6.4 0.8 1.0 0.5 0.7
12-17 0.3 0.2 0.2 0.1 0.0 0.0
12-13 0.1 0.0 0.1 0.0 0.0 0.0
14-15 0.2 0.1 0.1 0.1 0.1 0.1
16-17 0.6 0.5 0.3 0.2 0.0 0.0
18 or Older 6.4 6.1 0.8 1.0 0.5 0.7
18-25 2.7 1.6 0.8 0.5 0.3 0.2
18-20 1.3 0.6 0.6 0.3 0.2 0.2
21-25 3.6 2.2 1.0 0.6 0.4 0.2
26 or Older 6.9 6.8 0.8 1.1 0.5 0.8
26-49 7.6 8.1 1.2 1.5 0.8 1.1
26-29 5.5 5.6 1.3 1.5 0.8 0.8
30-34 7.3 7.4 1.4 1.0 0.7 0.8
35-39 8.3 9.4 1.5 2.3 1.0 1.5
40-44 9.3 8.2 1.2 1.4 0.8 1.2
45-49 7.5 9.5 0.8 1.4 0.6 1.1
50 or Older 6.3 5.6 0.4 0.7 0.2 0.5
50-54 7.5 5.9 0.8 1.0 0.4 0.7
55-59 7.9 7.3 0.5 1.1 0.4 0.4
60-64 9.4 9.4 0.5 0.5 0.4 0.4
65 or Older 4.0 3.4 0.1 0.5 0.0 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.13A – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 82,559 75,198 9,724 9,254 2,819 2,536
12-20 7,054 5,543 1,143 781 301 162
21 or Older 75,505 69,655 8,582 8,474 2,518 2,374
12-17 3,980 3,079 567 396 165 96
12-13 950 710 112 84 36 16
14-15 1,400 1,166 176 130 51 42
16-17 1,630 1,203 278 183 77 38
18 or Older 78,579 72,118 9,158 8,858 2,654 2,440
18-25 8,357 6,858 1,754 1,361 420 288
18-20 3,074 2,463 576 385 136 66
21-25 5,284 4,395 1,178 976 284 222
26 or Older 70,222 65,261 7,404 7,498 2,234 2,152
26-49 30,585 26,783 4,797 4,535 1,370 1,264
26-29 5,089 3,898 1,023 795 322 231
30-34 6,752 5,650 1,205 943 325 191
35-39 6,459 5,927 1,074 946 277 236
40-44 5,992 4,880 802 727 205 218
45-49 6,292 6,429 693 1,125 241 388
50 or Older 39,637 38,477 2,607 2,962 864 888
50-54 6,674 6,084 646 567 227 138
55-59 7,169 7,373 638 682 208 194
60-64 7,325 7,285 422 682 197 266
65 or Older 18,470 17,735 900 1,032 232 289
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.13B – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 30.0 27.2 3.5 3.3 1.0 0.9
12-20 18.5 14.8 3.0 2.1 0.8 0.4
21 or Older 31.8 29.1 3.6 3.5 1.1 1.0
12-17 16.0 12.3 2.3 1.6 0.7 0.4
12-13 11.6 8.4 1.4 1.0 0.4 0.2
14-15 16.5 13.5 2.1 1.5 0.6 0.5
16-17 19.7 15.3 3.4 2.3 0.9 0.5
18 or Older 31.4 28.6 3.7 3.5 1.1 1.0
18-25 24.8 20.5 5.2 4.1 1.2 0.9
18-20 23.3 19.8 4.4 3.1 1.0 0.5
21-25 25.7 20.9 5.7 4.6 1.4 1.1
26 or Older 32.4 29.9 3.4 3.4 1.0 1.0
26-49 30.2 26.4 4.7 4.5 1.4 1.2
26-29 28.2 21.9 5.7 4.5 1.8 1.3
30-34 30.3 24.9 5.4 4.2 1.5 0.8
35-39 30.1 26.6 5.0 4.2 1.3 1.1
40-44 31.1 25.2 4.2 3.8 1.1 1.1
45-49 31.1 33.3 3.4 5.8 1.2 2.0
50 or Older 34.4 32.9 2.3 2.5 0.7 0.8
50-54 32.4 30.6 3.1 2.8 1.1 0.7
55-59 33.7 34.2 3.0 3.2 1.0 0.9
60-64 35.6 34.8 2.1 3.3 1.0 1.3
65 or Older 35.0 32.5 1.7 1.9 0.4 0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 18,290 18,332 4,929 5,092 1,566 1,493
12-20 3,339 2,793 1,093 769 301 131
21 or Older 14,950 15,539 3,835 4,323 1,265 1,363
12-17 1,837 1,593 430 288 123 72
12-13 378 389 24 29 3 3
14-15 619 526 119 103 38 19
16-17 841 678 287 157 82 51
18 or Older 16,453 16,739 4,499 4,804 1,443 1,421
18-25 4,320 3,773 1,951 1,616 587 267
18-20 1,502 1,199 664 481 178 58
21-25 2,818 2,574 1,287 1,135 409 209
26 or Older 12,133 12,966 2,548 3,188 856 1,154
26-49 8,105 8,086 2,247 2,640 754 1,072
26-29 1,998 1,841 695 718 198 193
30-34 2,134 2,195 748 835 253 327
35-39 1,588 1,634 410 529 147 260
40-44 1,230 1,159 263 332 114 141
45-49 1,156 1,257 130 226 43 152
50 or Older 4,028 4,880 301 548 102 82
50-54 865 1,464 72 295 5 65
55-59 1,096 962 128 117 38 5
60-64 727 754 66 78 59 13
65 or Older 1,340 1,700 34 58 * *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 6.6 6.6 1.8 1.8 0.6 0.5
12-20 8.8 7.5 2.9 2.1 0.8 0.3
21 or Older 6.3 6.5 1.6 1.8 0.5 0.6
12-17 7.4 6.4 1.7 1.2 0.5 0.3
12-13 4.6 4.6 0.3 0.3 0.0 0.0
14-15 7.3 6.1 1.4 1.2 0.5 0.2
16-17 10.2 8.6 3.5 2.0 1.0 0.6
18 or Older 6.6 6.6 1.8 1.9 0.6 0.6
18-25 12.8 11.3 5.8 4.8 1.7 0.8
18-20 11.4 9.6 5.0 3.9 1.3 0.5
21-25 13.7 12.2 6.3 5.4 2.0 1.0
26 or Older 5.6 5.9 1.2 1.5 0.4 0.5
26-49 8.0 8.0 2.2 2.6 0.7 1.1
26-29 11.1 10.3 3.9 4.0 1.1 1.1
30-34 9.6 9.7 3.4 3.7 1.1 1.4
35-39 7.4 7.3 1.9 2.4 0.7 1.2
40-44 6.4 6.0 1.4 1.7 0.6 0.7
45-49 5.7 6.5 0.6 1.2 0.2 0.8
50 or Older 3.5 4.2 0.3 0.5 0.1 0.1
50-54 4.2 7.4 0.3 1.5 0.0 0.3
55-59 5.2 4.5 0.6 0.5 0.2 0.0
60-64 3.5 3.6 0.3 0.4 0.3 0.1
65 or Older 2.5 3.1 0.1 0.1 * *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 44,051 43,001 5,895 6,205 1,958 2,196
12-20 2,564 2,102 909 641 231 109
21 or Older 41,488 40,899 4,986 5,564 1,727 2,088
12-17 1,370 936 436 226 121 26
12-13 276 234 24 33 10 2
14-15 435 340 124 70 34 12
16-17 659 362 287 122 78 13
18 or Older 42,682 42,065 5,459 5,979 1,837 2,170
18-25 3,995 3,805 1,409 1,237 365 371
18-20 1,194 1,166 473 415 110 82
21-25 2,801 2,638 936 822 254 289
26 or Older 38,687 38,261 4,050 4,742 1,472 1,799
26-49 16,129 16,192 2,582 3,175 1,006 1,053
26-29 2,519 2,301 600 662 230 171
30-34 3,428 2,957 743 648 318 177
35-39 3,305 3,509 514 721 180 294
40-44 3,363 3,603 413 552 181 233
45-49 3,514 3,823 312 593 97 179
50 or Older 22,558 22,068 1,468 1,567 467 746
50-54 3,575 3,642 358 325 106 114
55-59 4,234 3,911 408 479 151 250
60-64 4,133 4,209 378 350 103 119
65 or Older 10,615 10,306 325 412 106 262
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 16.0 15.5 2.1 2.2 0.7 0.8
12-20 6.7 5.6 2.4 1.7 0.6 0.3
21 or Older 17.5 17.1 2.1 2.3 0.7 0.9
12-17 5.5 3.7 1.8 0.9 0.5 0.1
12-13 3.4 2.8 0.3 0.4 0.1 0.0
14-15 5.1 3.9 1.5 0.8 0.4 0.1
16-17 8.0 4.6 3.5 1.6 0.9 0.2
18 or Older 17.1 16.7 2.2 2.4 0.7 0.9
18-25 11.8 11.4 4.2 3.7 1.1 1.1
18-20 9.1 9.4 3.6 3.3 0.8 0.7
21-25 13.6 12.5 4.6 3.9 1.2 1.4
26 or Older 17.9 17.5 1.9 2.2 0.7 0.8
26-49 15.9 15.9 2.5 3.1 1.0 1.0
26-29 14.0 12.9 3.3 3.7 1.3 1.0
30-34 15.4 13.0 3.3 2.9 1.4 0.8
35-39 15.4 15.7 2.4 3.2 0.8 1.3
40-44 17.4 18.6 2.1 2.8 0.9 1.2
45-49 17.3 19.8 1.5 3.1 0.5 0.9
50 or Older 19.6 18.9 1.3 1.3 0.4 0.6
50-54 17.3 18.3 1.7 1.6 0.5 0.6
55-59 19.9 18.2 1.9 2.2 0.7 1.2
60-64 20.1 20.1 1.8 1.7 0.5 0.6
65 or Older 20.1 18.9 0.6 0.8 0.2 0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 35,601 35,018 5,220 5,460 1,781 1,891
12-20 1,995 1,552 840 547 216 106
21 or Older 33,606 33,466 4,381 4,912 1,565 1,785
12-17 1,010 588 392 196 112 25
12-13 140 125 16 32 5 2
14-15 308 216 105 59 32 12
16-17 562 246 271 105 75 12
18 or Older 34,591 34,430 4,829 5,264 1,669 1,866
18-25 3,419 3,338 1,313 1,108 337 357
18-20 985 965 448 352 104 81
21-25 2,434 2,374 865 756 233 276
26 or Older 31,172 31,092 3,516 4,156 1,332 1,509
26-49 13,668 13,962 2,342 2,901 952 924
26-29 2,183 1,981 570 598 227 154
30-34 2,986 2,624 711 624 312 169
35-39 2,835 3,029 448 648 161 261
40-44 2,886 3,136 373 516 169 199
45-49 2,778 3,192 240 515 83 141
50 or Older 17,504 17,130 1,174 1,255 380 585
50-54 2,905 2,930 300 264 94 100
55-59 3,335 3,136 300 402 124 231
60-64 3,234 3,453 336 333 97 119
65 or Older 8,030 7,611 238 256 65 135
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 12.9 12.6 1.9 2.0 0.6 0.7
12-20 5.2 4.1 2.2 1.5 0.6 0.3
21 or Older 14.2 14.0 1.8 2.1 0.7 0.7
12-17 4.1 2.4 1.6 0.8 0.5 0.1
12-13 1.7 1.5 0.2 0.4 0.1 0.0
14-15 3.6 2.5 1.2 0.7 0.4 0.1
16-17 6.8 3.1 3.3 1.3 0.9 0.1
18 or Older 13.8 13.7 1.9 2.1 0.7 0.7
18-25 10.1 10.0 3.9 3.3 1.0 1.1
18-20 7.5 7.8 3.4 2.8 0.8 0.7
21-25 11.8 11.3 4.2 3.6 1.1 1.3
26 or Older 14.4 14.2 1.6 1.9 0.6 0.7
26-49 13.5 13.8 2.3 2.9 0.9 0.9
26-29 12.1 11.1 3.2 3.4 1.3 0.9
30-34 13.4 11.6 3.2 2.7 1.4 0.7
35-39 13.2 13.6 2.1 2.9 0.8 1.2
40-44 15.0 16.2 1.9 2.7 0.9 1.0
45-49 13.7 16.5 1.2 2.7 0.4 0.7
50 or Older 15.2 14.7 1.0 1.1 0.3 0.5
50-54 14.1 14.7 1.5 1.3 0.5 0.5
55-59 15.7 14.6 1.4 1.9 0.6 1.1
60-64 15.7 16.5 1.6 1.6 0.5 0.6
65 or Older 15.2 14.0 0.5 0.5 0.1 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 15,636 15,364 1,098 1,240 304 481
12-20 883 799 138 139 43 23
21 or Older 14,752 14,565 960 1,101 261 458
12-17 545 429 82 35 29 1
12-13 166 131 10 2 5 *
14-15 187 160 35 15 14 *
16-17 192 139 37 18 10 1
18 or Older 15,091 14,935 1,016 1,205 275 480
18-25 1,051 1,066 175 251 44 78
18-20 339 370 56 104 15 21
21-25 712 695 119 147 30 56
26 or Older 14,040 13,869 841 954 231 402
26-49 4,862 4,751 423 483 112 179
26-29 615 626 71 90 11 23
30-34 967 759 85 41 43 9
35-39 978 1,040 104 127 31 54
40-44 1,008 940 72 125 12 55
45-49 1,293 1,385 91 99 14 38
50 or Older 9,178 9,119 417 472 119 223
50-54 1,320 1,574 93 96 35 49
55-59 1,752 1,525 145 171 38 43
60-64 1,701 1,509 72 47 6 4
65 or Older 4,405 4,510 107 158 41 127
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past
Year
(2019)
Any Use in Past
Year
(2020)
Misuse in Past
Year
(2019)
Misuse in Past
Year
(2020)
Misuse in Past
Month
(2019)
Misuse in Past
Month
(2020)
TOTAL 5.7 5.5 0.4 0.4 0.1 0.2
12-20 2.3 2.1 0.4 0.4 0.1 0.1
21 or Older 6.2 6.1 0.4 0.5 0.1 0.2
12-17 2.2 1.7 0.3 0.1 0.1 0.0
12-13 2.0 1.6 0.1 0.0 0.1 *
14-15 2.2 1.8 0.4 0.2 0.2 *
16-17 2.3 1.8 0.4 0.2 0.1 0.0
18 or Older 6.0 5.9 0.4 0.5 0.1 0.2
18-25 3.1 3.2 0.5 0.7 0.1 0.2
18-20 2.6 3.0 0.4 0.8 0.1 0.2
21-25 3.5 3.3 0.6 0.7 0.1 0.3
26 or Older 6.5 6.3 0.4 0.4 0.1 0.2
26-49 4.8 4.7 0.4 0.5 0.1 0.2
26-29 3.4 3.5 0.4 0.5 0.1 0.1
30-34 4.3 3.3 0.4 0.2 0.2 0.0
35-39 4.6 4.7 0.5 0.6 0.1 0.2
40-44 5.2 4.9 0.4 0.6 0.1 0.3
45-49 6.4 7.2 0.5 0.5 0.1 0.2
50 or Older 8.0 7.8 0.4 0.4 0.1 0.2
50-54 6.4 7.9 0.4 0.5 0.2 0.2
55-59 8.2 7.1 0.7 0.8 0.2 0.2
60-64 8.3 7.2 0.4 0.2 0.0 0.0
65 or Older 8.3 8.3 0.2 0.3 0.1 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Any Use in Past Year
(2019)
Any Use in Past Year
(2020)
Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
TOTAL 29,408 27,026 4,841 4,779
12-20 1,619 1,259 817 504
21 or Older 27,789 25,766 4,024 4,275
12-17 749 418 381 157
12-13 78 52 14 10
14-15 215 163 107 59
16-17 455 203 259 88
18 or Older 28,659 26,607 4,460 4,622
18-25 2,983 2,861 1,266 1,097
18-20 870 841 436 347
21-25 2,113 2,019 830 749
26 or Older 25,676 23,747 3,194 3,526
26-49 11,285 10,816 2,169 2,608
26-29 1,850 1,628 550 542
30-34 2,617 2,160 683 538
35-39 2,268 2,339 399 573
40-44 2,343 2,407 312 496
45-49 2,207 2,282 225 457
50 or Older 14,391 12,931 1,026 918
50-54 2,384 2,003 251 199
55-59 2,705 2,428 269 290
60-64 2,629 2,654 268 255
65 or Older 6,673 5,846 238 174
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Any Use in Past Year
(2019)
Any Use in Past Year
(2020)
Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
TOTAL 10.7 9.8 1.8 1.7
12-20 4.3 3.4 2.1 1.3
21 or Older 11.7 10.8 1.7 1.8
12-17 3.0 1.7 1.5 0.6
12-13 1.0 0.6 0.2 0.1
14-15 2.5 1.9 1.3 0.7
16-17 5.5 2.6 3.1 1.1
18 or Older 11.4 10.6 1.8 1.8
18-25 8.8 8.5 3.8 3.3
18-20 6.6 6.8 3.3 2.8
21-25 10.3 9.6 4.0 3.6
26 or Older 11.9 10.9 1.5 1.6
26-49 11.1 10.7 2.1 2.6
26-29 10.2 9.1 3.0 3.0
30-34 11.7 9.5 3.1 2.4
35-39 10.6 10.5 1.9 2.6
40-44 12.2 12.4 1.6 2.6
45-49 10.9 11.8 1.1 2.4
50 or Older 12.5 11.1 0.9 0.8
50-54 11.6 10.1 1.2 1.0
55-59 12.7 11.3 1.3 1.3
60-64 12.8 12.7 1.3 1.2
65 or Older 12.6 10.7 0.5 0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.19A – Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
Misuse in Past Month
(2019)
Misuse in Past Month
(2020)
TOTAL 10,065 9,490 3,101 2,885
12-20 1,145 781 305 162
21 or Older 8,920 8,709 2,796 2,723
12-17 567 396 165 96
12-13 112 84 36 16
14-15 176 130 51 42
16-17 278 183 77 38
18 or Older 9,499 9,094 2,936 2,789
18-25 1,776 1,376 439 296
18-20 578 385 140 66
21-25 1,197 992 300 229
26 or Older 7,723 7,717 2,497 2,493
26-49 4,971 4,704 1,514 1,419
26-29 1,041 841 351 294
30-34 1,271 984 351 221
35-39 1,126 982 328 263
40-44 821 740 222 245
45-49 712 1,157 262 397
50 or Older 2,752 3,013 983 1,075
50-54 657 568 237 188
55-59 680 695 248 295
60-64 436 682 209 276
65 or Older 979 1,068 290 316
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.19B – Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
Misuse in Past Month
(2019)
Misuse in Past Month
(2020)
TOTAL 3.7 3.4 1.1 1.0
12-20 3.0 2.1 0.8 0.4
21 or Older 3.8 3.6 1.2 1.1
12-17 2.3 1.6 0.7 0.4
12-13 1.4 1.0 0.4 0.2
14-15 2.1 1.5 0.6 0.5
16-17 3.4 2.3 0.9 0.5
18 or Older 3.8 3.6 1.2 1.1
18-25 5.3 4.1 1.3 0.9
18-20 4.4 3.1 1.1 0.5
21-25 5.8 4.7 1.5 1.1
26 or Older 3.6 3.5 1.2 1.1
26-49 4.9 4.6 1.5 1.4
26-29 5.8 4.7 1.9 1.7
30-34 5.7 4.3 1.6 1.0
35-39 5.3 4.4 1.5 1.2
40-44 4.3 3.8 1.2 1.3
45-49 3.5 6.0 1.3 2.1
50 or Older 2.4 2.6 0.9 0.9
50-54 3.2 2.9 1.2 0.9
55-59 3.2 3.2 1.2 1.4
60-64 2.1 3.3 1.0 1.3
65 or Older 1.9 2.0 0.5 0.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.20A – Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
Misuse in Past Month
(2019)
Misuse in Past Month
(2020)
TOTAL 10,136 10,306 4,264 4,483
12-20 1,444 1,021 465 237
21 or Older 8,693 9,285 3,799 4,246
12-17 499 346 160 87
12-13 39 34 7 4
14-15 144 123 54 24
16-17 316 189 100 59
18 or Older 9,638 9,960 4,103 4,396
18-25 3,205 2,567 1,127 682
18-20 945 675 305 150
21-25 2,260 1,892 823 532
26 or Older 6,433 7,393 2,976 3,714
26-49 5,196 5,742 2,311 2,889
26-29 1,591 1,531 570 593
30-34 1,467 1,305 637 584
35-39 1,039 1,334 489 797
40-44 617 884 370 538
45-49 483 688 245 376
50 or Older 1,236 1,651 665 825
50-54 367 644 202 326
55-59 379 468 208 164
60-64 316 221 223 95
65 or Older 174 318 33 239
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.20B – Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Misuse in Past Year
(2019)
Misuse in Past Year
(2020)
Misuse in Past Month
(2019)
Misuse in Past Month
(2020)
TOTAL 3.7 3.7 1.5 1.6
12-20 3.8 2.7 1.2 0.6
21 or Older 3.7 3.9 1.6 1.8
12-17 2.0 1.4 0.6 0.3
12-13 0.5 0.4 0.1 0.0
14-15 1.7 1.4 0.6 0.3
16-17 3.8 2.4 1.2 0.7
18 or Older 3.9 4.0 1.6 1.7
18-25 9.5 7.7 3.3 2.0
18-20 7.2 5.4 2.3 1.2
21-25 11.0 9.0 4.0 2.5
26 or Older 3.0 3.4 1.4 1.7
26-49 5.1 5.7 2.3 2.8
26-29 8.8 8.6 3.2 3.3
30-34 6.6 5.7 2.9 2.6
35-39 4.9 6.0 2.3 3.6
40-44 3.2 4.6 1.9 2.8
45-49 2.4 3.6 1.2 1.9
50 or Older 1.1 1.4 0.6 0.7
50-54 1.8 3.2 1.0 1.6
55-59 1.8 2.2 1.0 0.8
60-64 1.5 1.1 1.1 0.5
65 or Older 0.3 0.6 0.1 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 23,588 23,962 9,333 9,305
12-20 3,788 3,077 1,224 799
21 or Older 19,800 20,885 8,110 8,506
12-17 1,862 1,507 598 305
12-13 425 359 141 48
14-15 590 513 165 113
16-17 848 635 292 144
18 or Older 21,727 22,455 8,735 9,000
18-25 5,791 5,169 2,059 1,600
18-20 1,926 1,570 626 494
21-25 3,865 3,598 1,433 1,106
26 or Older 15,936 17,286 6,676 7,400
26-49 11,025 11,693 4,650 5,034
26-29 2,888 2,743 1,132 1,144
30-34 2,966 2,861 1,266 965
35-39 2,169 2,419 926 1,138
40-44 1,625 1,628 685 847
45-49 1,377 2,042 641 940
50 or Older 4,911 5,593 2,026 2,366
50-54 1,257 1,468 504 597
55-59 1,224 1,434 512 689
60-64 996 1,133 518 416
65 or Older 1,433 1,557 493 665
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 8.6 8.7 3.4 3.4
12-20 9.9 8.2 3.2 2.1
21 or Older 8.3 8.7 3.4 3.6
12-17 7.5 6.0 2.4 1.2
12-13 5.2 4.3 1.7 0.6
14-15 6.9 5.9 1.9 1.3
16-17 10.3 8.1 3.5 1.8
18 or Older 8.7 8.9 3.5 3.6
18-25 17.2 15.4 6.1 4.8
18-20 14.6 12.6 4.8 4.0
21-25 18.8 17.1 7.0 5.3
26 or Older 7.4 7.9 3.1 3.4
26-49 10.9 11.5 4.6 5.0
26-29 16.0 15.4 6.3 6.4
30-34 13.3 12.6 5.7 4.2
35-39 10.1 10.8 4.3 5.1
40-44 8.4 8.4 3.6 4.4
45-49 6.8 10.6 3.2 4.9
50 or Older 4.3 4.8 1.8 2.0
50-54 6.1 7.4 2.4 3.0
55-59 5.8 6.7 2.4 3.2
60-64 4.8 5.4 2.5 2.0
65 or Older 2.7 2.9 0.9 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2019 and 2020
Prescription Drug/Age Group Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users
(2019)
Misuse
in Past Year
among
Past Year
Any Users
(2020)
PSYCHOTHERAPEUTICS 108,037 101,602 16,304 16,073 16,304 16,073
12-17 5,612 4,723 1,062 688 1,062 688
18 or Older 102,425 96,879 15,242 15,385 15,242 15,385
18-25 12,187 10,529 3,868 3,193 3,868 3,193
26 or Older 90,238 86,350 11,374 12,192 11,374 12,192
PAIN RELIEVERS 82,559 75,198 9,724 9,254 9,724 9,254
12-17 3,980 3,079 567 396 567 396
18 or Older 78,579 72,118 9,158 8,858 9,158 8,858
18-25 8,357 6,858 1,754 1,361 1,754 1,361
26 or Older 70,222 65,261 7,404 7,498 7,404 7,498
STIMULANTS 18,290 18,332 4,929 5,092 4,929 5,092
12-17 1,837 1,593 430 288 430 288
18 or Older 16,453 16,739 4,499 4,804 4,499 4,804
18-25 4,320 3,773 1,951 1,616 1,951 1,616
26 or Older 12,133 12,966 2,548 3,188 2,548 3,188
TRANQUILIZERS OR SEDATIVES 44,051 43,001 5,895 6,205 5,895 6,205
12-17 1,370 936 436 226 436 226
18 or Older 42,682 42,065 5,459 5,979 5,459 5,979
18-25 3,995 3,805 1,409 1,237 1,409 1,237
26 or Older 38,687 38,261 4,050 4,742 4,050 4,742
TRANQUILIZERS 35,601 35,018 5,220 5,460 5,220 5,460
12-17 1,010 588 392 196 392 196
18 or Older 34,591 34,430 4,829 5,264 4,829 5,264
18-25 3,419 3,338 1,313 1,108 1,313 1,108
26 or Older 31,172 31,092 3,516 4,156 3,516 4,156
SEDATIVES 15,636 15,364 1,098 1,240 1,098 1,240
12-17 545 429 82 35 82 35
18 or Older 15,091 14,935 1,016 1,205 1,016 1,205
18-25 1,051 1,066 175 251 175 251
26 or Older 14,040 13,869 841 954 841 954
BENZODIAZEPINES 29,408 27,026 4,841 4,779 4,841 4,779
12-17 749 418 381 157 381 *
18 or Older 28,659 26,607 4,460 4,622 4,460 4,622
18-25 2,983 2,861 1,266 1,097 1,266 1,097
26 or Older 25,676 23,747 3,194 3,526 3,194 3,526
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2019 and 2020
Prescription Drug/Age Group Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users
(2019)
Misuse
in Past Year
among
Past Year
Any Users
(2020)
PSYCHOTHERAPEUTICS 39.3 36.7 5.9 5.8 15.1 15.8
12-17 22.5 18.9 4.3 2.8 18.9 14.6
18 or Older 40.9 38.5 6.1 6.1 14.9 15.9
18-25 36.1 31.4 11.5 9.5 31.7 30.3
26 or Older 41.7 39.5 5.3 5.6 12.6 14.1
PAIN RELIEVERS 30.0 27.2 3.5 3.3 11.8 12.3
12-17 16.0 12.3 2.3 1.6 14.2 12.9
18 or Older 31.4 28.6 3.7 3.5 11.7 12.3
18-25 24.8 20.5 5.2 4.1 21.0 19.8
26 or Older 32.4 29.9 3.4 3.4 10.5 11.5
STIMULANTS 6.6 6.6 1.8 1.8 26.9 27.8
12-17 7.4 6.4 1.7 1.2 23.4 18.1
18 or Older 6.6 6.6 1.8 1.9 27.3 28.7
18-25 12.8 11.3 5.8 4.8 45.2 42.8
26 or Older 5.6 5.9 1.2 1.5 21.0 24.6
TRANQUILIZERS OR SEDATIVES 16.0 15.5 2.1 2.2 13.4 14.4
12-17 5.5 3.7 1.8 0.9 31.8 24.1
18 or Older 17.1 16.7 2.2 2.4 12.8 14.2
18-25 11.8 11.4 4.2 3.7 35.3 32.5
26 or Older 17.9 17.5 1.9 2.2 10.5 12.4
TRANQUILIZERS 12.9 12.6 1.9 2.0 14.7 15.6
12-17 4.1 2.4 1.6 0.8 38.8 33.3
18 or Older 13.8 13.7 1.9 2.1 14.0 15.3
18-25 10.1 10.0 3.9 3.3 38.4 33.2
26 or Older 14.4 14.2 1.6 1.9 11.3 13.4
SEDATIVES 5.7 5.5 0.4 0.4 7.0 8.1
12-17 2.2 1.7 0.3 0.1 15.1 8.1
18 or Older 6.0 5.9 0.4 0.5 6.7 8.1
18-25 3.1 3.2 0.5 0.7 16.6 23.5
26 or Older 6.5 6.3 0.4 0.4 6.0 6.9
BENZODIAZEPINES 10.7 9.8 1.8 1.7 16.5 17.7
12-17 3.0 1.7 1.5 0.6 50.9 *
18 or Older 11.4 10.6 1.8 1.8 15.6 17.4
18-25 8.8 8.5 3.8 3.3 42.4 38.3
26 or Older 11.9 10.9 1.5 1.6 12.4 14.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 138,027 138,543 6,090 5,229 131,937 133,314 18,832 17,879 113,104 115,435
GENDER                    
Male 72,406 70,362 3,015 2,406 69,390 67,957 9,451 8,624 59,939 59,332
Female 65,621 68,181 3,075 2,823 62,546 65,358 9,381 9,255 53,165 56,103
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 118,981 119,274 4,505 3,877 114,476 115,397 14,881 14,325 99,595 101,072
White 94,912 95,781 3,122 2,752 91,790 93,029 10,891 10,566 80,899 82,463
Black or African American 15,581 15,491 856 627 14,725 14,863 2,449 2,267 12,276 12,596
AIAN 871 1,056 65 * 806 936 139 * 667 *
NHOPI 481 * * * 449 * * * 386 *
Asian 3,805 3,404 169 235 3,636 3,169 737 672 2,899 2,497
Two or More Races 3,331 3,218 261 131 3,070 3,087 601 669 2,469 2,418
Hispanic or Latino 19,046 19,269 1,585 1,352 17,461 17,917 3,952 3,554 13,509 14,363
EDUCATION LEVEL                    
< High School da da da da 12,295 11,139 2,341 1,524 9,953 9,615
High School Graduate da da da da 29,913 35,032 5,528 5,203 24,384 29,828
Some College/Associate’s Degree da da da da 45,346 44,402 7,868 7,943 37,478 36,460
College Graduate da da da da 44,383 42,741 3,094 3,209 41,289 39,532
EMPLOYMENT STATUS                    
Full-Time da da da da 72,662 68,078 9,025 7,574 63,637 60,504
Part-Time da da da da 18,201 17,264 4,539 4,729 13,663 12,534
Unemployed da da da da 5,717 7,094 1,750 1,822 3,967 5,272
Other1 da da da da 35,357 40,879 3,519 3,754 31,838 37,125
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 50.2 50.0 24.5 20.9 52.7 52.9 55.8 53.4 52.2 52.8
GENDER                    
Male 54.2 52.4 23.8 18.9 57.4 55.9 55.9 51.4 57.7 56.6
Female 46.3 47.8 25.2 23.0 48.3 50.2 55.7 55.3 47.2 49.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 52.2 52.2 24.1 20.8 54.8 55.0 57.1 55.6 54.4 54.9
White 55.6 56.1 24.3 21.5 58.2 58.9 60.4 59.0 57.9 58.9
Black or African American 46.9 46.1 25.5 20.1 49.3 48.7 52.8 49.3 48.6 48.6
AIAN 55.7 63.7 37.5 * 58.0 65.0 64.0 * 56.8 *
NHOPI 44.0 * * * 45.5 * * * 46.4 *
Asian 24.0 21.0 12.9 12.6 24.9 22.1 35.3 33.8 23.2 20.2
Two or More Races 62.6 60.6 27.9 21.2 70.0 65.8 64.0 64.6 71.6 66.2
Hispanic or Latino 40.1 39.8 25.6 21.4 42.3 42.6 51.6 46.0 40.2 41.8
EDUCATION LEVEL                    
< High School da da da da 40.8 38.5 50.0 39.8 39.1 38.4
High School Graduate da da da da 49.2 50.4 52.1 48.5 48.6 50.8
Some College/Associate’s Degree da da da da 58.9 58.1 58.3 56.8 59.0 58.4
College Graduate da da da da 53.9 55.4 62.7 64.7 53.3 54.8
EMPLOYMENT STATUS                    
Full-Time da da da da 58.5 58.4 62.9 59.6 57.9 58.2
Part-Time da da da da 55.8 55.2 54.4 55.2 56.3 55.2
Unemployed da da da da 57.6 55.1 53.1 53.8 59.8 55.6
Other1 da da da da 42.3 44.8 45.4 42.5 42.0 45.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 57,203 59,277 4,279 3,436 52,924 55,841 13,193 12,398 39,731 43,443
GENDER                    
Male 31,742 31,069 2,103 1,610 29,639 29,459 6,823 6,094 22,817 23,365
Female 25,461 28,208 2,176 1,826 23,285 26,382 6,371 6,303 16,914 20,078
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 48,158 50,108 3,098 2,562 45,059 47,547 10,475 10,228 34,584 37,319
White 37,036 38,499 2,180 1,909 34,856 36,590 7,562 7,580 27,294 29,011
Black or African American 7,277 7,786 582 353 6,696 7,433 1,822 1,695 4,874 5,738
AIAN 393 536 49 * 344 487 88 * 256 *
NHOPI 173 80 * * 154 68 * * 103 *
Asian 1,581 1,569 77 145 1,504 1,424 523 395 981 1,029
Two or More Races 1,697 1,638 192 94 1,505 1,545 430 458 1,076 1,086
Hispanic or Latino 9,045 9,169 1,180 874 7,865 8,295 2,718 2,170 5,147 6,125
EDUCATION LEVEL                    
< High School da da da da 5,878 5,320 1,715 1,108 4,162 4,211
High School Graduate da da da da 12,518 14,976 3,906 3,398 8,612 11,578
Some College/Associate’s Degree da da da da 19,068 19,831 5,578 5,713 13,490 14,118
College Graduate da da da da 15,460 15,715 1,994 2,178 13,466 13,537
EMPLOYMENT STATUS                    
Full-Time da da da da 28,663 27,799 6,028 5,082 22,635 22,717
Part-Time da da da da 7,875 8,757 3,330 3,391 4,545 5,366
Unemployed da da da da 3,342 4,094 1,328 1,385 2,014 2,708
Other1 da da da da 13,044 15,191 2,507 2,540 10,537 12,651
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 20.8 21.4 17.2 13.8 21.1 22.2 39.1 37.0 18.3 19.9
GENDER                    
Male 23.8 23.1 16.6 12.7 24.5 24.2 40.4 36.3 21.9 22.3
Female 18.0 19.8 17.8 14.9 18.0 20.3 37.9 37.7 15.0 17.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 21.1 21.9 16.6 13.7 21.6 22.7 40.2 39.7 18.9 20.3
White 21.7 22.5 17.0 14.9 22.1 23.2 41.9 42.3 19.5 20.7
Black or African American 21.9 23.2 17.3 11.3 22.4 24.4 39.3 36.9 19.3 22.2
AIAN 25.1 32.3 28.2 * 24.7 33.8 40.5 * 21.8 *
NHOPI 15.8 8.0 * * 15.6 7.0 * * 12.4 *
Asian 10.0 9.7 5.9 7.8 10.3 9.9 25.0 19.9 7.9 8.3
Two or More Races 31.9 30.9 20.5 15.2 34.3 32.9 45.8 44.3 31.2 29.7
Hispanic or Latino 19.1 19.0 19.0 13.9 19.1 19.7 35.5 28.1 15.3 17.8
EDUCATION LEVEL                    
< High School da da da da 19.5 18.4 36.6 29.0 16.3 16.8
High School Graduate da da da da 20.6 21.6 36.8 31.7 17.2 19.7
Some College/Associate’s Degree da da da da 24.7 25.9 41.3 40.9 21.2 22.6
College Graduate da da da da 18.8 20.4 40.4 43.9 17.4 18.8
EMPLOYMENT STATUS                    
Full-Time da da da da 23.1 23.8 42.0 40.0 20.6 21.9
Part-Time da da da da 24.2 28.0 39.9 39.6 18.7 23.6
Unemployed da da da da 33.7 31.8 40.3 40.9 30.3 28.6
Other1 da da da da 15.6 16.7 32.3 28.7 13.9 15.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 35,803 37,309 2,167 1,679 33,636 35,630 8,406 8,016 25,231 27,614
GENDER                    
Male 20,669 20,063 1,124 903 19,545 19,160 4,474 4,082 15,071 15,077
Female 15,135 17,245 1,043 776 14,091 16,470 3,932 3,933 10,160 12,537
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 30,528 31,978 1,540 1,241 28,988 30,737 6,726 6,625 22,262 24,112
White 23,228 24,317 1,086 915 22,142 23,402 4,766 4,845 17,376 18,557
Black or African American 4,866 5,299 287 168 4,579 5,131 1,280 1,251 3,299 3,880
AIAN 227 441 22 * 205 * 50 * 155 *
NHOPI 122 44 * * 109 41 * * 86 *
Asian 888 760 29 62 859 698 304 191 555 507
Two or More Races 1,197 1,117 103 50 1,094 1,067 303 297 791 770
Hispanic or Latino 5,275 5,331 627 438 4,648 4,893 1,680 1,390 2,969 3,502
EDUCATION LEVEL                    
< High School da da da da 3,818 3,558 1,151 771 2,667 2,788
High School Graduate da da da da 8,429 10,168 2,519 2,335 5,909 7,833
Some College/Associate’s Degree da da da da 12,505 12,957 3,589 3,620 8,916 9,338
College Graduate da da da da 8,884 8,946 1,146 1,291 7,739 7,655
EMPLOYMENT STATUS                    
Full-Time da da da da 17,793 17,293 3,897 3,318 13,896 13,976
Part-Time da da da da 4,883 5,462 2,044 2,062 2,839 3,400
Unemployed da da da da 2,455 2,985 913 1,004 1,542 1,981
Other1 da da da da 8,505 9,889 1,551 1,632 6,954 8,257
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 13.0 13.5 8.7 6.7 13.4 14.1 24.9 23.9 11.6 12.6
GENDER                    
Male 15.5 14.9 8.9 7.1 16.2 15.7 26.5 24.3 14.5 14.4
Female 10.7 12.1 8.5 6.3 10.9 12.6 23.4 23.5 9.0 11.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 13.4 14.0 8.2 6.6 13.9 14.6 25.8 25.7 12.2 13.1
White 13.6 14.2 8.5 7.1 14.0 14.8 26.4 27.0 12.4 13.3
Black or African American 14.6 15.8 8.5 5.4 15.3 16.8 27.6 27.2 13.1 15.0
AIAN 14.5 26.6 12.8 * 14.8 * 23.0 * 13.2 *
NHOPI 11.1 4.4 * * 11.0 4.3 * * 10.3 *
Asian 5.6 4.7 2.2 3.4 5.9 4.9 14.5 9.6 4.4 4.1
Two or More Races 22.5 21.0 11.0 8.1 24.9 22.7 32.2 28.7 23.0 21.1
Hispanic or Latino 11.1 11.0 10.1 6.9 11.3 11.6 21.9 18.0 8.8 10.2
EDUCATION LEVEL                    
< High School da da da da 12.7 12.3 24.6 20.1 10.5 11.1
High School Graduate da da da da 13.9 14.6 23.7 21.8 11.8 13.3
Some College/Associate’s Degree da da da da 16.2 16.9 26.6 25.9 14.0 14.9
College Graduate da da da da 10.8 11.6 23.2 26.0 10.0 10.6
EMPLOYMENT STATUS                    
Full-Time da da da da 14.3 14.8 27.2 26.1 12.6 13.5
Part-Time da da da da 15.0 17.5 24.5 24.1 11.7 15.0
Unemployed da da da da 24.7 23.2 27.7 29.6 23.2 20.9
Other1 da da da da 10.2 10.8 20.0 18.5 9.2 10.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 127,139 126,504 3,947 3,103 123,192 123,401 17,450 16,604 105,742 106,797
GENDER                    
Male 67,085 64,536 1,985 1,438 65,099 63,097 8,753 8,046 56,346 55,051
Female 60,054 61,968 1,961 1,664 58,093 60,304 8,697 8,558 49,396 51,746
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 110,720 109,823 2,810 2,229 107,910 107,594 13,835 13,242 94,075 94,352
White 88,899 88,604 1,987 1,633 86,912 86,971 10,194 9,877 76,717 77,094
Black or African American 14,305 14,213 516 327 13,788 13,886 2,253 2,102 11,535 11,784
AIAN 770 913 44 * 726 * 126 * 600 *
NHOPI 444 * * * 422 * * * 366 *
Asian 3,211 2,812 73 122 3,138 2,690 648 530 2,490 2,160
Two or More Races 3,091 2,985 168 95 2,924 2,890 557 619 2,367 2,271
Hispanic or Latino 16,419 16,681 1,137 873 15,282 15,807 3,615 3,362 11,666 12,445
EDUCATION LEVEL                    
< High School da da da da 10,805 9,487 2,112 1,337 8,693 8,150
High School Graduate da da da da 28,233 32,844 5,135 4,858 23,099 27,985
Some College/Associate’s Degree da da da da 42,869 41,563 7,306 7,374 35,563 34,189
College Graduate da da da da 41,285 39,507 2,897 3,034 38,388 36,473
EMPLOYMENT STATUS                    
Full-Time da da da da 68,319 63,702 8,501 7,118 59,818 56,584
Part-Time da da da da 16,984 15,982 4,122 4,458 12,862 11,524
Unemployed da da da da 5,444 6,539 1,645 1,697 3,799 4,842
Other1 da da da da 32,444 37,178 3,182 3,331 29,262 33,847
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 46.2 45.7 15.8 12.4 49.2 49.0 51.7 49.6 48.8 48.9
GENDER                    
Male 50.2 48.0 15.7 11.3 53.9 51.9 51.8 48.0 54.2 52.5
Female 42.4 43.5 16.0 13.6 44.9 46.3 51.7 51.2 43.9 45.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 48.6 48.1 15.0 11.9 51.6 51.3 53.1 51.4 51.4 51.3
White 52.1 51.9 15.5 12.7 55.1 55.1 56.5 55.1 54.9 55.1
Black or African American 43.0 42.3 15.4 10.5 46.1 45.5 48.6 45.7 45.7 45.5
AIAN 49.2 55.0 25.3 * 52.2 * 57.9 * 51.1 *
NHOPI 40.7 * * * 42.7 * * * 44.1 *
Asian 20.2 17.4 5.5 6.6 21.5 18.8 31.0 26.7 19.9 17.5
Two or More Races 58.1 56.2 18.0 15.4 66.7 61.6 59.3 59.8 68.7 62.1
Hispanic or Latino 34.6 34.5 18.3 13.8 37.0 37.6 47.2 43.5 34.7 36.2
EDUCATION LEVEL                    
< High School da da da da 35.8 32.8 45.1 34.9 34.1 32.5
High School Graduate da da da da 46.5 47.3 48.4 45.3 46.1 47.6
Some College/Associate’s Degree da da da da 55.6 54.4 54.1 52.8 56.0 54.7
College Graduate da da da da 50.1 51.2 58.7 61.2 49.6 50.6
EMPLOYMENT STATUS                    
Full-Time da da da da 55.0 54.6 59.3 56.0 54.5 54.5
Part-Time da da da da 52.1 51.1 49.4 52.1 53.0 50.7
Unemployed da da da da 54.8 50.8 50.0 50.1 57.2 51.1
Other1 da da da da 38.8 40.8 41.0 37.7 38.6 41.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 48,242 49,634 3,284 2,531 44,958 47,103 11,952 11,566 33,007 35,537
GENDER                    
Male 27,222 26,773 1,649 1,205 25,573 25,568 6,173 5,730 19,400 19,838
Female 21,020 22,861 1,635 1,326 19,386 21,535 5,779 5,837 13,607 15,698
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 41,018 42,216 2,343 1,897 38,676 40,319 9,548 9,535 29,128 30,784
White 31,448 32,532 1,671 1,428 29,778 31,105 6,870 7,059 22,908 24,045
Black or African American 6,406 6,518 426 250 5,979 6,268 1,714 1,603 4,265 4,665
AIAN 314 436 31 * 283 * 72 * 211 *
NHOPI 162 67 * * 144 55 * * 101 *
Asian 1,207 1,216 52 93 1,155 1,123 453 374 702 749
Two or More Races 1,481 1,447 144 75 1,336 1,372 395 414 941 957
Hispanic or Latino 7,223 7,418 941 634 6,283 6,784 2,404 2,032 3,879 4,753
EDUCATION LEVEL                    
< High School da da da da 4,723 4,023 1,535 976 3,188 3,047
High School Graduate da da da da 10,638 12,818 3,530 3,207 7,109 9,611
Some College/Associate’s Degree da da da da 16,585 17,218 5,079 5,403 11,506 11,815
College Graduate da da da da 13,013 13,045 1,809 1,981 11,204 11,064
EMPLOYMENT STATUS                    
Full-Time da da da da 24,661 23,655 5,520 4,671 19,141 18,984
Part-Time da da da da 6,832 7,442 2,982 3,257 3,850 4,185
Unemployed da da da da 2,913 3,771 1,223 1,344 1,690 2,428
Other1 da da da da 10,552 12,235 2,226 2,295 8,326 9,940
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 17.5 17.9 13.2 10.1 18.0 18.7 35.4 34.5 15.2 16.3
GENDER                    
Male 20.4 19.9 13.0 9.5 21.2 21.0 36.5 34.2 18.7 18.9
Female 14.8 16.0 13.4 10.8 15.0 16.5 34.3 34.9 12.1 13.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 18.0 18.5 12.5 10.2 18.5 19.2 36.6 37.0 15.9 16.7
White 18.4 19.1 13.0 11.1 18.9 19.7 38.1 39.4 16.4 17.2
Black or African American 19.3 19.4 12.7 8.0 20.0 20.6 37.0 34.9 16.9 18.0
AIAN 20.1 26.3 17.9 * 20.4 * 33.2 * 18.0 *
NHOPI 14.8 6.7 * * 14.6 5.6 * * 12.2 *
Asian 7.6 7.5 4.0 5.0 7.9 7.8 21.7 18.8 5.6 6.1
Two or More Races 27.8 27.3 15.4 12.2 30.5 29.2 42.1 40.0 27.3 26.2
Hispanic or Latino 15.2 15.3 15.2 10.0 15.2 16.1 31.4 26.3 11.5 13.8
EDUCATION LEVEL                    
< High School da da da da 15.7 13.9 32.8 25.5 12.5 12.2
High School Graduate da da da da 17.5 18.4 33.3 29.9 14.2 16.4
Some College/Associate’s Degree da da da da 21.5 22.5 37.6 38.6 18.1 18.9
College Graduate da da da da 15.8 16.9 36.6 39.9 14.5 15.3
EMPLOYMENT STATUS                    
Full-Time da da da da 19.9 20.3 38.5 36.8 17.4 18.3
Part-Time da da da da 21.0 23.8 35.7 38.0 15.9 18.4
Unemployed da da da da 29.3 29.3 37.2 39.7 25.5 25.6
Other1 da da da da 12.6 13.4 28.7 26.0 11.0 12.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 31,606 32,784 1,837 1,472 29,769 31,312 7,749 7,727 22,020 23,585
GENDER                    
Male 18,614 17,930 981 789 17,632 17,141 4,171 3,925 13,461 13,216
Female 12,993 14,854 856 683 12,137 14,171 3,578 3,802 8,559 10,369
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 27,085 28,133 1,307 1,060 25,778 27,073 6,234 6,386 19,544 20,687
White 20,464 21,274 934 801 19,531 20,472 4,397 4,647 15,133 15,825
Black or African American 4,565 4,788 238 118 4,327 4,670 1,248 1,216 3,078 3,454
AIAN 188 * 19 * 169 * 45 * 124 *
NHOPI 116 40 * * 104 37 * * 86 *
Asian 703 642 26 60 676 582 259 188 417 394
Two or More Races 1,049 1,025 77 48 972 977 266 294 706 682
Hispanic or Latino 4,521 4,651 531 411 3,991 4,240 1,515 1,341 2,475 2,899
EDUCATION LEVEL                    
< High School da da da da 3,368 2,942 1,052 728 2,316 2,215
High School Graduate da da da da 7,573 9,235 2,376 2,275 5,197 6,960
Some College/Associate’s Degree da da da da 11,239 11,534 3,315 3,524 7,924 8,010
College Graduate da da da da 7,590 7,601 1,007 1,201 6,583 6,400
EMPLOYMENT STATUS                    
Full-Time da da da da 15,908 15,068 3,614 3,171 12,293 11,897
Part-Time da da da da 4,429 4,853 1,894 2,029 2,535 2,824
Unemployed da da da da 2,100 2,827 845 962 1,254 1,865
Other1 da da da da 7,332 8,564 1,395 1,565 5,938 6,999
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 11.5 11.8 7.4 5.9 11.9 12.4 23.0 23.1 10.2 10.8
GENDER                    
Male 13.9 13.3 7.7 6.2 14.6 14.1 24.7 23.4 12.9 12.6
Female 9.2 10.4 7.0 5.6 9.4 10.9 21.3 22.7 7.6 9.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 11.9 12.3 7.0 5.7 12.3 12.9 23.9 24.8 10.7 11.2
White 12.0 12.5 7.3 6.3 12.4 13.0 24.4 25.9 10.8 11.3
Black or African American 13.7 14.2 7.1 3.8 14.5 15.3 26.9 26.5 12.2 13.3
AIAN 12.0 * 11.1 * 12.1 * 20.8 * 10.5 *
NHOPI 10.6 4.0 * * 10.5 3.8 * * 10.3 *
Asian 4.4 4.0 2.0 3.2 4.6 4.1 12.4 9.4 3.3 3.2
Two or More Races 19.7 19.3 8.3 7.7 22.2 20.8 28.3 28.5 20.5 18.7
Hispanic or Latino 9.5 9.6 8.6 6.5 9.7 10.1 19.8 17.4 7.4 8.4
EDUCATION LEVEL                    
< High School da da da da 11.2 10.2 22.5 19.0 9.1 8.8
High School Graduate da da da da 12.5 13.3 22.4 21.2 10.4 11.8
Some College/Associate’s Degree da da da da 14.6 15.1 24.6 25.2 12.5 12.8
College Graduate da da da da 9.2 9.9 20.4 24.2 8.5 8.9
EMPLOYMENT STATUS                    
Full-Time da da da da 12.8 12.9 25.2 25.0 11.2 11.5
Part-Time da da da da 13.6 15.5 22.7 23.7 10.5 12.4
Unemployed da da da da 21.1 22.0 25.7 28.4 18.9 19.7
Other1 da da da da 8.8 9.4 18.0 17.7 7.8 8.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 41,445 39,261 154 105 41,291 39,155 3,809 3,065 37,483 36,091
GENDER                    
Male 24,493 23,060 73 66 24,419 22,994 2,073 1,699 22,346 21,295
Female 16,952 16,200 80 39 16,872 16,161 1,736 1,366 15,136 14,796
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 36,131 34,135 109 70 36,022 34,064 3,018 2,523 33,004 31,541
White 31,300 29,498 86 50 31,214 29,448 2,587 2,237 28,627 27,211
Black or African American 2,829 2,926 10 * 2,820 2,926 133 135 2,687 2,792
AIAN 218 264 * * 217 256 25 * 192 253
NHOPI 111 52 * * 111 52 * * 100 *
Asian 598 502 6 7 592 495 118 36 474 460
Two or More Races 1,075 892 7 6 1,068 886 144 112 924 774
Hispanic or Latino 5,313 5,126 44 35 5,269 5,091 790 541 4,479 4,550
EDUCATION LEVEL                    
< High School da da da da 3,885 3,431 391 193 3,494 3,238
High School Graduate da da da da 9,961 11,064 1,031 818 8,930 10,246
Some College/Associate’s Degree da da da da 14,752 13,767 1,597 1,316 13,156 12,451
College Graduate da da da da 12,693 10,893 790 737 11,903 10,156
EMPLOYMENT STATUS                    
Full-Time da da da da 22,774 20,390 2,082 1,565 20,693 18,825
Part-Time da da da da 5,373 4,880 805 548 4,568 4,332
Unemployed da da da da 1,982 2,308 355 396 1,627 1,913
Other1 da da da da 11,162 11,577 567 556 10,595 11,021
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 15.1 14.2 0.6 0.4 16.5 15.5 11.3 9.1 17.3 16.5
GENDER                    
Male 18.3 17.2 0.6 0.5 20.2 18.9 12.3 10.1 21.5 20.3
Female 12.0 11.4 0.7 0.3 13.0 12.4 10.3 8.2 13.4 13.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15.9 14.9 0.6 0.4 17.2 16.2 11.6 9.8 18.0 17.1
White 18.3 17.3 0.7 0.4 19.8 18.6 14.3 12.5 20.5 19.4
Black or African American 8.5 8.7 0.3 * 9.4 9.6 2.9 2.9 10.6 10.8
AIAN 14.0 15.9 * * 15.6 17.8 11.4 * 16.4 20.2
NHOPI 10.2 5.2 * * 11.2 5.4 * * 12.0 *
Asian 3.8 3.1 0.4 0.4 4.1 3.5 5.7 1.8 3.8 3.7
Two or More Races 20.2 16.8 0.7 1.0 24.4 18.9 15.4 10.8 26.8 21.2
Hispanic or Latino 11.2 10.6 0.7 0.5 12.8 12.1 10.3 7.0 13.3 13.2
EDUCATION LEVEL                    
< High School da da da da 12.9 11.9 8.4 5.1 13.7 12.9
High School Graduate da da da da 16.4 15.9 9.7 7.6 17.8 17.4
Some College/Associate’s Degree da da da da 19.1 18.0 11.8 9.4 20.7 19.9
College Graduate da da da da 15.4 14.1 16.0 14.9 15.4 14.1
EMPLOYMENT STATUS                    
Full-Time da da da da 18.3 17.5 14.5 12.3 18.8 18.1
Part-Time da da da da 16.5 15.6 9.6 6.4 18.8 19.1
Unemployed da da da da 20.0 17.9 10.8 11.7 24.5 20.2
Other1 da da da da 13.4 12.7 7.3 6.3 14.0 13.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,468 5,172 97 84 5,371 5,088 1,789 1,441 3,582 3,646
GENDER                    
Male 3,382 3,315 46 51 3,336 3,263 1,014 802 2,322 2,461
Female 2,086 1,857 51 33 2,035 1,824 774 639 1,260 1,185
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,498 4,344 66 52 4,432 4,292 1,380 1,152 3,051 3,140
White 3,587 3,564 48 38 3,539 3,526 1,179 1,001 2,359 2,525
Black or African American 521 405 7 * 514 405 59 77 455 328
AIAN 22 50 * * 22 * 6 * 15 *
NHOPI 31 0 * * 31 0 * * 27 *
Asian 174 149 6 4 168 145 62 4 106 140
Two or More Races 163 176 6 2 158 174 69 67 88 107
Hispanic or Latino 970 828 30 32 939 796 408 290 531 506
EDUCATION LEVEL                    
< High School da da da da 551 458 125 120 426 338
High School Graduate da da da da 1,362 1,280 447 410 915 870
Some College/Associate’s Degree da da da da 2,037 1,644 840 570 1,197 1,075
College Graduate da da da da 1,421 1,706 376 342 1,045 1,365
EMPLOYMENT STATUS                    
Full-Time da da da da 2,963 2,734 942 722 2,021 2,012
Part-Time da da da da 768 623 406 218 363 405
Unemployed da da da da 391 664 160 251 232 413
Other1 da da da da 1,249 1,067 282 250 967 817
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2.0 1.9 0.4 0.3 2.1 2.0 5.3 4.3 1.7 1.7
GENDER                    
Male 2.5 2.5 0.4 0.4 2.8 2.7 6.0 4.8 2.2 2.3
Female 1.5 1.3 0.4 0.3 1.6 1.4 4.6 3.8 1.1 1.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.0 1.9 0.4 0.3 2.1 2.0 5.3 4.5 1.7 1.7
White 2.1 2.1 0.4 0.3 2.2 2.2 6.5 5.6 1.7 1.8
Black or African American 1.6 1.2 0.2 * 1.7 1.3 1.3 1.7 1.8 1.3
AIAN 1.4 3.0 * * 1.6 * 3.0 * 1.3 *
NHOPI 2.8 0.0 * * 3.1 0.0 * * 3.2 *
Asian 1.1 0.9 0.4 0.2 1.2 1.0 3.0 0.2 0.9 1.1
Two or More Races 3.1 3.3 0.6 0.3 3.6 3.7 7.4 6.5 2.6 2.9
Hispanic or Latino 2.0 1.7 0.5 0.5 2.3 1.9 5.3 3.7 1.6 1.5
EDUCATION LEVEL                    
< High School da da da da 1.8 1.6 2.7 3.1 1.7 1.3
High School Graduate da da da da 2.2 1.8 4.2 3.8 1.8 1.5
Some College/Associate’s Degree da da da da 2.6 2.2 6.2 4.1 1.9 1.7
College Graduate da da da da 1.7 2.2 7.6 6.9 1.3 1.9
EMPLOYMENT STATUS                    
Full-Time da da da da 2.4 2.3 6.6 5.7 1.8 1.9
Part-Time da da da da 2.4 2.0 4.9 2.5 1.5 1.8
Unemployed da da da da 3.9 5.2 4.8 7.4 3.5 4.4
Other1 da da da da 1.5 1.2 3.6 2.8 1.3 1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,998 1,831 34 11 1,965 1,821 540 424 1,425 1,396
GENDER                    
Male 1,221 1,157 17 * 1,204 1,157 297 193 906 964
Female 777 674 16 10 761 664 242 231 519 433
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,655 1,500 20 11 1,635 1,490 416 324 1,219 1,166
White 1,245 1,119 14 10 1,231 1,109 352 288 879 821
Black or African American 292 154 3 * 289 154 21 12 268 142
AIAN 6 * * * 6 * 0 * 5 *
NHOPI 2 * * * 2 * * * 2 *
Asian 73 101 3 * 70 101 21 * 49 101
Two or More Races 38 108 * 1 38 108 23 * 15 85
Hispanic or Latino 343 331 14 * 329 331 123 101 206 230
EDUCATION LEVEL                    
< High School da da da da 201 225 34 46 167 179
High School Graduate da da da da 611 421 140 122 470 299
Some College/Associate’s Degree da da da da 668 554 274 132 394 422
College Graduate da da da da 485 621 91 125 394 497
EMPLOYMENT STATUS                    
Full-Time da da da da 995 1,039 285 250 710 788
Part-Time da da da da 319 243 137 80 182 163
Unemployed da da da da 154 191 33 58 121 134
Other1 da da da da 497 348 85 36 412 312
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.7 0.1 0.0 0.8 0.7 1.6 1.3 0.7 0.6
GENDER                    
Male 0.9 0.9 0.1 * 1.0 1.0 1.8 1.2 0.9 0.9
Female 0.5 0.5 0.1 0.1 0.6 0.5 1.4 1.4 0.5 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.1 0.1 0.8 0.7 1.6 1.3 0.7 0.6
White 0.7 0.7 0.1 0.1 0.8 0.7 2.0 1.6 0.6 0.6
Black or African American 0.9 0.5 0.1 * 1.0 0.5 0.4 0.3 1.1 0.5
AIAN 0.4 * * * 0.4 * 0.2 * 0.4 *
NHOPI 0.2 * * * 0.2 * * * 0.3 *
Asian 0.5 0.6 0.2 * 0.5 0.7 1.0 * 0.4 0.8
Two or More Races 0.7 2.0 * 0.1 0.9 2.3 2.4 * 0.4 2.3
Hispanic or Latino 0.7 0.7 0.2 * 0.8 0.8 1.6 1.3 0.6 0.7
EDUCATION LEVEL                    
< High School da da da da 0.7 0.8 0.7 1.2 0.7 0.7
High School Graduate da da da da 1.0 0.6 1.3 1.1 0.9 0.5
Some College/Associate’s Degree da da da da 0.9 0.7 2.0 0.9 0.6 0.7
College Graduate da da da da 0.6 0.8 1.8 2.5 0.5 0.7
EMPLOYMENT STATUS                    
Full-Time da da da da 0.8 0.9 2.0 2.0 0.6 0.8
Part-Time da da da da 1.0 0.8 1.6 0.9 0.8 0.7
Unemployed da da da da 1.5 1.5 1.0 1.7 1.8 1.4
Other1 da da da da 0.6 0.4 1.1 0.4 0.5 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9,375 9,356 20 3 9,355 9,354 339 247 9,016 9,107
GENDER                    
Male 6,009 5,748 12 1 5,997 5,747 181 138 5,817 5,609
Female 3,365 3,608 8 2 3,358 3,607 158 109 3,200 3,498
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8,440 8,248 18 3 8,422 8,246 272 205 8,150 8,040
White 6,521 6,482 18 3 6,503 6,479 237 188 6,266 6,291
Black or African American 1,268 1,338 * * 1,268 1,338 2 7 1,266 1,331
AIAN 64 139 * * 64 139 6 * 59 *
NHOPI 39 13 * * 39 13 * * 38 *
Asian 99 46 * * 99 46 4 2 96 44
Two or More Races 448 231 * * 448 231 23 8 426 223
Hispanic or Latino 935 1,108 2 * 933 1,108 66 41 867 1,066
EDUCATION LEVEL                    
< High School da da da da 1,428 1,504 77 29 1,351 1,475
High School Graduate da da da da 3,001 3,394 151 132 2,850 3,263
Some College/Associate’s Degree da da da da 3,565 3,486 95 72 3,470 3,415
College Graduate da da da da 1,361 969 15 14 1,346 955
EMPLOYMENT STATUS                    
Full-Time da da da da 4,360 3,922 175 91 4,185 3,831
Part-Time da da da da 1,011 1,251 45 56 966 1,195
Unemployed da da da da 629 699 42 25 587 674
Other1 da da da da 3,355 3,482 77 75 3,278 3,407
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.4 3.4 0.1 0.0 3.7 3.7 1.0 0.7 4.2 4.2
GENDER                    
Male 4.5 4.3 0.1 0.0 5.0 4.7 1.1 0.8 5.6 5.3
Female 2.4 2.5 0.1 0.0 2.6 2.8 0.9 0.6 2.8 3.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.7 3.6 0.1 0.0 4.0 3.9 1.0 0.8 4.5 4.4
White 3.8 3.8 0.1 0.0 4.1 4.1 1.3 1.1 4.5 4.5
Black or African American 3.8 4.0 * * 4.2 4.4 0.0 0.2 5.0 5.1
AIAN 4.1 8.4 * * 4.6 9.7 2.7 * 5.0 *
NHOPI 3.5 1.3 * * 3.9 1.4 * * 4.5 *
Asian 0.6 0.3 * * 0.7 0.3 0.2 0.1 0.8 0.4
Two or More Races 8.4 4.3 * * 10.2 4.9 2.4 0.7 12.3 6.1
Hispanic or Latino 2.0 2.3 0.0 * 2.3 2.6 0.9 0.5 2.6 3.1
EDUCATION LEVEL                    
< High School da da da da 4.7 5.2 1.6 0.8 5.3 5.9
High School Graduate da da da da 4.9 4.9 1.4 1.2 5.7 5.6
Some College/Associate’s Degree da da da da 4.6 4.6 0.7 0.5 5.5 5.5
College Graduate da da da da 1.7 1.3 0.3 0.3 1.7 1.3
EMPLOYMENT STATUS                    
Full-Time da da da da 3.5 3.4 1.2 0.7 3.8 3.7
Part-Time da da da da 3.1 4.0 0.5 0.7 4.0 5.3
Unemployed da da da da 6.3 5.4 1.3 0.7 8.8 7.1
Other1 da da da da 4.0 3.8 1.0 0.9 4.3 4.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 778 657 11 2 766 655 61 49 706 606
GENDER                    
Male 499 411 7 * 491 411 38 25 453 386
Female 279 246 4 2 275 244 23 25 252 220
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 738 584 11 2 727 582 53 35 674 547
White 512 401 11 2 501 400 50 34 451 366
Black or African American 197 121 * * 197 121 2 1 195 120
AIAN * 0 * * * 0 * * * *
NHOPI 10 * * * 10 * * * * *
Asian 2 9 * * 2 9 * * 2 9
Two or More Races 17 52 * * 17 52 1 * 16 52
Hispanic or Latino 40 73 1 * 40 73 8 14 32 59
EDUCATION LEVEL                    
< High School da da da da 152 173 14 3 139 170
High School Graduate da da da da 316 205 34 42 282 163
Some College/Associate’s Degree da da da da 274 267 11 5 262 262
College Graduate da da da da 24 11 1 * 23 11
EMPLOYMENT STATUS                    
Full-Time da da da da 208 132 27 6 181 126
Part-Time da da da da 54 105 3 16 51 89
Unemployed da da da da 78 94 17 16 61 78
Other1 da da da da 427 325 14 12 413 313
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.3 0.2 0.0 0.0 0.3 0.3 0.2 0.1 0.3 0.3
GENDER                    
Male 0.4 0.3 0.1 * 0.4 0.3 0.2 0.1 0.4 0.4
Female 0.2 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3 0.3 0.1 0.0 0.3 0.3 0.2 0.1 0.4 0.3
White 0.3 0.2 0.1 0.0 0.3 0.3 0.3 0.2 0.3 0.3
Black or African American 0.6 0.4 * * 0.7 0.4 0.0 0.0 0.8 0.5
AIAN * 0.0 * * * 0.0 * * * *
NHOPI 0.9 * * * 1.0 * * * * *
Asian 0.0 0.1 * * 0.0 0.1 * * 0.0 0.1
Two or More Races 0.3 1.0 * * 0.4 1.1 0.1 * 0.5 1.4
Hispanic or Latino 0.1 0.2 0.0 * 0.1 0.2 0.1 0.2 0.1 0.2
EDUCATION LEVEL                    
< High School da da da da 0.5 0.6 0.3 0.1 0.5 0.7
High School Graduate da da da da 0.5 0.3 0.3 0.4 0.6 0.3
Some College/Associate’s Degree da da da da 0.4 0.3 0.1 0.0 0.4 0.4
College Graduate da da da da 0.0 0.0 0.0 * 0.0 0.0
EMPLOYMENT STATUS                    
Full-Time da da da da 0.2 0.1 0.2 0.0 0.2 0.1
Part-Time da da da da 0.2 0.3 0.0 0.2 0.2 0.4
Unemployed da da da da 0.8 0.7 0.5 0.5 0.9 0.8
Other1 da da da da 0.5 0.4 0.2 0.1 0.5 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 378 335 5 2 372 333 18 35 355 298
GENDER                    
Male 244 232 5 * 239 232 6 12 233 219
Female 134 103 * 2 134 102 12 23 122 78
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 364 284 5 2 359 282 14 29 344 253
White 245 143 5 2 240 142 11 29 229 113
Black or African American 111 92 * * 111 92 2 * 109 92
AIAN * * * * * * * * * *
NHOPI * * * * * * * * * *
Asian * 9 * * * 9 * * 1 9
Two or More Races 7 40 * * 7 40 1 * 6 40
Hispanic or Latino 14 51 * * 14 51 3 6 11 44
EDUCATION LEVEL                    
< High School da da da da 93 104 3 1 90 103
High School Graduate da da da da 143 141 14 30 129 111
Some College/Associate’s Degree da da da da 120 89 * 5 120 84
College Graduate da da da da 17 * 1 * 16 *
EMPLOYMENT STATUS                    
Full-Time da da da da 82 43 5 * 77 43
Part-Time da da da da 32 23 1 8 31 15
Unemployed da da da da 47 60 9 16 38 44
Other1 da da da da 211 208 3 11 208 197
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1
GENDER                    
Male 0.2 0.2 0.0 * 0.2 0.2 0.0 0.1 0.2 0.2
Female 0.1 0.1 * 0.0 0.1 0.1 0.1 0.1 0.1 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1
White 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.1
Black or African American 0.3 0.3 * * 0.4 0.3 0.0 * 0.4 0.4
AIAN * * * * * * * * * *
NHOPI * * * * * * * * * *
Asian * 0.1 * * * 0.1 * * 0.0 0.1
Two or More Races 0.1 0.7 * * 0.2 0.8 0.1 * 0.2 1.1
Hispanic or Latino 0.0 0.1 * * 0.0 0.1 0.0 0.1 0.0 0.1
EDUCATION LEVEL                    
< High School da da da da 0.3 0.4 0.1 0.0 0.4 0.4
High School Graduate da da da da 0.2 0.2 0.1 0.3 0.3 0.2
Some College/Associate’s Degree da da da da 0.2 0.1 * 0.0 0.2 0.1
College Graduate da da da da 0.0 * 0.0 * 0.0 *
EMPLOYMENT STATUS                    
Full-Time da da da da 0.1 0.0 0.0 * 0.1 0.0
Part-Time da da da da 0.1 0.1 0.0 0.1 0.1 0.1
Unemployed da da da da 0.5 0.5 0.3 0.5 0.6 0.5
Other1 da da da da 0.3 0.2 0.0 0.1 0.3 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 44,087 43,949 615 563 43,472 43,386 5,597 5,269 37,876 38,117
GENDER                    
Male 26,051 25,629 342 309 25,710 25,320 3,239 2,905 22,471 22,415
Female 18,036 18,320 273 254 17,763 18,066 2,358 2,365 15,405 15,701
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 38,978 38,823 462 420 38,516 38,403 4,558 4,392 33,958 34,011
White 33,659 33,522 345 281 33,314 33,241 3,673 3,734 29,641 29,507
Black or African American 2,431 2,393 52 27 2,379 2,366 369 278 2,010 2,088
AIAN 366 478 24 * 342 445 54 * 287 *
NHOPI 125 60 * * 120 60 * * 97 *
Asian 1,029 1,037 4 60 1,025 977 232 133 793 844
Two or More Races 1,367 1,333 31 19 1,337 1,314 207 197 1,130 1,117
Hispanic or Latino 5,110 5,127 153 144 4,957 4,983 1,039 878 3,917 4,105
EDUCATION LEVEL                    
< High School da da da da 3,458 3,252 587 399 2,871 2,854
High School Graduate da da da da 9,297 11,251 1,681 1,356 7,616 9,895
Some College/Associate’s Degree da da da da 16,147 15,418 2,323 2,434 13,825 12,984
College Graduate da da da da 14,570 13,465 1,006 1,081 13,564 12,384
EMPLOYMENT STATUS                    
Full-Time da da da da 24,955 22,907 3,020 2,219 21,935 20,687
Part-Time da da da da 6,171 5,604 1,219 1,312 4,952 4,292
Unemployed da da da da 2,204 2,806 491 662 1,713 2,144
Other1 da da da da 10,142 12,069 866 1,077 9,276 10,993
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 16.0 15.9 2.5 2.3 17.4 17.2 16.6 15.7 17.5 17.5
GENDER                    
Male 19.5 19.1 2.7 2.4 21.3 20.8 19.2 17.3 21.6 21.4
Female 12.7 12.9 2.2 2.1 13.7 13.9 14.0 14.1 13.7 13.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17.1 17.0 2.5 2.2 18.4 18.3 17.5 17.0 18.6 18.5
White 19.7 19.6 2.7 2.2 21.1 21.0 20.4 20.8 21.2 21.1
Black or African American 7.3 7.1 1.6 0.9 8.0 7.8 8.0 6.0 8.0 8.1
AIAN 23.4 28.8 13.8 * 24.6 30.9 25.0 * 24.5 *
NHOPI 11.5 6.0 * * 12.1 6.2 * * 11.7 *
Asian 6.5 6.4 0.3 3.2 7.0 6.8 11.1 6.7 6.3 6.8
Two or More Races 25.7 25.1 3.3 3.1 30.5 28.0 22.0 19.0 32.8 30.5
Hispanic or Latino 10.8 10.6 2.5 2.3 12.0 11.8 13.6 11.4 11.7 12.0
EDUCATION LEVEL                    
< High School da da da da 11.5 11.3 12.5 10.4 11.3 11.4
High School Graduate da da da da 15.3 16.2 15.8 12.6 15.2 16.8
Some College/Associate’s Degree da da da da 21.0 20.2 17.2 17.4 21.8 20.8
College Graduate da da da da 17.7 17.5 20.4 21.8 17.5 17.2
EMPLOYMENT STATUS                    
Full-Time da da da da 20.1 19.6 21.1 17.5 20.0 19.9
Part-Time da da da da 18.9 17.9 14.6 15.3 20.4 18.9
Unemployed da da da da 22.2 21.8 14.9 19.5 25.8 22.6
Other1 da da da da 12.1 13.2 11.2 12.2 12.2 13.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 6,010 7,133 440 370 5,571 6,763 2,425 2,446 3,146 4,317
GENDER                    
Male 3,835 4,178 261 185 3,575 3,993 1,487 1,423 2,088 2,570
Female 2,175 2,955 179 185 1,996 2,770 938 1,023 1,058 1,747
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5,004 6,169 324 301 4,680 5,869 2,015 2,103 2,665 3,766
White 3,963 4,969 257 222 3,706 4,747 1,616 1,825 2,090 2,921
Black or African American 459 467 31 15 429 452 159 130 269 322
AIAN 61 82 13 * 48 53 23 * 25 52
NHOPI 23 2 * * 22 2 * * * *
Asian 260 372 1 19 259 354 124 55 135 298
Two or More Races 238 277 22 16 217 261 90 92 127 169
Hispanic or Latino 1,006 964 116 69 891 894 410 343 480 551
EDUCATION LEVEL                    
< High School da da da da 442 478 225 197 217 281
High School Graduate da da da da 1,145 1,261 700 501 445 760
Some College/Associate’s Degree da da da da 2,270 2,729 1,122 1,240 1,148 1,489
College Graduate da da da da 1,714 2,295 378 508 1,335 1,787
EMPLOYMENT STATUS                    
Full-Time da da da da 2,986 3,441 1,100 1,062 1,886 2,379
Part-Time da da da da 1,165 1,325 619 634 546 692
Unemployed da da da da 493 743 280 354 212 389
Other1 da da da da 927 1,253 426 395 501 858
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2.2 2.6 1.8 1.5 2.2 2.7 7.2 7.3 1.5 2.0
GENDER                    
Male 2.9 3.1 2.1 1.5 3.0 3.3 8.8 8.5 2.0 2.5
Female 1.5 2.1 1.5 1.5 1.5 2.1 5.6 6.1 0.9 1.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.2 2.7 1.7 1.6 2.2 2.8 7.7 8.2 1.5 2.0
White 2.3 2.9 2.0 1.7 2.3 3.0 9.0 10.2 1.5 2.1
Black or African American 1.4 1.4 0.9 0.5 1.4 1.5 3.4 2.8 1.1 1.2
AIAN 3.9 5.0 7.4 * 3.4 3.7 10.4 * 2.1 4.2
NHOPI 2.1 0.2 * * 2.2 0.2 * * * *
Asian 1.6 2.3 0.1 1.0 1.8 2.5 5.9 2.8 1.1 2.4
Two or More Races 4.5 5.2 2.3 2.6 4.9 5.6 9.6 8.9 3.7 4.6
Hispanic or Latino 2.1 2.0 1.9 1.1 2.2 2.1 5.4 4.4 1.4 1.6
EDUCATION LEVEL                    
< High School da da da da 1.5 1.7 4.8 5.1 0.9 1.1
High School Graduate da da da da 1.9 1.8 6.6 4.7 0.9 1.3
Some College/Associate’s Degree da da da da 2.9 3.6 8.3 8.9 1.8 2.4
College Graduate da da da da 2.1 3.0 7.7 10.2 1.7 2.5
EMPLOYMENT STATUS                    
Full-Time da da da da 2.4 3.0 7.7 8.4 1.7 2.3
Part-Time da da da da 3.6 4.2 7.4 7.4 2.3 3.0
Unemployed da da da da 5.0 5.8 8.5 10.5 3.2 4.1
Other1 da da da da 1.1 1.4 5.5 4.5 0.7 1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,915 1,761 152 80 1,763 1,681 625 645 1,138 1,036
GENDER                    
Male 1,226 1,172 89 50 1,137 1,122 368 417 769 706
Female 689 589 63 30 626 559 257 229 369 330
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,655 1,533 105 67 1,550 1,466 508 547 1,042 919
White 1,284 1,184 85 45 1,199 1,139 390 440 809 699
Black or African American 150 168 7 4 143 164 34 63 109 102
AIAN 29 24 * * 25 * 6 * 19 *
NHOPI 0 2 * * * 2 * * * *
Asian 122 7 * 2 122 5 52 3 70 2
Two or More Races 68 148 8 8 60 140 26 41 34 99
Hispanic or Latino 260 228 47 12 213 216 117 98 96 117
EDUCATION LEVEL                    
< High School da da da da 169 186 71 64 99 122
High School Graduate da da da da 362 351 183 150 179 201
Some College/Associate’s Degree da da da da 626 619 256 307 370 312
College Graduate da da da da 605 525 114 125 491 400
EMPLOYMENT STATUS                    
Full-Time da da da da 886 872 259 271 627 601
Part-Time da da da da 386 252 171 172 214 80
Unemployed da da da da 147 261 79 105 68 156
Other1 da da da da 344 297 116 98 229 199
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.6 0.6 0.3 0.7 0.7 1.9 1.9 0.5 0.5
GENDER                    
Male 0.9 0.9 0.7 0.4 0.9 0.9 2.2 2.5 0.7 0.7
Female 0.5 0.4 0.5 0.2 0.5 0.4 1.5 1.4 0.3 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.6 0.4 0.7 0.7 1.9 2.1 0.6 0.5
White 0.8 0.7 0.7 0.4 0.8 0.7 2.2 2.5 0.6 0.5
Black or African American 0.5 0.5 0.2 0.1 0.5 0.5 0.7 1.4 0.4 0.4
AIAN 1.9 1.4 * * 1.8 * 2.9 * 1.6 *
NHOPI 0.0 0.2 * * * 0.2 * * * *
Asian 0.8 0.0 * 0.1 0.8 0.0 2.5 0.1 0.6 0.0
Two or More Races 1.3 2.8 0.9 1.3 1.4 3.0 2.8 4.0 1.0 2.7
Hispanic or Latino 0.5 0.5 0.8 0.2 0.5 0.5 1.5 1.3 0.3 0.3
EDUCATION LEVEL                    
< High School da da da da 0.6 0.6 1.5 1.7 0.4 0.5
High School Graduate da da da da 0.6 0.5 1.7 1.4 0.4 0.3
Some College/Associate’s Degree da da da da 0.8 0.8 1.9 2.2 0.6 0.5
College Graduate da da da da 0.7 0.7 2.3 2.5 0.6 0.6
EMPLOYMENT STATUS                    
Full-Time da da da da 0.7 0.7 1.8 2.1 0.6 0.6
Part-Time da da da da 1.2 0.8 2.0 2.0 0.9 0.4
Unemployed da da da da 1.5 2.0 2.4 3.1 1.0 1.6
Other1 da da da da 0.4 0.3 1.5 1.1 0.3 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 25,090 26,749 2,202 2,327 22,889 24,422 3,099 2,929 19,790 21,493
GENDER                    
Male 15,563 15,899 1,112 996 14,451 14,903 1,728 1,484 12,723 13,419
Female 9,528 10,850 1,090 1,331 8,438 9,519 1,370 1,445 7,067 8,074
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 21,985 23,264 1,725 1,783 20,260 21,481 2,495 2,337 17,766 19,144
White 19,100 19,876 1,211 1,225 17,889 18,651 1,977 1,872 15,912 16,779
Black or African American 1,214 1,522 297 274 917 1,248 255 196 663 1,052
AIAN 137 276 21 * 116 189 22 * 94 160
NHOPI 80 29 * * 65 29 * * 61 *
Asian 623 855 78 138 545 717 90 113 455 604
Two or More Races 830 707 102 60 728 647 148 117 580 530
Hispanic or Latino 3,105 3,485 477 544 2,628 2,941 604 592 2,024 2,349
EDUCATION LEVEL                    
< High School da da da da 1,946 1,851 383 273 1,563 1,577
High School Graduate da da da da 4,607 5,544 878 787 3,729 4,756
Some College/Associate’s Degree da da da da 8,290 8,602 1,294 1,389 6,995 7,213
College Graduate da da da da 8,047 8,426 543 480 7,503 7,946
EMPLOYMENT STATUS                    
Full-Time da da da da 13,382 13,542 1,427 1,108 11,954 12,434
Part-Time da da da da 3,568 3,146 800 818 2,768 2,328
Unemployed da da da da 1,011 1,384 276 319 735 1,065
Other1 da da da da 4,928 6,350 596 683 4,333 5,666
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9.1 9.7 8.8 9.3 9.1 9.7 9.2 8.7 9.1 9.8
GENDER                    
Male 11.7 11.8 8.8 7.8 12.0 12.2 10.2 8.9 12.2 12.8
Female 6.7 7.6 8.9 10.9 6.5 7.3 8.1 8.6 6.3 7.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 9.7 10.2 9.2 9.5 9.7 10.2 9.6 9.1 9.7 10.4
White 11.2 11.6 9.4 9.6 11.3 11.8 11.0 10.4 11.4 12.0
Black or African American 3.7 4.5 8.8 8.8 3.1 4.1 5.5 4.3 2.6 4.1
AIAN 8.8 16.6 12.4 * 8.3 13.1 10.1 * 8.0 12.8
NHOPI 7.3 2.9 * * 6.6 3.0 * * 7.4 *
Asian 3.9 5.3 6.0 7.4 3.7 5.0 4.3 5.7 3.6 4.9
Two or More Races 15.6 13.3 11.0 9.6 16.6 13.8 15.7 11.3 16.8 14.5
Hispanic or Latino 6.5 7.2 7.7 8.6 6.4 7.0 7.9 7.7 6.0 6.8
EDUCATION LEVEL                    
< High School da da da da 6.5 6.4 8.2 7.1 6.1 6.3
High School Graduate da da da da 7.6 8.0 8.3 7.3 7.4 8.1
Some College/Associate’s Degree da da da da 10.8 11.2 9.6 9.9 11.0 11.5
College Graduate da da da da 9.8 10.9 11.0 9.7 9.7 11.0
EMPLOYMENT STATUS                    
Full-Time da da da da 10.8 11.6 10.0 8.7 10.9 12.0
Part-Time da da da da 10.9 10.1 9.6 9.6 11.4 10.2
Unemployed da da da da 10.2 10.8 8.4 9.4 11.1 11.2
Other1 da da da da 5.9 7.0 7.7 7.7 5.7 6.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2,142 2,390 743 683 1,399 1,707 577 507 822 1,200
GENDER                    
Male 1,358 1,444 345 277 1,014 1,167 338 261 675 906
Female 784 946 398 407 386 539 239 246 147 294
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,725 1,869 561 522 1,164 1,347 452 375 713 972
White 1,253 1,411 418 403 835 1,008 355 292 480 716
Black or African American 203 195 76 35 126 159 46 22 80 137
AIAN 31 28 * * 21 22 4 * * 21
NHOPI 12 * * * 11 * * * * *
Asian 159 138 19 50 140 88 26 2 113 86
Two or More Races 68 88 36 27 32 60 17 48 15 12
Hispanic or Latino 417 521 182 162 235 359 125 131 110 228
EDUCATION LEVEL                    
< High School da da da da 153 194 69 80 84 114
High School Graduate da da da da 302 401 147 120 155 281
Some College/Associate’s Degree da da da da 447 459 263 205 184 254
College Graduate da da da da 497 653 97 102 399 551
EMPLOYMENT STATUS                    
Full-Time da da da da 787 867 214 171 572 696
Part-Time da da da da 267 323 191 137 76 186
Unemployed da da da da 89 197 42 105 47 92
Other1 da da da da 257 320 130 93 127 227
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.8 0.9 3.0 2.7 0.6 0.7 1.7 1.5 0.4 0.5
GENDER                    
Male 1.0 1.1 2.7 2.2 0.8 1.0 2.0 1.6 0.6 0.9
Female 0.6 0.7 3.3 3.3 0.3 0.4 1.4 1.5 0.1 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8 0.8 3.0 2.8 0.6 0.6 1.7 1.5 0.4 0.5
White 0.7 0.8 3.3 3.1 0.5 0.6 2.0 1.6 0.3 0.5
Black or African American 0.6 0.6 2.3 1.1 0.4 0.5 1.0 0.5 0.3 0.5
AIAN 2.0 1.7 * * 1.5 1.5 1.9 * * 1.7
NHOPI 1.1 * * * 1.1 * * * * *
Asian 1.0 0.9 1.5 2.7 1.0 0.6 1.3 0.1 0.9 0.7
Two or More Races 1.3 1.6 3.9 4.4 0.7 1.3 1.8 4.7 0.4 0.3
Hispanic or Latino 0.9 1.1 2.9 2.6 0.6 0.9 1.6 1.7 0.3 0.7
EDUCATION LEVEL                    
< High School da da da da 0.5 0.7 1.5 2.1 0.3 0.5
High School Graduate da da da da 0.5 0.6 1.4 1.1 0.3 0.5
Some College/Associate’s Degree da da da da 0.6 0.6 1.9 1.5 0.3 0.4
College Graduate da da da da 0.6 0.8 2.0 2.0 0.5 0.8
EMPLOYMENT STATUS                    
Full-Time da da da da 0.6 0.7 1.5 1.3 0.5 0.7
Part-Time da da da da 0.8 1.0 2.3 1.6 0.3 0.8
Unemployed da da da da 0.9 1.5 1.3 3.1 0.7 1.0
Other1 da da da da 0.3 0.4 1.7 1.1 0.2 0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 807 904 216 106 591 797 157 160 434 637
GENDER                    
Male 598 639 94 65 504 574 90 72 414 502
Female 209 265 122 41 87 223 68 88 19 135
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 633 658 156 89 477 569 113 113 364 456
White 457 437 115 63 341 374 87 73 255 301
Black or African American 64 88 17 13 47 74 17 8 30 66
AIAN 4 26 * * 4 21 0 * 4 21
NHOPI * * * * * * * * * *
Asian 74 62 3 3 72 60 5 2 67 *
Two or More Races 26 45 21 6 5 40 4 * 1 10
Hispanic or Latino 174 246 60 17 114 228 44 47 70 182
EDUCATION LEVEL                    
< High School da da da da 80 135 25 45 55 90
High School Graduate da da da da 113 193 34 50 79 142
Some College/Associate’s Degree da da da da 134 173 51 42 83 131
College Graduate da da da da 263 296 47 22 216 274
EMPLOYMENT STATUS                    
Full-Time da da da da 347 488 55 101 292 387
Part-Time da da da da 92 114 58 10 34 104
Unemployed da da da da 28 76 6 34 22 43
Other1 da da da da 125 119 39 16 86 103
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.3 0.3 0.9 0.4 0.2 0.3 0.5 0.5 0.2 0.3
GENDER                    
Male 0.4 0.5 0.7 0.5 0.4 0.5 0.5 0.4 0.4 0.5
Female 0.1 0.2 1.0 0.3 0.1 0.2 0.4 0.5 0.0 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3 0.3 0.8 0.5 0.2 0.3 0.4 0.4 0.2 0.2
White 0.3 0.3 0.9 0.5 0.2 0.2 0.5 0.4 0.2 0.2
Black or African American 0.2 0.3 0.5 0.4 0.2 0.2 0.4 0.2 0.1 0.3
AIAN 0.2 1.6 * * 0.3 1.5 0.1 * 0.3 1.7
NHOPI * * * * * * * * * *
Asian 0.5 0.4 0.2 0.2 0.5 0.4 0.2 0.1 0.5 *
Two or More Races 0.5 0.8 2.2 0.9 0.1 0.8 0.4 * 0.0 0.3
Hispanic or Latino 0.4 0.5 1.0 0.3 0.3 0.5 0.6 0.6 0.2 0.5
EDUCATION LEVEL                    
< High School da da da da 0.3 0.5 0.5 1.2 0.2 0.4
High School Graduate da da da da 0.2 0.3 0.3 0.5 0.2 0.2
Some College/Associate’s Degree da da da da 0.2 0.2 0.4 0.3 0.1 0.2
College Graduate da da da da 0.3 0.4 1.0 0.4 0.3 0.4
EMPLOYMENT STATUS                    
Full-Time da da da da 0.3 0.4 0.4 0.8 0.3 0.4
Part-Time da da da da 0.3 0.4 0.7 0.1 0.1 0.5
Unemployed da da da da 0.3 0.6 0.2 1.0 0.3 0.4
Other1 da da da da 0.1 0.1 0.5 0.2 0.1 0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 16,013 15,397 75 48 15,939 15,349 904 538 15,034 14,811
GENDER                    
Male 9,528 8,958 38 8 9,490 8,950 491 256 9,000 8,694
Female 6,485 6,439 37 40 6,448 6,399 414 282 6,035 6,117
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 14,177 13,300 52 48 14,126 13,252 730 394 13,396 12,858
White 12,828 11,623 42 21 12,786 11,602 630 367 12,155 11,235
Black or African American 476 735 5 26 471 709 41 1 429 708
AIAN 118 * * * 117 * 15 * 102 *
NHOPI 69 41 * * 68 41 * * 65 *
Asian 193 216 2 1 191 215 11 0 179 215
Two or More Races 494 460 1 * 494 460 28 22 466 439
Hispanic or Latino 1,836 2,097 23 * 1,813 2,097 174 144 1,638 1,953
EDUCATION LEVEL                    
< High School da da da da 2,037 1,702 237 80 1,800 1,622
High School Graduate da da da da 4,609 5,719 343 220 4,265 5,499
Some College/Associate’s Degree da da da da 6,118 5,436 264 202 5,854 5,234
College Graduate da da da da 3,175 2,493 60 37 3,116 2,456
EMPLOYMENT STATUS                    
Full-Time da da da da 7,983 6,996 428 203 7,555 6,794
Part-Time da da da da 1,926 1,739 132 147 1,794 1,592
Unemployed da da da da 994 1,152 121 52 873 1,100
Other1 da da da da 5,036 5,462 223 136 4,812 5,326
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5.8 5.6 0.3 0.2 6.4 6.1 2.7 1.6 6.9 6.8
GENDER                    
Male 7.1 6.7 0.3 0.1 7.9 7.4 2.9 1.5 8.7 8.3
Female 4.6 4.5 0.3 0.3 5.0 4.9 2.5 1.7 5.4 5.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6.2 5.8 0.3 0.3 6.8 6.3 2.8 1.5 7.3 7.0
White 7.5 6.8 0.3 0.2 8.1 7.3 3.5 2.0 8.7 8.0
Black or African American 1.4 2.2 0.2 0.8 1.6 2.3 0.9 0.0 1.7 2.7
AIAN 7.5 * * * 8.4 * 7.0 * 8.7 *
NHOPI 6.3 4.1 * * 6.9 4.3 * * 7.8 *
Asian 1.2 1.3 0.2 0.1 1.3 1.5 0.5 0.0 1.4 1.7
Two or More Races 9.3 8.7 0.1 * 11.3 9.8 3.0 2.1 13.5 12.0
Hispanic or Latino 3.9 4.3 0.4 * 4.4 5.0 2.3 1.9 4.9 5.7
EDUCATION LEVEL                    
< High School da da da da 6.8 5.9 5.1 2.1 7.1 6.5
High School Graduate da da da da 7.6 8.2 3.2 2.0 8.5 9.4
Some College/Associate’s Degree da da da da 7.9 7.1 2.0 1.4 9.2 8.4
College Graduate da da da da 3.9 3.2 1.2 0.7 4.0 3.4
EMPLOYMENT STATUS                    
Full-Time da da da da 6.4 6.0 3.0 1.6 6.9 6.5
Part-Time da da da da 5.9 5.6 1.6 1.7 7.4 7.0
Unemployed da da da da 10.0 9.0 3.7 1.5 13.2 11.6
Other1 da da da da 6.0 6.0 2.9 1.5 6.3 6.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,999 2,550 41 21 1,958 2,528 275 171 1,682 2,358
GENDER                    
Male 1,262 1,201 18 6 1,244 1,196 164 58 1,080 1,138
Female 737 1,348 23 16 714 1,333 112 113 602 1,220
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,711 2,166 32 21 1,679 2,145 224 125 1,455 2,019
White 1,508 1,876 30 10 1,478 1,866 194 118 1,284 1,747
Black or African American 81 92 1 10 80 82 7 1 73 80
AIAN 29 * * * 29 * 3 * 27 *
NHOPI 16 * * * 16 * * * 13 *
Asian 19 60 * 1 19 59 5 * 13 *
Two or More Races 58 85 1 * 57 85 12 3 45 82
Hispanic or Latino 288 384 10 * 279 384 51 45 228 338
EDUCATION LEVEL                    
< High School da da da da 307 399 78 23 229 376
High School Graduate da da da da 751 861 105 77 646 784
Some College/Associate’s Degree da da da da 700 997 92 68 608 930
College Graduate da da da da 199 271 * 4 199 268
EMPLOYMENT STATUS                    
Full-Time da da da da 765 750 111 37 655 713
Part-Time da da da da 168 399 37 36 131 363
Unemployed da da da da 347 303 51 33 297 269
Other1 da da da da 677 1,077 77 64 600 1,012
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.9 0.2 0.1 0.8 1.0 0.8 0.5 0.8 1.1
GENDER                    
Male 0.9 0.9 0.1 0.0 1.0 1.0 1.0 0.3 1.0 1.1
Female 0.5 0.9 0.2 0.1 0.6 1.0 0.7 0.7 0.5 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8 0.9 0.2 0.1 0.8 1.0 0.9 0.5 0.8 1.1
White 0.9 1.1 0.2 0.1 0.9 1.2 1.1 0.7 0.9 1.2
Black or African American 0.2 0.3 0.0 0.3 0.3 0.3 0.1 0.0 0.3 0.3
AIAN 1.9 * * * 2.1 * 1.3 * 2.3 *
NHOPI 1.5 * * * 1.6 * * * 1.6 *
Asian 0.1 0.4 * 0.1 0.1 0.4 0.2 * 0.1 *
Two or More Races 1.1 1.6 0.1 * 1.3 1.8 1.3 0.3 1.3 2.2
Hispanic or Latino 0.6 0.8 0.2 * 0.7 0.9 0.7 0.6 0.7 1.0
EDUCATION LEVEL                    
< High School da da da da 1.0 1.4 1.7 0.6 0.9 1.5
High School Graduate da da da da 1.2 1.2 1.0 0.7 1.3 1.3
Some College/Associate’s Degree da da da da 0.9 1.3 0.7 0.5 1.0 1.5
College Graduate da da da da 0.2 0.4 * 0.1 0.3 0.4
EMPLOYMENT STATUS                    
Full-Time da da da da 0.6 0.6 0.8 0.3 0.6 0.7
Part-Time da da da da 0.5 1.3 0.4 0.4 0.5 1.6
Unemployed da da da da 3.5 2.4 1.5 1.0 4.5 2.8
Other1 da da da da 0.8 1.2 1.0 0.7 0.8 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,173 1,722 11 7 1,161 1,715 110 74 1,051 1,641
GENDER                    
Male 721 789 4 6 717 783 58 19 659 764
Female 452 934 7 2 444 932 53 55 392 878
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 985 1,451 8 7 977 1,444 81 50 896 1,394
White 863 1,285 6 6 857 1,279 73 45 785 1,235
Black or African American 50 34 1 * 49 34 2 1 47 33
AIAN 16 20 * * 16 20 1 * 15 *
NHOPI 12 * * * 12 * * * * *
Asian 13 60 * 1 13 59 * * 13 *
Two or More Races 31 52 1 * 30 52 3 3 27 49
Hispanic or Latino 187 271 3 * 184 271 29 24 155 248
EDUCATION LEVEL                    
< High School da da da da 162 275 34 6 129 269
High School Graduate da da da da 488 601 48 44 440 557
Some College/Associate’s Degree da da da da 371 649 29 24 342 625
College Graduate da da da da 140 190 * * 140 190
EMPLOYMENT STATUS                    
Full-Time da da da da 427 491 43 12 384 479
Part-Time da da da da 100 289 14 19 86 270
Unemployed da da da da 265 223 23 19 242 203
Other1 da da da da 369 713 30 23 339 690
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.4 0.6 0.0 0.0 0.5 0.7 0.3 0.2 0.5 0.8
GENDER                    
Male 0.5 0.6 0.0 0.0 0.6 0.6 0.3 0.1 0.6 0.7
Female 0.3 0.7 0.1 0.0 0.3 0.7 0.3 0.3 0.3 0.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4 0.6 0.0 0.0 0.5 0.7 0.3 0.2 0.5 0.8
White 0.5 0.8 0.0 0.0 0.5 0.8 0.4 0.2 0.6 0.9
Black or African American 0.2 0.1 0.0 * 0.2 0.1 0.0 0.0 0.2 0.1
AIAN 1.0 1.2 * * 1.2 1.4 0.3 * 1.3 *
NHOPI 1.1 * * * 1.2 * * * * *
Asian 0.1 0.4 * 0.1 0.1 0.4 * * 0.1 *
Two or More Races 0.6 1.0 0.1 * 0.7 1.1 0.3 0.3 0.8 1.3
Hispanic or Latino 0.4 0.6 0.1 * 0.4 0.6 0.4 0.3 0.5 0.7
EDUCATION LEVEL                    
< High School da da da da 0.5 1.0 0.7 0.1 0.5 1.1
High School Graduate da da da da 0.8 0.9 0.5 0.4 0.9 0.9
Some College/Associate’s Degree da da da da 0.5 0.8 0.2 0.2 0.5 1.0
College Graduate da da da da 0.2 0.2 * * 0.2 0.3
EMPLOYMENT STATUS                    
Full-Time da da da da 0.3 0.4 0.3 0.1 0.3 0.5
Part-Time da da da da 0.3 0.9 0.2 0.2 0.4 1.2
Unemployed da da da da 2.7 1.7 0.7 0.6 3.6 2.1
Other1 da da da da 0.4 0.8 0.4 0.3 0.4 0.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.44A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 82,559 75,198 3,980 3,079 78,579 72,118 8,357 6,858 70,222 65,261
GENDER                    
Male 37,510 33,689 1,898 1,544 35,612 32,146 3,602 2,890 32,010 29,256
Female 45,049 41,508 2,083 1,536 42,967 39,973 4,755 3,968 38,211 36,004
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 70,541 63,567 2,932 2,239 67,610 61,328 6,519 5,332 61,091 55,997
White 54,877 49,205 2,021 1,588 52,856 47,617 4,583 3,883 48,273 43,734
Black or African American 10,587 9,785 601 449 9,986 9,336 1,208 945 8,778 8,392
AIAN 582 482 30 * 552 * 63 * 488 *
NHOPI 218 * * * 213 * * * 172 *
Asian 2,593 2,231 128 91 2,464 2,140 364 219 2,100 1,922
Two or More Races 1,685 1,715 146 90 1,539 1,625 259 233 1,280 1,392
Hispanic or Latino 12,018 11,631 1,049 841 10,969 10,790 1,838 1,526 9,131 9,264
EDUCATION LEVEL                    
< High School da da da da 8,979 8,633 1,200 786 7,779 7,846
High School Graduate da da da da 19,289 20,669 2,548 2,171 16,740 18,498
Some College/Associate’s Degree da da da da 27,613 24,501 3,605 3,016 24,008 21,486
College Graduate da da da da 22,698 18,316 1,004 885 21,694 17,430
EMPLOYMENT STATUS                    
Full-Time da da da da 35,946 30,315 3,612 2,777 32,333 27,537
Part-Time da da da da 9,701 8,046 1,973 1,592 7,728 6,454
Unemployed da da da da 3,137 3,156 914 732 2,224 2,424
Other1 da da da da 29,795 30,602 1,858 1,757 27,937 28,845
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.44B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 30.0 27.2 16.0 12.3 31.4 28.6 24.8 20.5 32.4 29.9
GENDER                    
Male 28.1 25.1 15.0 12.1 29.5 26.4 21.3 17.2 30.8 27.9
Female 31.8 29.1 17.0 12.5 33.2 30.7 28.3 23.7 33.9 31.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 31.0 27.8 15.7 12.0 32.3 29.2 25.0 20.7 33.4 30.4
White 32.2 28.8 15.7 12.4 33.5 30.2 25.4 21.7 34.5 31.2
Black or African American 31.8 29.1 17.9 14.4 33.4 30.6 26.1 20.6 34.8 32.4
AIAN 37.2 29.0 17.4 * 39.6 * 29.0 * 41.6 *
NHOPI 20.0 * * * 21.5 * * * 20.6 *
Asian 16.3 13.8 9.8 4.9 16.9 14.9 17.4 11.0 16.8 15.6
Two or More Races 31.7 32.3 15.7 14.6 35.1 34.6 27.6 22.5 37.1 38.1
Hispanic or Latino 25.3 24.0 16.9 13.3 26.6 25.6 24.0 19.8 27.2 27.0
EDUCATION LEVEL                    
< High School da da da da 29.8 29.9 25.6 20.6 30.5 31.3
High School Graduate da da da da 31.7 29.8 24.0 20.2 33.4 31.5
Some College/Associate’s Degree da da da da 35.8 32.0 26.7 21.6 37.8 34.4
College Graduate da da da da 27.6 23.8 20.3 17.8 28.0 24.2
EMPLOYMENT STATUS                    
Full-Time da da da da 28.9 26.0 25.2 21.9 29.4 26.5
Part-Time da da da da 29.8 25.7 23.6 18.6 31.9 28.4
Unemployed da da da da 31.6 24.5 27.8 21.6 33.5 25.6
Other1 da da da da 35.6 33.6 24.0 19.9 36.8 35.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.45A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9,724 9,254 567 396 9,158 8,858 1,754 1,361 7,404 7,498
GENDER                    
Male 5,134 4,213 254 215 4,880 3,998 895 616 3,985 3,382
Female 4,590 5,042 312 181 4,278 4,860 859 744 3,418 4,116
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7,979 7,496 407 248 7,572 7,248 1,316 1,089 6,256 6,159
White 6,290 5,704 289 166 6,001 5,538 995 869 5,006 4,669
Black or African American 1,059 1,206 85 61 975 1,145 178 153 797 992
AIAN 79 52 5 * 74 48 14 * 60 31
NHOPI 23 6 * * 22 6 * * 20 *
Asian 262 390 3 4 259 386 66 21 193 365
Two or More Races 266 137 24 12 242 125 61 * 181 96
Hispanic or Latino 1,745 1,758 160 148 1,585 1,610 438 272 1,147 1,338
EDUCATION LEVEL                    
< High School da da da da 1,276 1,183 294 142 983 1,040
High School Graduate da da da da 2,240 2,406 546 412 1,694 1,994
Some College/Associate’s Degree da da da da 3,331 3,301 729 566 2,602 2,735
College Graduate da da da da 2,310 1,969 185 240 2,125 1,729
EMPLOYMENT STATUS                    
Full-Time da da da da 4,764 3,798 823 667 3,941 3,131
Part-Time da da da da 1,174 1,312 389 238 785 1,074
Unemployed da da da da 625 537 194 161 431 376
Other1 da da da da 2,594 3,212 348 295 2,246 2,916
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.45B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.5 3.3 2.3 1.6 3.7 3.5 5.2 4.1 3.4 3.4
GENDER                    
Male 3.8 3.1 2.0 1.7 4.0 3.3 5.3 3.7 3.8 3.2
Female 3.2 3.5 2.6 1.5 3.3 3.7 5.1 4.4 3.0 3.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.5 3.3 2.2 1.3 3.6 3.5 5.0 4.2 3.4 3.3
White 3.7 3.3 2.3 1.3 3.8 3.5 5.5 4.9 3.6 3.3
Black or African American 3.2 3.6 2.5 1.9 3.3 3.8 3.8 3.3 3.2 3.8
AIAN 5.0 3.2 2.9 * 5.3 3.3 6.4 * 5.1 2.4
NHOPI 2.1 0.6 * * 2.3 0.6 * * 2.5 *
Asian 1.6 2.4 0.3 0.2 1.8 2.7 3.2 1.1 1.5 3.0
Two or More Races 5.0 2.6 2.6 2.0 5.5 2.7 6.5 * 5.3 2.6
Hispanic or Latino 3.7 3.6 2.6 2.3 3.8 3.8 5.7 3.5 3.4 3.9
EDUCATION LEVEL                    
< High School da da da da 4.2 4.1 6.3 3.7 3.9 4.1
High School Graduate da da da da 3.7 3.5 5.1 3.8 3.4 3.4
Some College/Associate’s Degree da da da da 4.3 4.3 5.4 4.0 4.1 4.4
College Graduate da da da da 2.8 2.6 3.8 4.8 2.7 2.4
EMPLOYMENT STATUS                    
Full-Time da da da da 3.8 3.3 5.7 5.2 3.6 3.0
Part-Time da da da da 3.6 4.2 4.7 2.8 3.2 4.7
Unemployed da da da da 6.3 4.2 5.9 4.7 6.5 4.0
Other1 da da da da 3.1 3.5 4.5 3.3 3.0 3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.46A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2,819 2,536 165 96 2,654 2,440 420 288 2,234 2,152
GENDER                    
Male 1,450 1,133 68 61 1,382 1,072 183 133 1,199 939
Female 1,369 1,403 97 35 1,271 1,369 236 155 1,035 1,213
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2,324 1,955 117 80 2,207 1,876 324 246 1,883 1,629
White 1,894 1,475 79 52 1,815 1,423 255 187 1,560 1,237
Black or African American 238 324 24 24 214 299 45 60 169 240
AIAN 15 28 * * 15 28 3 * 12 28
NHOPI * 1 * * * 1 * * * *
Asian 77 106 * 0 77 106 5 * 72 106
Two or More Races 87 22 14 3 74 19 14 0 59 19
Hispanic or Latino 495 581 48 16 447 564 96 42 352 523
EDUCATION LEVEL                    
< High School da da da da 297 327 88 36 210 291
High School Graduate da da da da 714 610 113 93 601 518
Some College/Associate’s Degree da da da da 958 1,059 179 127 779 932
College Graduate da da da da 684 444 40 33 645 412
EMPLOYMENT STATUS                    
Full-Time da da da da 1,280 1,024 186 107 1,094 917
Part-Time da da da da 336 331 87 41 249 291
Unemployed da da da da 239 132 61 29 179 103
Other1 da da da da 798 953 85 112 713 841
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.46B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.0 0.9 0.7 0.4 1.1 1.0 1.2 0.9 1.0 1.0
GENDER                    
Male 1.1 0.8 0.5 0.5 1.1 0.9 1.1 0.8 1.2 0.9
Female 1.0 1.0 0.8 0.3 1.0 1.1 1.4 0.9 0.9 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.0 0.9 0.6 0.4 1.1 0.9 1.2 1.0 1.0 0.9
White 1.1 0.9 0.6 0.4 1.2 0.9 1.4 1.0 1.1 0.9
Black or African American 0.7 1.0 0.7 0.8 0.7 1.0 1.0 1.3 0.7 0.9
AIAN 1.0 1.7 * * 1.1 1.9 1.2 * 1.1 2.2
NHOPI * 0.1 * * * 0.1 * * * *
Asian 0.5 0.7 * 0.0 0.5 0.7 0.2 * 0.6 0.9
Two or More Races 1.6 0.4 1.5 0.5 1.7 0.4 1.5 0.0 1.7 0.5
Hispanic or Latino 1.0 1.2 0.8 0.3 1.1 1.3 1.2 0.5 1.0 1.5
EDUCATION LEVEL                    
< High School da da da da 1.0 1.1 1.9 0.9 0.8 1.2
High School Graduate da da da da 1.2 0.9 1.1 0.9 1.2 0.9
Some College/Associate’s Degree da da da da 1.2 1.4 1.3 0.9 1.2 1.5
College Graduate da da da da 0.8 0.6 0.8 0.7 0.8 0.6
EMPLOYMENT STATUS                    
Full-Time da da da da 1.0 0.9 1.3 0.8 1.0 0.9
Part-Time da da da da 1.0 1.1 1.0 0.5 1.0 1.3
Unemployed da da da da 2.4 1.0 1.8 0.9 2.7 1.1
Other1 da da da da 1.0 1.0 1.1 1.3 0.9 1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 18,290 18,332 1,837 1,593 16,453 16,739 4,320 3,773 12,133 12,966
GENDER                    
Male 8,575 8,276 1,117 962 7,458 7,314 2,322 1,978 5,136 5,336
Female 9,715 10,057 720 631 8,995 9,425 1,998 1,795 6,996 7,630
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 16,013 15,954 1,483 1,367 14,530 14,587 3,727 3,289 10,803 11,298
White 13,601 13,293 1,205 1,090 12,395 12,204 3,045 2,760 9,350 9,443
Black or African American 1,284 1,433 154 184 1,130 1,250 305 287 825 963
AIAN 80 * 8 * 71 * 28 * 43 *
NHOPI 53 6 * * 47 6 * * 25 *
Asian 552 712 29 54 523 659 156 138 368 520
Two or More Races 444 373 81 24 363 349 172 101 191 248
Hispanic or Latino 2,277 2,378 354 226 1,923 2,152 594 485 1,329 1,667
EDUCATION LEVEL                    
< High School da da da da 1,387 1,578 392 231 995 1,347
High School Graduate da da da da 3,063 3,638 990 915 2,073 2,723
Some College/Associate’s Degree da da da da 6,350 6,230 1,977 1,891 4,373 4,339
College Graduate da da da da 5,653 5,293 962 736 4,691 4,557
EMPLOYMENT STATUS                    
Full-Time da da da da 8,900 8,005 1,864 1,521 7,036 6,484
Part-Time da da da da 2,555 2,619 1,198 1,041 1,357 1,578
Unemployed da da da da 954 1,006 430 318 523 688
Other1 da da da da 4,044 5,108 828 892 3,216 4,216
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 6.6 6.6 7.4 6.4 6.6 6.6 12.8 11.3 5.6 5.9
GENDER                    
Male 6.4 6.2 8.8 7.6 6.2 6.0 13.7 11.8 4.9 5.1
Female 6.9 7.1 5.9 5.1 6.9 7.2 11.9 10.7 6.2 6.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7.0 7.0 7.9 7.3 7.0 7.0 14.3 12.8 5.9 6.1
White 8.0 7.8 9.4 8.5 7.9 7.7 16.9 15.4 6.7 6.7
Black or African American 3.9 4.3 4.6 5.9 3.8 4.1 6.6 6.2 3.3 3.7
AIAN 5.1 * 4.8 * 5.1 * 12.8 * 3.7 *
NHOPI 4.8 0.6 * * 4.7 0.6 * * 3.0 *
Asian 3.5 4.4 2.2 2.9 3.6 4.6 7.4 7.0 2.9 4.2
Two or More Races 8.3 7.0 8.6 3.9 8.3 7.4 18.3 9.8 5.5 6.8
Hispanic or Latino 4.8 4.9 5.7 3.6 4.7 5.1 7.7 6.3 4.0 4.9
EDUCATION LEVEL                    
< High School da da da da 4.6 5.5 8.4 6.0 3.9 5.4
High School Graduate da da da da 5.0 5.2 9.3 8.5 4.1 4.6
Some College/Associate’s Degree da da da da 8.2 8.1 14.6 13.5 6.9 6.9
College Graduate da da da da 6.9 6.9 19.5 14.8 6.1 6.3
EMPLOYMENT STATUS                    
Full-Time da da da da 7.2 6.9 13.0 12.0 6.4 6.2
Part-Time da da da da 7.8 8.4 14.4 12.2 5.6 6.9
Unemployed da da da da 9.6 7.8 13.1 9.4 7.9 7.3
Other1 da da da da 4.8 5.6 10.7 10.1 4.2 5.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,929 5,092 430 288 4,499 4,804 1,951 1,616 2,548 3,188
GENDER                    
Male 2,771 2,676 253 135 2,517 2,541 1,068 859 1,450 1,682
Female 2,158 2,417 176 154 1,982 2,263 883 757 1,098 1,507
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,334 4,468 326 242 4,008 4,226 1,691 1,388 2,318 2,839
White 3,743 3,903 263 201 3,480 3,702 1,399 1,216 2,081 2,486
Black or African American 251 274 22 26 229 247 111 81 118 167
AIAN 23 30 3 * 20 25 10 * 10 25
NHOPI 9 2 * * 9 2 * * 2 *
Asian 159 142 19 3 140 139 80 45 60 95
Two or More Races 149 117 18 6 131 111 84 46 47 64
Hispanic or Latino 595 625 104 47 491 578 260 228 230 350
EDUCATION LEVEL                    
< High School da da da da 291 349 169 32 122 318
High School Graduate da da da da 793 986 355 344 439 642
Some College/Associate’s Degree da da da da 1,897 1,767 943 855 954 912
College Graduate da da da da 1,518 1,702 484 385 1,034 1,317
EMPLOYMENT STATUS                    
Full-Time da da da da 2,614 2,581 865 694 1,748 1,887
Part-Time da da da da 910 889 604 410 307 479
Unemployed da da da da 328 411 171 147 157 265
Other1 da da da da 648 922 311 365 336 557
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.8 1.8 1.7 1.2 1.8 1.9 5.8 4.8 1.2 1.5
GENDER                    
Male 2.1 2.0 2.0 1.1 2.1 2.1 6.3 5.1 1.4 1.6
Female 1.5 1.7 1.4 1.3 1.5 1.7 5.2 4.5 1.0 1.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.9 2.0 1.7 1.3 1.9 2.0 6.5 5.4 1.3 1.5
White 2.2 2.3 2.0 1.6 2.2 2.3 7.8 6.8 1.5 1.8
Black or African American 0.8 0.8 0.7 0.8 0.8 0.8 2.4 1.8 0.5 0.6
AIAN 1.5 1.8 1.9 * 1.5 1.7 4.6 * 0.9 2.0
NHOPI 0.8 0.2 * * 0.9 0.2 * * 0.2 *
Asian 1.0 0.9 1.5 0.2 1.0 1.0 3.8 2.3 0.5 0.8
Two or More Races 2.8 2.2 1.9 1.0 3.0 2.4 9.0 4.5 1.4 1.8
Hispanic or Latino 1.3 1.3 1.7 0.7 1.2 1.4 3.4 2.9 0.7 1.0
EDUCATION LEVEL                    
< High School da da da da 1.0 1.2 3.6 0.8 0.5 1.3
High School Graduate da da da da 1.3 1.4 3.3 3.2 0.9 1.1
Some College/Associate’s Degree da da da da 2.5 2.3 7.0 6.1 1.5 1.5
College Graduate da da da da 1.8 2.2 9.8 7.8 1.3 1.8
EMPLOYMENT STATUS                    
Full-Time da da da da 2.1 2.2 6.0 5.5 1.6 1.8
Part-Time da da da da 2.8 2.8 7.2 4.8 1.3 2.1
Unemployed da da da da 3.3 3.2 5.2 4.3 2.4 2.8
Other1 da da da da 0.8 1.0 4.0 4.1 0.4 0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,566 1,493 123 72 1,443 1,421 587 267 856 1,154
GENDER                    
Male 865 836 91 34 774 802 323 136 451 666
Female 701 657 32 39 668 619 264 131 405 488
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,369 1,361 85 68 1,284 1,294 514 223 770 1,070
White 1,187 1,181 74 50 1,114 1,132 417 200 697 932
Black or African American 50 45 4 13 46 31 28 1 18 30
AIAN 7 * * * 7 * * * * *
NHOPI 3 0 * * 3 0 * * 2 *
Asian 50 99 3 3 47 96 34 8 13 88
Two or More Races 72 23 4 * 68 21 33 14 36 7
Hispanic or Latino 198 132 39 5 159 127 73 43 86 84
EDUCATION LEVEL                    
< High School da da da da 92 54 57 5 36 49
High School Graduate da da da da 255 365 103 31 152 334
Some College/Associate’s Degree da da da da 628 498 289 159 338 339
College Graduate da da da da 468 504 138 72 330 432
EMPLOYMENT STATUS                    
Full-Time da da da da 778 796 222 102 556 694
Part-Time da da da da 268 314 185 84 83 230
Unemployed da da da da 135 109 48 18 87 92
Other1 da da da da 262 201 131 63 131 139
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.6 0.5 0.5 0.3 0.6 0.6 1.7 0.8 0.4 0.5
GENDER                    
Male 0.6 0.6 0.7 0.3 0.6 0.7 1.9 0.8 0.4 0.6
Female 0.5 0.5 0.3 0.3 0.5 0.5 1.6 0.8 0.4 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6 0.6 0.5 0.4 0.6 0.6 2.0 0.9 0.4 0.6
White 0.7 0.7 0.6 0.4 0.7 0.7 2.3 1.1 0.5 0.7
Black or African American 0.1 0.1 0.1 0.4 0.2 0.1 0.6 0.0 0.1 0.1
AIAN 0.4 * * * 0.5 * * * * *
NHOPI 0.3 0.0 * * 0.3 0.0 * * 0.2 *
Asian 0.3 0.6 0.2 0.2 0.3 0.7 1.6 0.4 0.1 0.7
Two or More Races 1.4 0.4 0.4 * 1.6 0.4 3.5 1.4 1.0 0.2
Hispanic or Latino 0.4 0.3 0.6 0.1 0.4 0.3 1.0 0.6 0.3 0.2
EDUCATION LEVEL                    
< High School da da da da 0.3 0.2 1.2 0.1 0.1 0.2
High School Graduate da da da da 0.4 0.5 1.0 0.3 0.3 0.6
Some College/Associate’s Degree da da da da 0.8 0.7 2.1 1.1 0.5 0.5
College Graduate da da da da 0.6 0.7 2.8 1.4 0.4 0.6
EMPLOYMENT STATUS                    
Full-Time da da da da 0.6 0.7 1.5 0.8 0.5 0.7
Part-Time da da da da 0.8 1.0 2.2 1.0 0.3 1.0
Unemployed da da da da 1.4 0.9 1.5 0.5 1.3 1.0
Other1 da da da da 0.3 0.2 1.7 0.7 0.2 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 44,051 43,001 1,370 936 42,682 42,065 3,995 3,805 38,687 38,261
GENDER                    
Male 16,396 16,761 597 407 15,799 16,355 1,608 1,662 14,191 14,692
Female 27,655 26,240 772 529 26,883 25,711 2,387 2,142 24,496 23,568
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 38,928 38,363 1,020 674 37,908 37,688 3,317 3,158 34,590 34,530
White 33,085 32,929 737 525 32,348 32,404 2,571 2,605 29,777 29,800
Black or African American 3,557 3,532 169 88 3,388 3,444 417 277 2,971 3,168
AIAN 264 198 8 * 256 188 20 * 236 *
NHOPI 50 * * * 47 * * * 36 *
Asian 1,125 740 44 25 1,081 714 176 66 905 648
Two or More Races 846 921 59 24 787 897 122 * 665 726
Hispanic or Latino 5,124 4,638 350 262 4,774 4,377 678 646 4,096 3,730
EDUCATION LEVEL                    
< High School da da da da 3,884 4,303 541 414 3,343 3,889
High School Graduate da da da da 9,203 10,958 1,073 1,009 8,130 9,948
Some College/Associate’s Degree da da da da 14,750 13,724 1,712 1,737 13,038 11,986
College Graduate da da da da 14,845 13,081 669 644 14,175 12,437
EMPLOYMENT STATUS                    
Full-Time da da da da 17,801 16,666 1,730 1,560 16,071 15,107
Part-Time da da da da 5,916 5,407 967 971 4,949 4,436
Unemployed da da da da 1,709 1,640 488 411 1,220 1,229
Other1 da da da da 17,256 18,352 810 863 16,447 17,489
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 16.0 15.5 5.5 3.7 17.1 16.7 11.8 11.4 17.9 17.5
GENDER                    
Male 12.3 12.5 4.7 3.2 13.1 13.4 9.5 9.9 13.7 14.0
Female 19.5 18.4 6.3 4.3 20.8 19.7 14.2 12.8 21.8 20.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17.1 16.8 5.5 3.6 18.1 18.0 12.7 12.3 18.9 18.8
White 19.4 19.3 5.7 4.1 20.5 20.5 14.3 14.5 21.3 21.3
Black or African American 10.7 10.5 5.0 2.8 11.3 11.3 9.0 6.0 11.8 12.2
AIAN 16.9 11.9 4.4 * 18.4 13.1 9.1 * 20.2 *
NHOPI 4.6 * * * 4.8 * * * 4.3 *
Asian 7.1 4.6 3.4 1.4 7.4 5.0 8.4 3.3 7.2 5.2
Two or More Races 15.9 17.4 6.3 3.9 17.9 19.1 13.0 * 19.3 19.9
Hispanic or Latino 10.8 9.6 5.6 4.1 11.6 10.4 8.8 8.4 12.2 10.9
EDUCATION LEVEL                    
< High School da da da da 12.9 14.9 11.5 10.8 13.1 15.5
High School Graduate da da da da 15.1 15.8 10.1 9.4 16.2 16.9
Some College/Associate’s Degree da da da da 19.1 17.9 12.7 12.4 20.5 19.2
College Graduate da da da da 18.0 17.0 13.6 13.0 18.3 17.2
EMPLOYMENT STATUS                    
Full-Time da da da da 14.3 14.3 12.1 12.3 14.6 14.5
Part-Time da da da da 18.1 17.3 11.6 11.3 20.4 19.5
Unemployed da da da da 17.2 12.7 14.8 12.1 18.4 13.0
Other1 da da da da 20.6 20.1 10.4 9.8 21.7 21.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,895 6,205 436 226 5,459 5,979 1,409 1,237 4,050 4,742
GENDER                    
Male 2,859 2,784 191 87 2,667 2,696 690 600 1,978 2,096
Female 3,036 3,421 245 139 2,792 3,283 719 637 2,072 2,646
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,940 5,435 298 148 4,642 5,287 1,160 1,010 3,482 4,277
White 4,206 4,583 234 111 3,972 4,472 911 787 3,062 3,685
Black or African American 404 453 29 19 375 435 131 117 244 318
AIAN 20 65 3 * 17 65 7 * 10 *
NHOPI 19 4 * * 19 4 * * * *
Asian 147 109 6 8 141 101 55 25 86 76
Two or More Races 144 220 26 10 118 210 52 * 66 150
Hispanic or Latino 955 770 138 78 817 692 249 227 568 465
EDUCATION LEVEL                    
< High School da da da da 538 516 196 171 342 346
High School Graduate da da da da 1,110 1,526 406 307 704 1,219
Some College/Associate’s Degree da da da da 2,095 2,068 595 579 1,500 1,489
College Graduate da da da da 1,715 1,869 212 180 1,503 1,688
EMPLOYMENT STATUS                    
Full-Time da da da da 2,789 2,801 633 534 2,156 2,267
Part-Time da da da da 935 1,024 352 282 583 742
Unemployed da da da da 368 466 173 144 195 322
Other1 da da da da 1,368 1,687 251 277 1,117 1,410
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2.1 2.2 1.8 0.9 2.2 2.4 4.2 3.7 1.9 2.2
GENDER                    
Male 2.1 2.1 1.5 0.7 2.2 2.2 4.1 3.6 1.9 2.0
Female 2.1 2.4 2.0 1.1 2.2 2.5 4.3 3.8 1.8 2.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.2 2.4 1.6 0.8 2.2 2.5 4.4 3.9 1.9 2.3
White 2.5 2.7 1.8 0.9 2.5 2.8 5.0 4.4 2.2 2.6
Black or African American 1.2 1.3 0.9 0.6 1.3 1.4 2.8 2.5 1.0 1.2
AIAN 1.3 3.9 1.8 * 1.2 4.5 3.3 * 0.9 *
NHOPI 1.7 0.4 * * 1.9 0.4 * * * *
Asian 0.9 0.7 0.5 0.4 1.0 0.7 2.6 1.2 0.7 0.6
Two or More Races 2.7 4.2 2.8 1.6 2.7 4.5 5.5 * 1.9 4.1
Hispanic or Latino 2.0 1.6 2.2 1.2 2.0 1.6 3.3 2.9 1.7 1.4
EDUCATION LEVEL                    
< High School da da da da 1.8 1.8 4.2 4.5 1.3 1.4
High School Graduate da da da da 1.8 2.2 3.8 2.9 1.4 2.1
Some College/Associate’s Degree da da da da 2.7 2.7 4.4 4.1 2.4 2.4
College Graduate da da da da 2.1 2.4 4.3 3.6 1.9 2.3
EMPLOYMENT STATUS                    
Full-Time da da da da 2.2 2.4 4.4 4.2 2.0 2.2
Part-Time da da da da 2.9 3.3 4.2 3.3 2.4 3.3
Unemployed da da da da 3.7 3.6 5.2 4.2 2.9 3.4
Other1 da da da da 1.6 1.9 3.2 3.1 1.5 1.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,958 2,196 121 26 1,837 2,170 365 371 1,472 1,799
GENDER                    
Male 910 888 83 6 828 882 193 184 635 698
Female 1,048 1,309 39 21 1,009 1,288 171 187 838 1,101
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,688 1,917 79 21 1,608 1,896 300 280 1,308 1,616
White 1,499 1,659 60 21 1,439 1,638 240 219 1,199 1,419
Black or African American 100 114 11 * 90 114 22 27 67 87
AIAN 4 44 * * 4 * * * 4 *
NHOPI 1 4 * * 1 4 * * * *
Asian 37 51 3 * 34 51 19 3 15 48
Two or More Races 46 46 5 0 41 45 18 * 23 21
Hispanic or Latino 271 279 42 5 229 274 64 91 164 183
EDUCATION LEVEL                    
< High School da da da da 162 258 56 48 106 210
High School Graduate da da da da 327 441 94 76 233 364
Some College/Associate’s Degree da da da da 785 842 150 189 636 653
College Graduate da da da da 563 630 65 58 498 572
EMPLOYMENT STATUS                    
Full-Time da da da da 856 922 135 169 722 753
Part-Time da da da da 339 363 88 70 251 293
Unemployed da da da da 182 167 74 68 108 99
Other1 da da da da 460 718 68 65 392 654
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.8 0.5 0.1 0.7 0.9 1.1 1.1 0.7 0.8
GENDER                    
Male 0.7 0.7 0.7 0.0 0.7 0.7 1.1 1.1 0.6 0.7
Female 0.7 0.9 0.3 0.2 0.8 1.0 1.0 1.1 0.7 1.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.8 0.4 0.1 0.8 0.9 1.2 1.1 0.7 0.9
White 0.9 1.0 0.5 0.2 0.9 1.0 1.3 1.2 0.9 1.0
Black or African American 0.3 0.3 0.3 * 0.3 0.4 0.5 0.6 0.3 0.3
AIAN 0.3 2.6 * * 0.3 * * * 0.4 *
NHOPI 0.1 0.4 * * 0.1 0.4 * * * *
Asian 0.2 0.3 0.2 * 0.2 0.4 0.9 0.1 0.1 0.4
Two or More Races 0.9 0.9 0.6 0.1 0.9 1.0 1.9 * 0.7 0.6
Hispanic or Latino 0.6 0.6 0.7 0.1 0.6 0.7 0.8 1.2 0.5 0.5
EDUCATION LEVEL                    
< High School da da da da 0.5 0.9 1.2 1.2 0.4 0.8
High School Graduate da da da da 0.5 0.6 0.9 0.7 0.5 0.6
Some College/Associate’s Degree da da da da 1.0 1.1 1.1 1.4 1.0 1.0
College Graduate da da da da 0.7 0.8 1.3 1.2 0.6 0.8
EMPLOYMENT STATUS                    
Full-Time da da da da 0.7 0.8 0.9 1.3 0.7 0.7
Part-Time da da da da 1.0 1.2 1.1 0.8 1.0 1.3
Unemployed da da da da 1.8 1.3 2.2 2.0 1.6 1.0
Other1 da da da da 0.6 0.8 0.9 0.7 0.5 0.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 35,601 35,018 1,010 588 34,591 34,430 3,419 3,338 31,172 31,092
GENDER                    
Male 12,603 13,006 435 238 12,168 12,768 1,350 1,404 10,818 11,364
Female 22,998 22,012 575 349 22,423 21,662 2,068 1,934 20,354 19,728
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 31,339 31,168 739 405 30,600 30,763 2,849 2,745 27,751 28,018
White 26,952 26,756 552 308 26,400 26,447 2,238 2,308 24,162 24,139
Black or African American 2,719 2,777 101 68 2,618 2,709 332 233 2,286 2,476
AIAN 223 176 7 * 216 173 15 * 201 *
NHOPI 46 * * * 44 * * * 36 *
Asian 712 627 35 12 677 615 143 61 534 554
Two or More Races 687 791 42 14 645 777 113 * 532 660
Hispanic or Latino 4,262 3,850 271 183 3,991 3,667 569 593 3,422 3,074
EDUCATION LEVEL                    
< High School da da da da 3,154 3,523 436 337 2,718 3,186
High School Graduate da da da da 7,336 9,102 940 881 6,396 8,221
Some College/Associate’s Degree da da da da 12,397 10,956 1,461 1,537 10,936 9,419
College Graduate da da da da 11,705 10,849 582 583 11,123 10,266
EMPLOYMENT STATUS                    
Full-Time da da da da 14,448 13,300 1,497 1,372 12,952 11,929
Part-Time da da da da 4,752 4,517 823 840 3,929 3,676
Unemployed da da da da 1,440 1,433 395 380 1,045 1,053
Other1 da da da da 13,951 15,180 704 746 13,247 14,434
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 12.9 12.6 4.1 2.4 13.8 13.7 10.1 10.0 14.4 14.2
GENDER                    
Male 9.4 9.7 3.4 1.9 10.1 10.5 8.0 8.4 10.4 10.8
Female 16.2 15.4 4.7 2.9 17.3 16.6 12.3 11.6 18.1 17.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 13.8 13.6 3.9 2.2 14.6 14.7 10.9 10.7 15.2 15.2
White 15.8 15.7 4.3 2.4 16.7 16.7 12.4 12.9 17.3 17.2
Black or African American 8.2 8.3 3.0 2.2 8.8 8.9 7.2 5.1 9.0 9.6
AIAN 14.2 10.6 4.0 * 15.5 12.0 6.9 * 17.1 *
NHOPI 4.2 * * * 4.5 * * * 4.3 *
Asian 4.5 3.9 2.7 0.7 4.6 4.3 6.9 3.1 4.3 4.5
Two or More Races 12.9 14.9 4.5 2.3 14.7 16.6 12.0 * 15.4 18.1
Hispanic or Latino 9.0 8.0 4.4 2.9 9.7 8.7 7.4 7.7 10.2 9.0
EDUCATION LEVEL                    
< High School da da da da 10.5 12.2 9.3 8.8 10.7 12.7
High School Graduate da da da da 12.1 13.1 8.9 8.2 12.8 14.0
Some College/Associate’s Degree da da da da 16.1 14.3 10.8 11.0 17.2 15.1
College Graduate da da da da 14.2 14.1 11.8 11.8 14.4 14.2
EMPLOYMENT STATUS                    
Full-Time da da da da 11.6 11.4 10.4 10.8 11.8 11.5
Part-Time da da da da 14.6 14.4 9.9 9.8 16.2 16.2
Unemployed da da da da 14.5 11.1 12.0 11.2 15.7 11.1
Other1 da da da da 16.7 16.6 9.1 8.4 17.5 17.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,220 5,460 392 196 4,829 5,264 1,313 1,108 3,516 4,156
GENDER                    
Male 2,479 2,470 175 71 2,303 2,399 650 525 1,653 1,874
Female 2,741 2,990 216 125 2,525 2,865 663 583 1,863 2,282
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,321 4,779 262 120 4,059 4,660 1,081 891 2,977 3,769
White 3,726 4,064 207 83 3,519 3,981 861 718 2,659 3,263
Black or African American 340 370 27 19 313 351 126 108 187 243
AIAN 17 51 3 * 14 51 4 * 10 *
NHOPI 19 4 * * 19 4 * * * *
Asian 96 105 5 8 91 97 41 24 49 72
Two or More Races 122 186 20 10 103 176 45 * 58 142
Hispanic or Latino 900 680 130 76 770 604 231 217 539 387
EDUCATION LEVEL                    
< High School da da da da 455 386 196 116 260 269
High School Graduate da da da da 1,000 1,435 390 275 610 1,160
Some College/Associate’s Degree da da da da 1,893 1,808 522 544 1,371 1,263
College Graduate da da da da 1,481 1,636 206 173 1,275 1,463
EMPLOYMENT STATUS                    
Full-Time da da da da 2,434 2,418 594 488 1,839 1,930
Part-Time da da da da 836 945 319 262 517 682
Unemployed da da da da 339 403 167 119 172 284
Other1 da da da da 1,220 1,498 232 239 988 1,259
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.9 2.0 1.6 0.8 1.9 2.1 3.9 3.3 1.6 1.9
GENDER                    
Male 1.9 1.8 1.4 0.6 1.9 2.0 3.8 3.1 1.6 1.8
Female 1.9 2.1 1.8 1.0 2.0 2.2 3.9 3.5 1.7 2.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.9 2.1 1.4 0.6 1.9 2.2 4.1 3.5 1.6 2.0
White 2.2 2.4 1.6 0.6 2.2 2.5 4.8 4.0 1.9 2.3
Black or African American 1.0 1.1 0.8 0.6 1.0 1.2 2.7 2.4 0.7 0.9
AIAN 1.1 3.1 1.8 * 1.0 3.5 1.9 * 0.9 *
NHOPI 1.7 0.4 * * 1.9 0.4 * * * *
Asian 0.6 0.6 0.4 0.4 0.6 0.7 2.0 1.2 0.4 0.6
Two or More Races 2.3 3.5 2.1 1.6 2.3 3.7 4.8 * 1.7 3.9
Hispanic or Latino 1.9 1.4 2.1 1.2 1.9 1.4 3.0 2.8 1.6 1.1
EDUCATION LEVEL                    
< High School da da da da 1.5 1.3 4.2 3.0 1.0 1.1
High School Graduate da da da da 1.6 2.1 3.7 2.6 1.2 2.0
Some College/Associate’s Degree da da da da 2.5 2.4 3.9 3.9 2.2 2.0
College Graduate da da da da 1.8 2.1 4.2 3.5 1.6 2.0
EMPLOYMENT STATUS                    
Full-Time da da da da 2.0 2.1 4.1 3.8 1.7 1.9
Part-Time da da da da 2.6 3.0 3.8 3.1 2.1 3.0
Unemployed da da da da 3.4 3.1 5.1 3.5 2.6 3.0
Other1 da da da da 1.5 1.6 3.0 2.7 1.3 1.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,781 1,891 112 25 1,669 1,866 337 357 1,332 1,509
GENDER                    
Male 842 814 75 6 767 808 182 181 585 628
Female 939 1,077 37 19 901 1,058 155 176 746 881
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,528 1,646 75 20 1,453 1,626 273 266 1,180 1,360
White 1,367 1,425 57 20 1,310 1,405 228 206 1,081 1,199
Black or African American 92 102 10 * 82 102 22 26 60 77
AIAN 4 20 * * 4 20 * * 4 *
NHOPI 1 4 * * 1 4 * * * *
Asian 21 51 3 * 18 51 7 3 10 48
Two or More Races 43 44 5 0 38 44 15 * 23 *
Hispanic or Latino 253 245 37 5 216 240 63 91 152 149
EDUCATION LEVEL                    
< High School da da da da 142 216 56 47 86 170
High School Graduate da da da da 289 390 90 68 198 322
Some College/Associate’s Degree da da da da 743 714 129 188 614 526
College Graduate da da da da 496 546 62 54 434 492
EMPLOYMENT STATUS                    
Full-Time da da da da 802 723 135 164 668 559
Part-Time da da da da 304 339 74 65 231 274
Unemployed da da da da 167 155 65 68 102 87
Other1 da da da da 395 649 64 60 331 589
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.6 0.7 0.5 0.1 0.7 0.7 1.0 1.1 0.6 0.7
GENDER                    
Male 0.6 0.6 0.6 0.0 0.6 0.7 1.1 1.1 0.6 0.6
Female 0.7 0.8 0.3 0.2 0.7 0.8 0.9 1.1 0.7 0.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.4 0.1 0.7 0.8 1.0 1.0 0.6 0.7
White 0.8 0.8 0.4 0.2 0.8 0.9 1.3 1.2 0.8 0.9
Black or African American 0.3 0.3 0.3 * 0.3 0.3 0.5 0.6 0.2 0.3
AIAN 0.3 1.2 * * 0.3 1.4 * * 0.4 *
NHOPI 0.1 0.4 * * 0.1 0.4 * * * *
Asian 0.1 0.3 0.2 * 0.1 0.4 0.4 0.1 0.1 0.4
Two or More Races 0.8 0.8 0.6 0.1 0.9 0.9 1.6 * 0.7 *
Hispanic or Latino 0.5 0.5 0.6 0.1 0.5 0.6 0.8 1.2 0.5 0.4
EDUCATION LEVEL                    
< High School da da da da 0.5 0.7 1.2 1.2 0.3 0.7
High School Graduate da da da da 0.5 0.6 0.9 0.6 0.4 0.5
Some College/Associate’s Degree da da da da 1.0 0.9 1.0 1.3 1.0 0.8
College Graduate da da da da 0.6 0.7 1.3 1.1 0.6 0.7
EMPLOYMENT STATUS                    
Full-Time da da da da 0.6 0.6 0.9 1.3 0.6 0.5
Part-Time da da da da 0.9 1.1 0.9 0.8 1.0 1.2
Unemployed da da da da 1.7 1.2 2.0 2.0 1.5 0.9
Other1 da da da da 0.5 0.7 0.8 0.7 0.4 0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 15,636 15,364 545 429 15,091 14,935 1,051 1,066 14,040 13,869
GENDER                    
Male 6,394 6,418 238 193 6,156 6,225 426 475 5,729 5,751
Female 9,242 8,946 307 236 8,936 8,710 624 591 8,311 8,119
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 13,938 13,636 416 333 13,522 13,302 877 932 12,645 12,370
White 11,707 11,824 291 252 11,416 11,572 653 768 10,764 10,804
Black or African American 1,287 1,267 82 48 1,204 1,218 114 63 1,090 1,155
AIAN 89 84 * * 88 77 6 * 82 *
NHOPI 13 4 * * 12 2 * * 9 *
Asian 571 151 19 13 552 138 75 9 477 129
Two or More Races 271 306 22 * 249 296 25 * 224 218
Hispanic or Latino 1,698 1,729 129 96 1,569 1,633 174 133 1,395 1,499
EDUCATION LEVEL                    
< High School da da da da 1,370 1,681 160 135 1,211 1,546
High School Graduate da da da da 3,252 3,444 260 324 2,992 3,120
Some College/Associate’s Degree da da da da 4,878 5,387 470 438 4,408 4,949
College Graduate da da da da 5,591 4,423 162 169 5,429 4,254
EMPLOYMENT STATUS                    
Full-Time da da da da 6,081 5,684 409 392 5,672 5,292
Part-Time da da da da 1,880 1,771 256 266 1,624 1,504
Unemployed da da da da 575 475 161 134 415 341
Other1 da da da da 6,554 7,005 225 273 6,330 6,732
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5.7 5.5 2.2 1.7 6.0 5.9 3.1 3.2 6.5 6.3
GENDER                    
Male 4.8 4.8 1.9 1.5 5.1 5.1 2.5 2.8 5.5 5.5
Female 6.5 6.3 2.5 1.9 6.9 6.7 3.7 3.5 7.4 7.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6.1 6.0 2.2 1.8 6.5 6.3 3.4 3.6 6.9 6.7
White 6.9 6.9 2.3 2.0 7.2 7.3 3.6 4.3 7.7 7.7
Black or African American 3.9 3.8 2.5 1.5 4.0 4.0 2.5 1.4 4.3 4.5
AIAN 5.7 5.1 * * 6.3 5.4 2.7 * 7.0 *
NHOPI 1.2 0.4 * * 1.3 0.2 * * 1.0 *
Asian 3.6 0.9 1.5 0.7 3.8 1.0 3.6 0.4 3.8 1.0
Two or More Races 5.1 5.8 2.3 * 5.7 6.3 2.7 * 6.5 6.0
Hispanic or Latino 3.6 3.6 2.1 1.5 3.8 3.9 2.3 1.7 4.2 4.4
EDUCATION LEVEL                    
< High School da da da da 4.5 5.8 3.4 3.5 4.8 6.2
High School Graduate da da da da 5.4 5.0 2.4 3.0 6.0 5.3
Some College/Associate’s Degree da da da da 6.3 7.0 3.5 3.1 6.9 7.9
College Graduate da da da da 6.8 5.7 3.3 3.4 7.0 5.9
EMPLOYMENT STATUS                    
Full-Time da da da da 4.9 4.9 2.9 3.1 5.2 5.1
Part-Time da da da da 5.8 5.7 3.1 3.1 6.7 6.6
Unemployed da da da da 5.8 3.7 4.9 4.0 6.2 3.6
Other1 da da da da 7.8 7.7 2.9 3.1 8.3 8.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,098 1,240 82 35 1,016 1,205 175 251 841 954
GENDER                    
Male 545 549 43 21 502 527 66 121 436 406
Female 553 692 40 13 514 678 109 130 405 548
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 971 1,134 60 28 911 1,106 150 236 761 870
White 806 928 48 28 757 899 107 160 651 739
Black or African American 66 100 5 * 61 100 5 13 57 87
AIAN 5 46 * * 5 * * * 1 *
NHOPI * * * * * * * * * *
Asian 66 4 1 * 65 4 22 0 43 4
Two or More Races 29 57 6 * 23 57 14 * 9 9
Hispanic or Latino 127 106 22 7 105 99 25 15 80 84
EDUCATION LEVEL                    
< High School da da da da 106 164 7 80 99 84
High School Graduate da da da da 180 232 42 64 138 168
Some College/Associate’s Degree da da da da 327 421 115 82 213 339
College Graduate da da da da 402 388 11 25 391 363
EMPLOYMENT STATUS                    
Full-Time da da da da 511 557 58 93 454 464
Part-Time da da da da 154 166 58 33 95 133
Unemployed da da da da 84 127 29 63 55 64
Other1 da da da da 267 356 29 62 237 294
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.4 0.4 0.3 0.1 0.4 0.5 0.5 0.7 0.4 0.4
GENDER                    
Male 0.4 0.4 0.3 0.2 0.4 0.4 0.4 0.7 0.4 0.4
Female 0.4 0.5 0.3 0.1 0.4 0.5 0.6 0.8 0.4 0.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4 0.5 0.3 0.2 0.4 0.5 0.6 0.9 0.4 0.5
White 0.5 0.5 0.4 0.2 0.5 0.6 0.6 0.9 0.5 0.5
Black or African American 0.2 0.3 0.2 * 0.2 0.3 0.1 0.3 0.2 0.3
AIAN 0.3 2.8 * * 0.3 * * * 0.1 *
NHOPI * * * * * * * * * *
Asian 0.4 0.0 0.1 * 0.4 0.0 1.1 0.0 0.3 0.0
Two or More Races 0.5 1.1 0.7 * 0.5 1.2 1.4 * 0.3 0.2
Hispanic or Latino 0.3 0.2 0.4 0.1 0.3 0.2 0.3 0.2 0.2 0.2
EDUCATION LEVEL                    
< High School da da da da 0.4 0.6 0.2 2.1 0.4 0.3
High School Graduate da da da da 0.3 0.3 0.4 0.6 0.3 0.3
Some College/Associate’s Degree da da da da 0.4 0.6 0.8 0.6 0.3 0.5
College Graduate da da da da 0.5 0.5 0.2 0.5 0.5 0.5
EMPLOYMENT STATUS                    
Full-Time da da da da 0.4 0.5 0.4 0.7 0.4 0.4
Part-Time da da da da 0.5 0.5 0.7 0.4 0.4 0.6
Unemployed da da da da 0.8 1.0 0.9 1.9 0.8 0.7
Other1 da da da da 0.3 0.4 0.4 0.7 0.3 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 304 481 29 1 275 480 44 78 231 402
GENDER                    
Male 144 130 26 * 118 130 17 21 101 109
Female 160 351 3 1 157 350 27 57 130 293
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 269 442 13 1 255 440 43 78 212 363
White 240 380 12 1 228 379 27 52 201 326
Black or African American 8 16 1 * 7 16 * 5 7 11
AIAN * * * * * * * * * *
NHOPI * * * * * * * * * *
Asian 16 * * * 16 * 12 * 4 *
Two or More Races 5 22 * * 5 22 5 * * 1
Hispanic or Latino 35 39 15 * 20 39 1 * 19 39
EDUCATION LEVEL                    
< High School da da da da 26 62 7 * 20 40
High School Graduate da da da da 64 100 8 17 57 83
Some College/Associate’s Degree da da da da 60 210 27 35 33 175
College Graduate da da da da 125 108 3 4 122 104
EMPLOYMENT STATUS                    
Full-Time da da da da 111 255 * 36 111 220
Part-Time da da da da 59 32 16 13 43 19
Unemployed da da da da 37 32 20 * 17 12
Other1 da da da da 68 160 8 9 61 151
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.2
GENDER                    
Male 0.1 0.1 0.2 * 0.1 0.1 0.1 0.1 0.1 0.1
Female 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.3 0.1 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.3 0.1 0.2
White 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.2
Black or African American 0.0 0.0 0.0 * 0.0 0.1 * 0.1 0.0 0.0
AIAN * * * * * * * * * *
NHOPI * * * * * * * * * *
Asian 0.1 * * * 0.1 * 0.6 * 0.0 *
Two or More Races 0.1 0.4 * * 0.1 0.5 0.5 * * 0.0
Hispanic or Latino 0.1 0.1 0.2 * 0.0 0.1 0.0 * 0.1 0.1
EDUCATION LEVEL                    
< High School da da da da 0.1 0.2 0.1 * 0.1 0.2
High School Graduate da da da da 0.1 0.1 0.1 0.2 0.1 0.1
Some College/Associate’s Degree da da da da 0.1 0.3 0.2 0.3 0.1 0.3
College Graduate da da da da 0.2 0.1 0.1 0.1 0.2 0.1
EMPLOYMENT STATUS                    
Full-Time da da da da 0.1 0.2 * 0.3 0.1 0.2
Part-Time da da da da 0.2 0.1 0.2 0.2 0.2 0.1
Unemployed da da da da 0.4 0.2 0.6 * 0.3 0.1
Other1 da da da da 0.1 0.2 0.1 0.1 0.1 0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 29,408 27,026 749 418 28,659 26,607 2,983 2,861 25,676 23,747
GENDER                    
Male 10,472 10,113 338 176 10,134 9,937 1,211 1,199 8,923 8,738
Female 18,935 16,912 411 242 18,525 16,670 1,771 1,662 16,753 15,008
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 26,010 24,100 538 274 25,472 23,826 2,486 2,335 22,986 21,491
White 22,519 20,806 418 233 22,100 20,573 1,979 1,920 20,121 18,653
Black or African American 2,074 2,071 70 17 2,004 2,054 287 227 1,718 1,827
AIAN 154 101 5 * 149 99 12 * 137 75
NHOPI 46 * * * 44 * * * 36 *
Asian 648 436 12 12 636 424 112 61 524 363
Two or More Races 569 646 31 9 538 637 88 * 450 533
Hispanic or Latino 3,398 2,925 211 144 3,187 2,782 496 525 2,690 2,256
EDUCATION LEVEL                    
< High School da da da da 2,446 2,693 394 302 2,052 2,390
High School Graduate da da da da 6,031 6,938 841 759 5,190 6,179
Some College/Associate’s Degree da da da da 10,241 8,539 1,232 1,335 9,008 7,204
College Graduate da da da da 9,941 8,438 515 465 9,426 7,974
EMPLOYMENT STATUS                    
Full-Time da da da da 11,879 10,066 1,326 1,160 10,553 8,906
Part-Time da da da da 4,103 3,630 708 736 3,394 2,894
Unemployed da da da da 1,283 1,146 353 320 930 827
Other1 da da da da 11,395 11,765 596 646 10,799 11,119
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10.7 9.8 3.0 1.7 11.4 10.6 8.8 8.5 11.9 10.9
GENDER                    
Male 7.8 7.5 2.7 1.4 8.4 8.2 7.2 7.1 8.6 8.3
Female 13.4 11.9 3.4 2.0 14.3 12.8 10.5 9.9 14.9 13.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 11.4 10.5 2.9 1.5 12.2 11.4 9.5 9.1 12.6 11.7
White 13.2 12.2 3.3 1.8 14.0 13.0 11.0 10.7 14.4 13.3
Black or African American 6.2 6.2 2.1 0.6 6.7 6.7 6.2 4.9 6.8 7.1
AIAN 9.8 6.1 2.8 * 10.7 6.8 5.6 * 11.7 6.0
NHOPI 4.2 * * * 4.5 * * * 4.3 *
Asian 4.1 2.7 0.9 0.7 4.4 3.0 5.3 3.1 4.2 2.9
Two or More Races 10.7 12.2 3.3 1.5 12.3 13.6 9.4 * 13.1 14.6
Hispanic or Latino 7.2 6.0 3.4 2.3 7.7 6.6 6.5 6.8 8.0 6.6
EDUCATION LEVEL                    
< High School da da da da 8.1 9.3 8.4 7.9 8.1 9.5
High School Graduate da da da da 9.9 10.0 7.9 7.1 10.3 10.5
Some College/Associate’s Degree da da da da 13.3 11.2 9.1 9.5 14.2 11.5
College Graduate da da da da 12.1 10.9 10.4 9.4 12.2 11.1
EMPLOYMENT STATUS                    
Full-Time da da da da 9.6 8.6 9.2 9.1 9.6 8.6
Part-Time da da da da 12.6 11.6 8.5 8.6 14.0 12.7
Unemployed da da da da 12.9 8.9 10.7 9.4 14.0 8.7
Other1 da da da da 13.6 12.9 7.7 7.3 14.2 13.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,841 4,779 381 157 4,460 4,622 1,266 1,097 3,194 3,526
GENDER                    
Male 2,287 2,245 173 59 2,114 2,186 630 526 1,484 1,660
Female 2,554 2,534 208 98 2,346 2,436 636 570 1,710 1,866
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,069 4,115 255 95 3,815 4,019 1,048 880 2,767 3,139
White 3,518 3,535 198 78 3,320 3,457 833 709 2,486 2,748
Black or African American 299 279 26 1 273 277 118 108 155 169
AIAN 17 27 3 * 14 27 4 * 10 *
NHOPI 19 4 * * 19 4 * * * *
Asian 96 88 5 8 91 79 41 * 49 56
Two or More Races 120 182 22 7 99 175 46 * 52 142
Hispanic or Latino 772 665 126 62 645 603 218 216 428 387
EDUCATION LEVEL                    
< High School da da da da 383 276 185 116 198 160
High School Graduate da da da da 937 1,304 376 274 560 1,030
Some College/Associate’s Degree da da da da 1,763 1,593 509 536 1,254 1,057
College Graduate da da da da 1,378 1,450 195 171 1,183 1,279
EMPLOYMENT STATUS                    
Full-Time da da da da 2,260 2,133 572 486 1,688 1,647
Part-Time da da da da 794 808 311 254 483 555
Unemployed da da da da 328 361 167 118 161 243
Other1 da da da da 1,078 1,320 216 239 862 1,081
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.8 1.7 1.5 0.6 1.8 1.8 3.8 3.3 1.5 1.6
GENDER                    
Male 1.7 1.7 1.4 0.5 1.7 1.8 3.7 3.1 1.4 1.6
Female 1.8 1.8 1.7 0.8 1.8 1.9 3.8 3.4 1.5 1.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.8 1.8 1.4 0.5 1.8 1.9 4.0 3.4 1.5 1.7
White 2.1 2.1 1.5 0.6 2.1 2.2 4.6 4.0 1.8 2.0
Black or African American 0.9 0.8 0.8 0.0 0.9 0.9 2.6 2.4 0.6 0.7
AIAN 1.1 1.6 1.8 * 1.0 1.9 1.9 * 0.9 *
NHOPI 1.7 0.4 * * 1.9 0.4 * * * *
Asian 0.6 0.5 0.4 0.4 0.6 0.6 2.0 * 0.4 0.5
Two or More Races 2.3 3.4 2.3 1.2 2.3 3.7 4.9 * 1.5 3.9
Hispanic or Latino 1.6 1.4 2.0 1.0 1.6 1.4 2.8 2.8 1.3 1.1
EDUCATION LEVEL                    
< High School da da da da 1.3 1.0 3.9 3.0 0.8 0.6
High School Graduate da da da da 1.5 1.9 3.5 2.6 1.1 1.8
Some College/Associate’s Degree da da da da 2.3 2.1 3.8 3.8 2.0 1.7
College Graduate da da da da 1.7 1.9 3.9 3.4 1.5 1.8
EMPLOYMENT STATUS                    
Full-Time da da da da 1.8 1.8 4.0 3.8 1.5 1.6
Part-Time da da da da 2.4 2.6 3.7 3.0 2.0 2.4
Unemployed da da da da 3.3 2.8 5.1 3.5 2.4 2.6
Other1 da da da da 1.3 1.4 2.8 2.7 1.1 1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.61A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10,065 9,490 567 396 9,499 9,094 1,776 1,376 7,723 7,717
GENDER                    
Male 5,420 4,375 254 215 5,166 4,160 903 630 4,263 3,530
Female 4,645 5,115 312 181 4,333 4,933 873 746 3,460 4,187
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8,305 7,712 407 248 7,898 7,464 1,335 1,103 6,563 6,361
White 6,518 5,778 289 166 6,229 5,612 1,015 883 5,214 4,729
Black or African American 1,139 1,259 85 61 1,055 1,198 178 153 877 1,046
AIAN 80 106 5 * 75 101 14 * 61 *
NHOPI 30 6 * * 30 6 * * 28 *
Asian 262 390 3 4 259 386 66 21 193 365
Two or More Races 275 173 24 12 251 161 61 * 190 132
Hispanic or Latino 1,760 1,777 160 148 1,600 1,630 440 274 1,160 1,356
EDUCATION LEVEL                    
< High School da da da da 1,321 1,206 295 143 1,025 1,063
High School Graduate da da da da 2,406 2,551 556 418 1,850 2,134
Some College/Associate’s Degree da da da da 3,408 3,342 739 576 2,669 2,766
College Graduate da da da da 2,364 1,994 185 240 2,178 1,754
EMPLOYMENT STATUS                    
Full-Time da da da da 4,842 3,883 828 673 4,014 3,211
Part-Time da da da da 1,189 1,321 401 240 788 1,081
Unemployed da da da da 695 565 197 163 498 402
Other1 da da da da 2,773 3,324 349 301 2,423 3,023
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.61B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.7 3.4 2.3 1.6 3.8 3.6 5.3 4.1 3.6 3.5
GENDER                    
Male 4.1 3.3 2.0 1.7 4.3 3.4 5.3 3.8 4.1 3.4
Female 3.3 3.6 2.6 1.5 3.3 3.8 5.2 4.5 3.1 3.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.6 3.4 2.2 1.3 3.8 3.6 5.1 4.3 3.6 3.5
White 3.8 3.4 2.3 1.3 3.9 3.6 5.6 4.9 3.7 3.4
Black or African American 3.4 3.7 2.5 1.9 3.5 3.9 3.8 3.3 3.5 4.0
AIAN 5.1 6.4 2.9 * 5.4 7.0 6.4 * 5.2 *
NHOPI 2.8 0.6 * * 3.0 0.6 * * 3.4 *
Asian 1.6 2.4 0.3 0.2 1.8 2.7 3.2 1.1 1.5 3.0
Two or More Races 5.2 3.3 2.6 2.0 5.7 3.4 6.5 * 5.5 3.6
Hispanic or Latino 3.7 3.7 2.6 2.3 3.9 3.9 5.7 3.5 3.5 3.9
EDUCATION LEVEL                    
< High School da da da da 4.4 4.2 6.3 3.7 4.0 4.2
High School Graduate da da da da 4.0 3.7 5.2 3.9 3.7 3.6
Some College/Associate’s Degree da da da da 4.4 4.4 5.5 4.1 4.2 4.4
College Graduate da da da da 2.9 2.6 3.8 4.8 2.8 2.4
EMPLOYMENT STATUS                    
Full-Time da da da da 3.9 3.3 5.8 5.3 3.7 3.1
Part-Time da da da da 3.6 4.2 4.8 2.8 3.2 4.8
Unemployed da da da da 7.0 4.4 6.0 4.8 7.5 4.2
Other1 da da da da 3.3 3.6 4.5 3.4 3.2 3.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.62A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3,101 2,885 165 96 2,936 2,789 439 296 2,497 2,493
GENDER                    
Male 1,676 1,258 68 61 1,609 1,197 198 140 1,411 1,057
Female 1,425 1,627 97 35 1,328 1,592 242 156 1,086 1,436
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2,582 2,275 117 80 2,465 2,195 343 253 2,122 1,942
White 2,061 1,701 79 52 1,982 1,649 274 193 1,708 1,456
Black or African American 319 401 24 24 294 376 45 60 249 316
AIAN 16 28 * * 16 28 3 * 14 28
NHOPI * 1 * * * 1 * * * *
Asian 77 106 * 0 77 106 5 * 72 106
Two or More Races 96 39 14 3 82 36 14 0 68 36
Hispanic or Latino 519 610 48 16 472 594 97 43 375 551
EDUCATION LEVEL                    
< High School da da da da 329 417 91 36 238 381
High School Graduate da da da da 867 677 127 100 740 578
Some College/Associate’s Degree da da da da 1,007 1,237 181 127 826 1,110
College Graduate da da da da 733 457 40 33 693 424
EMPLOYMENT STATUS                    
Full-Time da da da da 1,335 1,082 193 107 1,142 974
Part-Time da da da da 339 368 90 41 249 327
Unemployed da da da da 317 147 67 29 250 118
Other1 da da da da 945 1,192 89 118 856 1,074
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.62B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.1 1.0 0.7 0.4 1.2 1.1 1.3 0.9 1.2 1.1
GENDER                    
Male 1.3 0.9 0.5 0.5 1.3 1.0 1.2 0.8 1.4 1.0
Female 1.0 1.1 0.8 0.3 1.0 1.2 1.4 0.9 1.0 1.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.1 1.0 0.6 0.4 1.2 1.0 1.3 1.0 1.2 1.1
White 1.2 1.0 0.6 0.4 1.3 1.0 1.5 1.1 1.2 1.0
Black or African American 1.0 1.2 0.7 0.8 1.0 1.2 1.0 1.3 1.0 1.2
AIAN 1.0 1.7 * * 1.2 1.9 1.2 * 1.2 2.2
NHOPI * 0.1 * * * 0.1 * * * *
Asian 0.5 0.7 * 0.0 0.5 0.7 0.2 * 0.6 0.9
Two or More Races 1.8 0.7 1.5 0.5 1.9 0.8 1.5 0.0 2.0 1.0
Hispanic or Latino 1.1 1.3 0.8 0.3 1.1 1.4 1.3 0.6 1.1 1.6
EDUCATION LEVEL                    
< High School da da da da 1.1 1.4 2.0 0.9 0.9 1.5
High School Graduate da da da da 1.4 1.0 1.2 0.9 1.5 1.0
Some College/Associate’s Degree da da da da 1.3 1.6 1.3 0.9 1.3 1.8
College Graduate da da da da 0.9 0.6 0.8 0.7 0.9 0.6
EMPLOYMENT STATUS                    
Full-Time da da da da 1.1 0.9 1.3 0.8 1.0 0.9
Part-Time da da da da 1.0 1.2 1.1 0.5 1.0 1.4
Unemployed da da da da 3.2 1.1 2.0 0.9 3.8 1.2
Other1 da da da da 1.1 1.3 1.2 1.3 1.1 1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.63A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10,136 10,306 499 346 9,638 9,960 3,205 2,567 6,433 7,393
GENDER                    
Male 5,991 5,854 286 179 5,705 5,674 1,792 1,397 3,914 4,278
Female 4,145 4,452 213 166 3,932 4,286 1,413 1,171 2,519 3,115
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8,567 8,859 370 270 8,197 8,589 2,610 2,144 5,587 6,445
White 7,080 7,531 289 216 6,791 7,314 2,171 1,841 4,619 5,474
Black or African American 751 701 29 26 722 674 156 156 566 518
AIAN 62 116 3 * 59 103 17 * 42 *
NHOPI 45 6 * * 44 6 * * 32 *
Asian 311 223 25 8 286 215 122 45 164 170
Two or More Races 318 283 24 7 295 276 132 98 163 177
Hispanic or Latino 1,570 1,447 129 76 1,441 1,371 595 423 846 948
EDUCATION LEVEL                    
< High School da da da da 971 976 311 150 660 827
High School Graduate da da da da 2,314 2,535 706 630 1,608 1,904
Some College/Associate’s Degree da da da da 3,759 3,397 1,488 1,203 2,271 2,194
College Graduate da da da da 2,593 3,053 700 585 1,893 2,468
EMPLOYMENT STATUS                    
Full-Time da da da da 5,146 5,039 1,538 1,210 3,607 3,829
Part-Time da da da da 1,499 1,518 832 521 667 997
Unemployed da da da da 895 1,022 308 330 588 692
Other1 da da da da 2,098 2,381 527 506 1,571 1,875
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.63B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.7 3.7 2.0 1.4 3.9 4.0 9.5 7.7 3.0 3.4
GENDER                    
Male 4.5 4.4 2.3 1.4 4.7 4.7 10.6 8.3 3.8 4.1
Female 2.9 3.1 1.7 1.4 3.0 3.3 8.4 7.0 2.2 2.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.8 3.9 2.0 1.4 3.9 4.1 10.0 8.3 3.1 3.5
White 4.1 4.4 2.3 1.7 4.3 4.6 12.0 10.3 3.3 3.9
Black or African American 2.3 2.1 0.9 0.8 2.4 2.2 3.4 3.4 2.2 2.0
AIAN 4.0 7.0 1.9 * 4.2 7.2 7.7 * 3.6 *
NHOPI 4.1 0.6 * * 4.5 0.6 * * 3.9 *
Asian 2.0 1.4 1.9 0.4 2.0 1.5 5.8 2.3 1.3 1.4
Two or More Races 6.0 5.3 2.5 1.1 6.7 5.9 14.0 9.5 4.7 4.9
Hispanic or Latino 3.3 3.0 2.1 1.2 3.5 3.3 7.8 5.5 2.5 2.8
EDUCATION LEVEL                    
< High School da da da da 3.2 3.4 6.6 3.9 2.6 3.3
High School Graduate da da da da 3.8 3.6 6.7 5.9 3.2 3.2
Some College/Associate’s Degree da da da da 4.9 4.4 11.0 8.6 3.6 3.5
College Graduate da da da da 3.1 4.0 14.2 11.8 2.4 3.4
EMPLOYMENT STATUS                    
Full-Time da da da da 4.1 4.3 10.7 9.5 3.3 3.7
Part-Time da da da da 4.6 4.9 10.0 6.1 2.7 4.4
Unemployed da da da da 9.0 7.9 9.3 9.8 8.9 7.3
Other1 da da da da 2.5 2.6 6.8 5.7 2.1 2.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.64A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,264 4,483 160 87 4,103 4,396 1,127 682 2,976 3,714
GENDER                    
Male 2,524 2,513 106 40 2,418 2,474 623 322 1,795 2,152
Female 1,740 1,970 55 47 1,685 1,922 504 360 1,181 1,562
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,591 3,865 105 82 3,486 3,783 930 544 2,556 3,239
White 2,908 3,319 87 62 2,822 3,257 764 481 2,058 2,776
Black or African American 367 225 8 13 359 211 48 15 310 196
AIAN 28 36 * * 28 36 2 * 26 35
NHOPI 17 0 * * 17 0 * * 12 *
Asian 135 136 6 4 129 132 54 8 75 125
Two or More Races 136 148 4 3 131 146 56 39 76 107
Hispanic or Latino 672 618 55 5 617 613 198 139 419 475
EDUCATION LEVEL                    
< High School da da da da 432 487 118 52 315 434
High School Graduate da da da da 1,154 1,233 256 169 898 1,065
Some College/Associate’s Degree da da da da 1,480 1,439 529 277 951 1,162
College Graduate da da da da 1,037 1,237 224 184 812 1,053
EMPLOYMENT STATUS                    
Full-Time da da da da 2,025 2,211 511 348 1,514 1,863
Part-Time da da da da 611 659 305 154 306 505
Unemployed da da da da 512 450 99 78 413 371
Other1 da da da da 956 1,077 213 102 743 974
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.64B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.5 1.6 0.6 0.3 1.6 1.7 3.3 2.0 1.4 1.7
GENDER                    
Male 1.9 1.9 0.8 0.3 2.0 2.0 3.7 1.9 1.7 2.1
Female 1.2 1.4 0.4 0.4 1.3 1.5 3.0 2.2 1.0 1.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.6 1.7 0.6 0.4 1.7 1.8 3.6 2.1 1.4 1.8
White 1.7 1.9 0.7 0.5 1.8 2.1 4.2 2.7 1.5 2.0
Black or African American 1.1 0.7 0.2 0.4 1.2 0.7 1.0 0.3 1.2 0.8
AIAN 1.8 2.2 * * 2.0 2.5 1.1 * 2.2 2.8
NHOPI 1.5 0.0 * * 1.7 0.0 * * 1.4 *
Asian 0.9 0.8 0.5 0.2 0.9 0.9 2.6 0.4 0.6 1.0
Two or More Races 2.5 2.8 0.5 0.4 3.0 3.1 5.9 3.7 2.2 2.9
Hispanic or Latino 1.4 1.3 0.9 0.1 1.5 1.5 2.6 1.8 1.2 1.4
EDUCATION LEVEL                    
< High School da da da da 1.4 1.7 2.5 1.4 1.2 1.7
High School Graduate da da da da 1.9 1.8 2.4 1.6 1.8 1.8
Some College/Associate’s Degree da da da da 1.9 1.9 3.9 2.0 1.5 1.9
College Graduate da da da da 1.3 1.6 4.5 3.7 1.0 1.5
EMPLOYMENT STATUS                    
Full-Time da da da da 1.6 1.9 3.6 2.7 1.4 1.8
Part-Time da da da da 1.9 2.1 3.7 1.8 1.3 2.2
Unemployed da da da da 5.2 3.5 3.0 2.3 6.2 3.9
Other1 da da da da 1.1 1.2 2.7 1.2 1.0 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.65A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 23,588 23,962 1,862 1,507 21,727 22,455 5,791 5,169 15,936 17,286
GENDER                    
Male 13,083 12,370 894 704 12,189 11,667 3,187 2,757 9,002 8,910
Female 10,505 11,592 968 803 9,537 10,788 2,604 2,411 6,934 8,377
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 19,544 20,313 1,375 1,106 18,169 19,207 4,620 4,338 13,550 14,869
White 15,577 16,334 994 819 14,584 15,515 3,617 3,546 10,967 11,970
Black or African American 2,231 2,364 220 125 2,011 2,239 470 455 1,541 1,784
AIAN 177 204 31 * 146 164 46 * 100 136
NHOPI 61 26 * * 59 26 * * 40 *
Asian 802 770 38 76 763 694 253 108 510 586
Two or More Races 696 614 91 47 606 568 215 191 391 377
Hispanic or Latino 4,045 3,649 487 401 3,558 3,248 1,172 830 2,386 2,418
EDUCATION LEVEL                    
< High School da da da da 2,461 2,397 681 494 1,780 1,903
High School Graduate da da da da 5,037 5,334 1,576 1,247 3,461 4,086
Some College/Associate’s Degree da da da da 8,012 7,844 2,549 2,356 5,463 5,488
College Graduate da da da da 6,217 6,880 985 1,071 5,231 5,809
EMPLOYMENT STATUS                    
Full-Time da da da da 11,531 10,837 2,696 2,306 8,835 8,532
Part-Time da da da da 3,349 3,654 1,505 1,222 1,844 2,433
Unemployed da da da da 1,591 1,725 597 605 995 1,120
Other1 da da da da 5,255 6,238 994 1,036 4,262 5,202
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.65B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 8.6 8.7 7.5 6.0 8.7 8.9 17.2 15.4 7.4 7.9
GENDER                    
Male 9.8 9.2 7.0 5.5 10.1 9.6 18.9 16.4 8.7 8.5
Female 7.4 8.1 7.9 6.6 7.4 8.3 15.5 14.4 6.2 7.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8.6 8.9 7.3 5.9 8.7 9.2 17.7 16.8 7.4 8.1
White 9.1 9.6 7.7 6.4 9.2 9.8 20.1 19.8 7.8 8.5
Black or African American 6.7 7.0 6.5 4.0 6.7 7.3 10.1 9.9 6.1 6.9
AIAN 11.3 12.3 17.7 * 10.5 11.4 21.0 * 8.6 10.9
NHOPI 5.6 2.6 * * 5.9 2.7 * * 4.8 *
Asian 5.0 4.8 2.9 4.1 5.2 4.8 12.1 5.5 4.1 4.7
Two or More Races 13.1 11.6 9.7 7.5 13.8 12.1 22.9 18.5 11.3 10.3
Hispanic or Latino 8.5 7.5 7.9 6.4 8.6 7.7 15.3 10.7 7.1 7.0
EDUCATION LEVEL                    
< High School da da da da 8.2 8.3 14.5 12.9 7.0 7.6
High School Graduate da da da da 8.3 7.7 14.9 11.6 6.9 7.0
Some College/Associate’s Degree da da da da 10.4 10.3 18.9 16.9 8.6 8.8
College Graduate da da da da 7.5 8.9 20.0 21.6 6.8 8.1
EMPLOYMENT STATUS                    
Full-Time da da da da 9.3 9.3 18.8 18.1 8.0 8.2
Part-Time da da da da 10.3 11.7 18.0 14.3 7.6 10.7
Unemployed da da da da 16.0 13.4 18.1 17.9 15.0 11.8
Other1 da da da da 6.3 6.8 12.8 11.7 5.6 6.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.66A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9,333 9,305 598 305 8,735 9,000 2,059 1,600 6,676 7,400
GENDER                    
Male 5,281 4,974 291 163 4,991 4,812 1,116 924 3,875 3,888
Female 4,052 4,331 307 142 3,744 4,189 943 676 2,801 3,512
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7,844 7,908 419 269 7,425 7,640 1,650 1,283 5,775 6,356
White 6,267 6,391 303 179 5,964 6,212 1,307 1,058 4,657 5,154
Black or African American 834 855 61 55 772 800 133 130 639 670
AIAN 68 114 * * 64 101 10 * 53 93
NHOPI 31 7 * * 30 7 * * 22 *
Asian 344 263 9 8 335 255 98 12 237 242
Two or More Races 300 278 40 14 260 265 94 74 166 191
Hispanic or Latino 1,489 1,397 179 36 1,310 1,361 409 317 901 1,044
EDUCATION LEVEL                    
< High School da da da da 918 1,134 282 177 636 957
High School Graduate da da da da 2,228 2,151 514 376 1,714 1,775
Some College/Associate’s Degree da da da da 3,092 3,235 892 721 2,200 2,515
College Graduate da da da da 2,498 2,480 371 327 2,126 2,153
EMPLOYMENT STATUS                    
Full-Time da da da da 4,326 4,343 886 752 3,440 3,591
Part-Time da da da da 1,306 1,317 548 335 758 982
Unemployed da da da da 842 781 224 207 619 574
Other1 da da da da 2,261 2,558 401 306 1,860 2,252
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210604
Table 1.66B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.4 3.4 2.4 1.2 3.5 3.6 6.1 4.8 3.1 3.4
GENDER                    
Male 4.0 3.7 2.3 1.3 4.1 4.0 6.6 5.5 3.7 3.7
Female 2.9 3.0 2.5 1.2 2.9 3.2 5.6 4.0 2.5 3.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.4 3.5 2.2 1.4 3.6 3.6 6.3 5.0 3.2 3.5
White 3.7 3.7 2.4 1.4 3.8 3.9 7.2 5.9 3.3 3.7
Black or African American 2.5 2.5 1.8 1.8 2.6 2.6 2.9 2.8 2.5 2.6
AIAN 4.4 6.9 * * 4.6 7.0 4.7 * 4.5 7.4
NHOPI 2.8 0.7 * * 3.0 0.7 * * 2.7 *
Asian 2.2 1.6 0.7 0.4 2.3 1.8 4.7 0.6 1.9 2.0
Two or More Races 5.6 5.2 4.3 2.2 5.9 5.6 10.0 7.1 4.8 5.2
Hispanic or Latino 3.1 2.9 2.9 0.6 3.2 3.2 5.3 4.1 2.7 3.0
EDUCATION LEVEL                    
< High School da da da da 3.0 3.9 6.0 4.6 2.5 3.8
High School Graduate da da da da 3.7 3.1 4.8 3.5 3.4 3.0
Some College/Associate’s Degree da da da da 4.0 4.2 6.6 5.2 3.5 4.0
College Graduate da da da da 3.0 3.2 7.5 6.6 2.7 3.0
EMPLOYMENT STATUS                    
Full-Time da da da da 3.5 3.7 6.2 5.9 3.1 3.5
Part-Time da da da da 4.0 4.2 6.6 3.9 3.1 4.3
Unemployed da da da da 8.5 6.1 6.8 6.1 9.3 6.1
Other1 da da da da 2.7 2.8 5.2 3.5 2.5 2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.67A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 57,203 59,277 4,279 3,436 52,924 55,841 13,193 12,398 39,731 43,443
GEOGRAPHIC REGION                    
Northeast 10,280 10,856 690 581 9,590 10,275 2,406 2,066 7,184 8,209
Midwest 11,543 12,278 899 760 10,644 11,518 2,876 2,943 7,768 8,575
South 18,915 19,040 1,504 1,163 17,411 17,877 4,429 4,114 12,981 13,763
West 16,466 17,103 1,186 931 15,280 16,172 3,482 3,275 11,798 12,896
COUNTY TYPE                    
Large Metro 33,771 33,255 2,326 1,852 31,445 31,402 7,782 6,651 23,663 24,751
Small Metro 17,113 18,499 1,439 1,029 15,674 17,470 3,991 4,155 11,683 13,315
Nonmetro 6,319 7,524 514 555 5,805 6,969 1,420 1,591 4,385 5,378
Urbanized 3,013 3,401 249 233 2,764 3,167 741 785 2,024 2,383
Less Urbanized 2,687 3,677 208 289 2,479 3,388 554 721 1,925 2,668
Completely Rural 619 446 57 * 562 413 125 86 437 327
POVERTY LEVEL1                    
Less Than 100% 9,707 10,931 926 705 8,782 10,225 3,084 3,105 5,698 7,120
100-199% 11,834 10,817 938 584 10,896 10,233 2,892 2,852 8,004 7,381
200% or More 35,246 37,318 2,415 2,147 32,831 35,171 6,802 6,229 26,030 28,942
HEALTH INSURANCE2                    
Private 33,623 34,700 2,297 2,007 31,326 32,693 8,200 7,615 23,126 25,078
Medicaid/CHIP 12,840 13,687 1,766 1,204 11,074 12,483 2,743 2,653 8,331 9,830
Other3 8,849 10,494 214 198 8,635 10,296 957 926 7,678 9,370
No Coverage 7,642 7,544 207 207 7,434 7,337 1,769 1,729 5,665 5,608
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.67B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 20.8 21.4 17.2 13.8 21.1 22.2 39.1 37.0 18.3 19.9
GEOGRAPHIC REGION                    
Northeast 21.5 22.8 17.4 14.8 21.9 23.5 41.7 36.5 18.9 21.5
Midwest 20.1 21.4 17.1 14.4 20.5 22.1 40.1 41.5 17.3 19.0
South 18.1 18.0 15.5 11.9 18.3 18.6 34.8 32.4 15.8 16.5
West 25.1 25.9 19.8 15.4 25.7 26.9 43.0 40.8 22.9 24.8
COUNTY TYPE                    
Large Metro 22.0 22.0 17.1 13.1 22.4 22.9 41.4 37.5 19.5 20.8
Small Metro 20.5 21.8 18.6 13.4 20.7 22.7 37.6 37.8 18.0 20.2
Nonmetro 16.6 18.2 14.3 17.3 16.8 18.3 32.8 33.3 14.6 16.1
Urbanized 19.0 20.6 16.2 17.6 19.3 20.9 36.6 35.6 16.4 18.4
Less Urbanized 15.1 18.7 12.6 17.9 15.3 18.7 28.7 32.5 13.5 16.8
Completely Rural 14.2 8.8 13.9 * 14.3 8.6 33.2 24.4 12.3 7.3
POVERTY LEVEL1                    
Less Than 100% 25.9 26.1 18.2 15.3 27.2 27.4 39.1 38.2 23.3 24.4
100-199% 22.4 21.4 17.6 12.9 22.9 22.3 37.4 37.0 20.1 19.3
200% or More 19.2 20.3 16.7 13.5 19.4 20.9 40.1 36.0 17.1 19.2
HEALTH INSURANCE2                    
Private 18.7 20.0 16.1 13.4 18.9 20.6 40.2 38.9 15.9 18.0
Medicaid/CHIP 28.4 28.1 18.8 14.4 31.0 31.0 37.8 34.0 29.2 30.2
Other3 12.6 13.7 17.4 11.9 12.5 13.8 37.7 38.1 11.6 13.0
No Coverage 28.3 26.5 17.8 14.1 28.7 27.2 36.7 32.8 26.9 25.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.68A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 35,803 37,309 2,167 1,679 33,636 35,630 8,406 8,016 25,231 27,614
GEOGRAPHIC REGION                    
Northeast 6,403 7,153 385 351 6,019 6,802 1,600 1,472 4,419 5,331
Midwest 7,122 7,738 429 361 6,693 7,376 1,841 1,853 4,852 5,523
South 11,420 11,437 715 475 10,705 10,962 2,619 2,483 8,086 8,479
West 10,859 10,980 639 492 10,220 10,489 2,346 2,207 7,873 8,282
COUNTY TYPE                    
Large Metro 21,422 20,397 1,209 874 20,212 19,523 5,029 4,462 15,183 15,061
Small Metro 10,350 12,104 707 547 9,644 11,557 2,480 2,619 7,164 8,938
Nonmetro 4,031 4,808 251 258 3,781 4,550 897 934 2,884 3,615
Urbanized 2,017 2,165 119 98 1,898 2,067 520 460 1,378 1,607
Less Urbanized 1,623 2,350 103 147 1,520 2,203 313 417 1,207 1,786
Completely Rural 392 293 29 13 363 280 65 58 298 222
POVERTY LEVEL1                    
Less Than 100% 6,304 7,528 487 301 5,817 7,227 2,023 2,066 3,794 5,161
100-199% 7,519 7,266 521 324 6,998 6,942 1,851 1,865 5,146 5,077
200% or More 21,741 22,403 1,159 1,054 20,582 21,349 4,292 3,973 16,290 17,376
HEALTH INSURANCE2                    
Private 20,095 20,469 1,128 1,009 18,966 19,460 5,060 4,769 13,906 14,691
Medicaid/CHIP 8,384 9,471 917 610 7,466 8,860 1,866 1,814 5,600 7,047
Other3 5,586 6,747 106 60 5,480 6,688 603 586 4,878 6,101
No Coverage 5,266 5,264 112 75 5,154 5,189 1,186 1,189 3,969 4,000
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.68B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 13.0 13.5 8.7 6.7 13.4 14.1 24.9 23.9 11.6 12.6
GEOGRAPHIC REGION                    
Northeast 13.4 15.0 9.7 8.9 13.7 15.5 27.7 26.0 11.6 14.0
Midwest 12.4 13.5 8.1 6.9 12.9 14.1 25.7 26.1 10.8 12.3
South 10.9 10.8 7.4 4.9 11.3 11.4 20.6 19.5 9.8 10.2
West 16.6 16.6 10.6 8.2 17.2 17.5 29.0 27.5 15.3 15.9
COUNTY TYPE                    
Large Metro 13.9 13.5 8.9 6.2 14.4 14.3 26.8 25.2 12.5 12.6
Small Metro 12.4 14.3 9.1 7.1 12.7 15.0 23.4 23.8 11.0 13.5
Nonmetro 10.6 11.6 7.0 8.1 11.0 11.9 20.7 19.6 9.6 10.9
Urbanized 12.7 13.1 7.7 7.4 13.2 13.6 25.7 20.9 11.2 12.4
Less Urbanized 9.1 11.9 6.2 9.1 9.4 12.2 16.2 18.8 8.5 11.2
Completely Rural 9.0 5.8 7.2 4.9 9.2 5.8 17.2 16.3 8.4 5.0
POVERTY LEVEL1                    
Less Than 100% 16.8 18.0 9.6 6.5 18.0 19.4 25.6 25.4 15.5 17.7
100-199% 14.2 14.4 9.8 7.2 14.7 15.1 23.9 24.2 12.9 13.3
200% or More 11.8 12.2 8.0 6.6 12.2 12.7 25.3 23.0 10.7 11.5
HEALTH INSURANCE2                    
Private 11.2 11.8 7.9 6.7 11.5 12.2 24.8 24.3 9.6 10.5
Medicaid/CHIP 18.6 19.4 9.7 7.3 20.9 22.0 25.7 23.3 19.6 21.7
Other3 8.0 8.8 8.7 3.6 7.9 9.0 23.7 24.1 7.3 8.4
No Coverage 19.5 18.5 9.6 5.1 19.9 19.2 24.6 22.6 18.8 18.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.69A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 48,242 49,634 3,284 2,531 44,958 47,103 11,952 11,566 33,007 35,537
GEOGRAPHIC REGION                    
Northeast 8,724 9,181 563 453 8,162 8,728 2,217 1,944 5,945 6,784
Midwest 9,678 10,493 670 552 9,008 9,941 2,634 2,738 6,374 7,203
South 15,583 15,135 1,101 828 14,482 14,307 3,913 3,794 10,569 10,514
West 14,257 14,825 950 698 13,307 14,127 3,188 3,091 10,119 11,036
COUNTY TYPE                    
Large Metro 28,739 27,927 1,791 1,396 26,948 26,531 7,084 6,230 19,864 20,301
Small Metro 14,087 15,640 1,093 739 12,994 14,900 3,551 3,895 9,443 11,005
Nonmetro 5,416 6,068 400 396 5,017 5,672 1,317 1,441 3,700 4,231
Urbanized 2,612 2,833 197 154 2,415 2,679 682 697 1,732 1,982
Less Urbanized 2,280 2,851 165 217 2,116 2,634 519 671 1,596 1,963
Completely Rural 524 384 38 * 486 359 115 73 371 286
POVERTY LEVEL1                    
Less Than 100% 8,006 9,084 678 450 7,328 8,635 2,767 2,891 4,561 5,743
100-199% 9,818 9,042 740 471 9,077 8,571 2,642 2,713 6,435 5,857
200% or More 30,047 31,298 1,865 1,610 28,182 29,688 6,171 5,752 22,011 23,936
HEALTH INSURANCE2                    
Private 28,599 29,215 1,757 1,560 26,842 27,655 7,468 7,062 19,373 20,593
Medicaid/CHIP 10,686 11,352 1,350 830 9,336 10,521 2,461 2,537 6,874 7,985
Other3 6,961 8,328 153 117 6,809 8,212 873 880 5,936 7,332
No Coverage 6,612 6,306 185 135 6,427 6,172 1,583 1,596 4,844 4,576
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.69B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 17.5 17.9 13.2 10.1 18.0 18.7 35.4 34.5 15.2 16.3
GEOGRAPHIC REGION                    
Northeast 18.3 19.3 14.2 11.5 18.6 19.9 38.5 34.3 15.6 17.8
Midwest 16.9 18.3 12.7 10.5 17.3 19.1 36.8 38.6 14.2 16.0
South 14.9 14.3 11.4 8.5 15.3 14.9 30.8 29.8 12.9 12.6
West 21.7 22.4 15.8 11.6 22.3 23.5 39.4 38.5 19.7 21.2
COUNTY TYPE                    
Large Metro 18.7 18.5 13.2 9.9 19.2 19.4 37.7 35.2 16.4 17.0
Small Metro 16.9 18.5 14.1 9.6 17.2 19.4 33.5 35.4 14.5 16.7
Nonmetro 14.2 14.7 11.1 12.3 14.6 14.9 30.4 30.2 12.3 12.7
Urbanized 16.4 17.2 12.8 11.7 16.8 17.6 33.7 31.6 14.1 15.3
Less Urbanized 12.8 14.5 9.9 13.4 13.1 14.6 26.9 30.3 11.2 12.4
Completely Rural 12.1 7.6 9.4 * 12.3 7.5 30.7 20.8 10.4 6.4
POVERTY LEVEL1                    
Less Than 100% 21.4 21.7 13.3 9.8 22.7 23.1 35.0 35.5 18.7 19.7
100-199% 18.5 17.9 13.9 10.4 19.1 18.7 34.2 35.2 16.1 15.3
200% or More 16.4 17.0 12.9 10.1 16.7 17.6 36.4 33.3 14.5 15.8
HEALTH INSURANCE2                    
Private 15.9 16.8 12.3 10.4 16.2 17.4 36.6 36.1 13.3 14.8
Medicaid/CHIP 23.7 23.3 14.4 9.9 26.1 26.1 34.0 32.6 24.1 24.5
Other3 9.9 10.9 12.4 7.0 9.9 11.0 34.4 36.2 8.9 10.1
No Coverage 24.5 22.2 15.9 9.2 24.8 22.9 32.8 30.3 23.0 21.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.70A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 31,606 32,784 1,837 1,472 29,769 31,312 7,749 7,727 22,020 23,585
GEOGRAPHIC REGION                    
Northeast 5,803 6,209 341 307 5,461 5,902 1,502 1,415 3,960 4,486
Midwest 6,188 6,909 359 294 5,829 6,616 1,701 1,797 4,127 4,818
South 10,021 9,818 584 405 9,437 9,412 2,398 2,383 7,039 7,030
West 9,595 9,848 553 465 9,042 9,383 2,149 2,131 6,893 7,252
COUNTY TYPE                    
Large Metro 18,846 17,913 1,030 774 17,816 17,139 4,623 4,290 13,193 12,848
Small Metro 9,166 10,573 594 470 8,572 10,103 2,282 2,551 6,290 7,552
Nonmetro 3,595 4,298 213 228 3,381 4,070 845 886 2,536 3,185
Urbanized 1,837 2,036 103 84 1,734 1,952 489 440 1,245 1,513
Less Urbanized 1,425 1,978 87 137 1,338 1,841 296 392 1,042 1,449
Completely Rural 333 284 24 * 309 277 60 54 250 222
POVERTY LEVEL1                    
Less Than 100% 5,527 6,729 418 257 5,109 6,471 1,845 1,997 3,265 4,474
100-199% 6,684 6,388 422 305 6,262 6,082 1,740 1,779 4,522 4,303
200% or More 19,168 19,557 998 909 18,170 18,648 3,937 3,839 14,233 14,808
HEALTH INSURANCE2                    
Private 17,794 17,947 956 873 16,838 17,075 4,661 4,579 12,177 12,496
Medicaid/CHIP 7,314 8,319 767 538 6,546 7,781 1,700 1,767 4,846 6,014
Other3 4,762 5,785 86 51 4,676 5,734 559 570 4,117 5,164
No Coverage 4,770 4,745 108 73 4,662 4,672 1,105 1,147 3,557 3,525
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.70B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 11.5 11.8 7.4 5.9 11.9 12.4 23.0 23.1 10.2 10.8
GEOGRAPHIC REGION                    
Northeast 12.1 13.0 8.6 7.8 12.5 13.5 26.0 25.0 10.4 11.8
Midwest 10.8 12.0 6.8 5.6 11.2 12.7 23.7 25.3 9.2 10.7
South 9.6 9.3 6.0 4.2 9.9 9.8 18.9 18.7 8.6 8.4
West 14.6 14.9 9.2 7.7 15.2 15.6 26.6 26.6 13.4 13.9
COUNTY TYPE                    
Large Metro 12.3 11.9 7.6 5.5 12.7 12.5 24.6 24.2 10.9 10.8
Small Metro 11.0 12.5 7.7 6.1 11.3 13.1 21.5 23.2 9.7 11.4
Nonmetro 9.4 10.4 5.9 7.1 9.8 10.7 19.5 18.6 8.4 9.6
Urbanized 11.6 12.3 6.7 6.3 12.1 12.9 24.1 20.0 10.1 11.7
Less Urbanized 8.0 10.0 5.2 8.4 8.3 10.2 15.3 17.7 7.3 9.1
Completely Rural 7.7 5.6 5.8 * 7.9 5.7 15.9 15.3 7.0 5.0
POVERTY LEVEL1                    
Less Than 100% 14.8 16.1 8.2 5.6 15.8 17.3 23.4 24.5 13.4 15.3
100-199% 12.6 12.7 7.9 6.8 13.2 13.2 22.5 23.1 11.3 11.3
200% or More 10.4 10.6 6.9 5.7 10.7 11.1 23.2 22.2 9.3 9.8
HEALTH INSURANCE2                    
Private 9.9 10.3 6.7 5.8 10.2 10.7 22.8 23.4 8.4 9.0
Medicaid/CHIP 16.2 17.1 8.2 6.4 18.3 19.3 23.4 22.7 17.0 18.5
Other3 6.8 7.6 7.0 3.1 6.8 7.7 22.0 23.5 6.2 7.1
No Coverage 17.6 16.7 9.3 5.0 18.0 17.3 22.9 21.8 16.9 16.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.71A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,468 5,172 97 84 5,371 5,088 1,789 1,441 3,582 3,646
GEOGRAPHIC REGION                    
Northeast 949 1,155 4 4 945 1,152 341 262 604 889
Midwest 1,035 1,027 23 2 1,012 1,025 324 300 688 725
South 1,797 1,532 27 37 1,769 1,495 504 410 1,266 1,085
West 1,688 1,458 42 41 1,645 1,416 621 468 1,025 948
COUNTY TYPE                    
Large Metro 3,456 3,219 47 50 3,410 3,169 1,101 833 2,309 2,336
Small Metro 1,535 1,528 40 26 1,495 1,502 541 464 954 1,038
Nonmetro 476 425 10 8 466 416 147 145 320 272
Urbanized 307 174 5 * 303 174 100 78 203 96
Less Urbanized 143 231 4 * 139 223 44 59 95 164
Completely Rural 26 20 1 0 25 20 4 * 21 12
POVERTY LEVEL1                    
Less Than 100% 1,042 979 25 15 1,017 964 366 336 651 628
100-199% 1,083 993 26 * 1,058 993 315 316 743 678
200% or More 3,302 3,194 46 69 3,256 3,125 1,068 784 2,188 2,341
HEALTH INSURANCE2                    
Private 3,128 2,826 45 47 3,083 2,779 1,316 977 1,766 1,803
Medicaid/CHIP 1,333 1,136 48 33 1,285 1,103 268 194 1,018 909
Other3 510 561 5 * 505 561 82 63 423 498
No Coverage 938 1,009 4 8 934 1,001 194 236 741 765
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.71B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2.0 1.9 0.4 0.3 2.1 2.0 5.3 4.3 1.7 1.7
GEOGRAPHIC REGION                    
Northeast 2.0 2.4 0.1 0.1 2.2 2.6 5.9 4.6 1.6 2.3
Midwest 1.8 1.8 0.4 0.0 1.9 2.0 4.5 4.2 1.5 1.6
South 1.7 1.4 0.3 0.4 1.9 1.6 4.0 3.2 1.5 1.3
West 2.6 2.2 0.7 0.7 2.8 2.4 7.7 5.8 2.0 1.8
COUNTY TYPE                    
Large Metro 2.2 2.1 0.3 0.4 2.4 2.3 5.9 4.7 1.9 2.0
Small Metro 1.8 1.8 0.5 0.3 2.0 2.0 5.1 4.2 1.5 1.6
Nonmetro 1.3 1.0 0.3 0.3 1.4 1.1 3.4 3.0 1.1 0.8
Urbanized 1.9 1.1 0.3 * 2.1 1.1 4.9 3.5 1.6 0.7
Less Urbanized 0.8 1.2 0.3 * 0.9 1.2 2.3 2.7 0.7 1.0
Completely Rural 0.6 0.4 0.2 0.2 0.6 0.4 0.9 * 0.6 0.3
POVERTY LEVEL1                    
Less Than 100% 2.8 2.3 0.5 0.3 3.1 2.6 4.6 4.1 2.7 2.2
100-199% 2.0 2.0 0.5 * 2.2 2.2 4.1 4.1 1.9 1.8
200% or More 1.8 1.7 0.3 0.4 1.9 1.9 6.3 4.5 1.4 1.5
HEALTH INSURANCE2                    
Private 1.7 1.6 0.3 0.3 1.9 1.7 6.4 5.0 1.2 1.3
Medicaid/CHIP 3.0 2.3 0.5 0.4 3.6 2.7 3.7 2.5 3.6 2.8
Other3 0.7 0.7 0.4 * 0.7 0.8 3.2 2.6 0.6 0.7
No Coverage 3.5 3.5 0.3 0.5 3.6 3.7 4.0 4.5 3.5 3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.72A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,998 1,831 34 11 1,965 1,821 540 424 1,425 1,396
GEOGRAPHIC REGION                    
Northeast 381 457 1 * 380 457 102 69 278 388
Midwest 372 307 7 * 365 307 101 65 264 242
South 730 565 13 2 717 563 167 194 550 369
West 515 503 12 9 503 494 169 97 333 397
COUNTY TYPE                    
Large Metro 1,327 1,293 15 8 1,312 1,285 316 254 997 1,031
Small Metro 501 447 16 2 485 445 180 163 305 281
Nonmetro 170 91 3 * 167 91 44 7 123 84
Urbanized 103 31 3 * 100 31 24 4 76 27
Less Urbanized 52 61 0 0 52 61 17 3 35 58
Completely Rural 15 * * * 15 * 2 * 13 *
POVERTY LEVEL1                    
Less Than 100% 443 353 11 2 432 351 136 96 297 255
100-199% 398 326 9 * 389 326 103 92 287 234
200% or More 1,147 1,149 14 9 1,133 1,140 291 233 842 908
HEALTH INSURANCE2                    
Private 1,100 1,000 15 8 1,086 992 390 274 696 717
Medicaid/CHIP 493 437 18 2 475 435 68 40 406 395
Other3 176 115 0 * 175 115 27 23 148 92
No Coverage 386 355 0 * 386 355 73 100 313 255
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.72B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.7 0.1 0.0 0.8 0.7 1.6 1.3 0.7 0.6
GEOGRAPHIC REGION                    
Northeast 0.8 1.0 0.0 * 0.9 1.0 1.8 1.2 0.7 1.0
Midwest 0.7 0.5 0.1 * 0.7 0.6 1.4 0.9 0.6 0.5
South 0.7 0.5 0.1 0.0 0.8 0.6 1.3 1.5 0.7 0.4
West 0.8 0.8 0.2 0.1 0.8 0.8 2.1 1.2 0.6 0.8
COUNTY TYPE                    
Large Metro 0.9 0.9 0.1 0.1 0.9 0.9 1.7 1.4 0.8 0.9
Small Metro 0.6 0.5 0.2 0.0 0.6 0.6 1.7 1.5 0.5 0.4
Nonmetro 0.4 0.2 0.1 * 0.5 0.2 1.0 0.1 0.4 0.3
Urbanized 0.6 0.2 0.2 * 0.7 0.2 1.2 0.2 0.6 0.2
Less Urbanized 0.3 0.3 0.0 0.0 0.3 0.3 0.9 0.1 0.2 0.4
Completely Rural 0.3 * * * 0.4 * 0.6 * 0.4 *
POVERTY LEVEL1                    
Less Than 100% 1.2 0.8 0.2 0.0 1.3 0.9 1.7 1.2 1.2 0.9
100-199% 0.8 0.6 0.2 * 0.8 0.7 1.3 1.2 0.7 0.6
200% or More 0.6 0.6 0.1 0.1 0.7 0.7 1.7 1.3 0.6 0.6
HEALTH INSURANCE2                    
Private 0.6 0.6 0.1 0.1 0.7 0.6 1.9 1.4 0.5 0.5
Medicaid/CHIP 1.1 0.9 0.2 0.0 1.3 1.1 0.9 0.5 1.4 1.2
Other3 0.3 0.2 0.0 * 0.3 0.2 1.1 0.9 0.2 0.1
No Coverage 1.4 1.2 0.0 * 1.5 1.3 1.5 1.9 1.5 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.73A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 9,375 9,356 778 657 378 335
GEOGRAPHIC REGION            
Northeast 1,450 1,829 154 145 80 87
Midwest 2,112 2,151 281 198 116 93
South 3,210 3,060 256 243 152 142
West 2,602 2,316 87 71 29 13
COUNTY TYPE            
Large Metro 5,042 4,148 448 312 261 213
Small Metro 2,852 3,613 244 283 83 90
Nonmetro 1,481 1,595 86 62 34 32
Urbanized 676 617 43 8 8 8
Less Urbanized 650 941 35 52 22 24
Completely Rural 155 36 7 1 4 *
POVERTY LEVEL1            
Less Than 100% 2,150 2,575 310 273 174 119
100-199% 2,271 2,045 218 238 74 118
200% or More 4,954 4,736 250 146 130 98
HEALTH INSURANCE2            
Private 4,298 3,530 224 89 119 51
Medicaid/CHIP 2,861 3,254 428 400 194 190
Other3 2,054 2,614 174 169 49 49
No Coverage 1,493 1,552 142 129 78 84
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.73B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 3.4 3.4 0.3 0.2 0.1 0.1
GEOGRAPHIC REGION            
Northeast 3.0 3.8 0.3 0.3 0.2 0.2
Midwest 3.7 3.7 0.5 0.3 0.2 0.2
South 3.1 2.9 0.2 0.2 0.1 0.1
West 4.0 3.5 0.1 0.1 0.0 0.0
COUNTY TYPE            
Large Metro 3.3 2.7 0.3 0.2 0.2 0.1
Small Metro 3.4 4.3 0.3 0.3 0.1 0.1
Nonmetro 3.9 3.9 0.2 0.1 0.1 0.1
Urbanized 4.3 3.7 0.3 0.1 0.1 0.0
Less Urbanized 3.6 4.8 0.2 0.3 0.1 0.1
Completely Rural 3.6 0.7 0.2 0.0 0.1 *
POVERTY LEVEL1            
Less Than 100% 5.7 6.1 0.8 0.7 0.5 0.3
100-199% 4.3 4.1 0.4 0.5 0.1 0.2
200% or More 2.7 2.6 0.1 0.1 0.1 0.1
HEALTH INSURANCE2            
Private 2.4 2.0 0.1 0.1 0.1 0.0
Medicaid/CHIP 6.3 6.7 0.9 0.8 0.4 0.4
Other3 2.9 3.4 0.2 0.2 0.1 0.1
No Coverage 5.5 5.5 0.5 0.5 0.3 0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.74A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 44,087 43,949 6,010 7,133 1,915 1,761
GEOGRAPHIC REGION            
Northeast 7,452 7,472 841 1,234 232 354
Midwest 8,996 9,498 1,170 1,476 366 396
South 13,599 13,832 1,803 1,994 579 455
West 14,040 13,147 2,196 2,429 738 556
COUNTY TYPE            
Large Metro 25,202 23,566 3,618 4,248 1,083 1,066
Small Metro 13,403 14,032 1,762 2,170 644 541
Nonmetro 5,483 6,351 630 715 187 155
Urbanized 2,721 2,980 424 348 117 45
Less Urbanized 2,211 2,872 163 348 57 109
Completely Rural 551 500 43 19 13 1
POVERTY LEVEL1            
Less Than 100% 5,239 6,164 1,072 1,450 302 409
100-199% 7,968 7,538 1,275 1,297 396 323
200% or More 30,803 30,209 3,598 4,357 1,203 1,009
HEALTH INSURANCE2            
Private 28,443 26,663 3,697 4,226 1,148 966
Medicaid/CHIP 7,347 8,090 1,164 1,523 405 376
Other3 8,176 9,477 482 598 147 124
No Coverage 5,067 5,693 915 1,206 288 395
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.74B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Lifetime
(2019)
Lifetime
(2020)
Past Year
(2019)
Past Year
(2020)
Past Month
(2019)
Past Month
(2020)
TOTAL 16.0 15.9 2.2 2.6 0.7 0.6
GEOGRAPHIC REGION            
Northeast 15.6 15.7 1.8 2.6 0.5 0.7
Midwest 15.7 16.5 2.0 2.6 0.6 0.7
South 13.0 13.1 1.7 1.9 0.6 0.4
West 21.4 19.9 3.3 3.7 1.1 0.8
COUNTY TYPE            
Large Metro 16.4 15.6 2.4 2.8 0.7 0.7
Small Metro 16.1 16.6 2.1 2.6 0.8 0.6
Nonmetro 14.4 15.4 1.7 1.7 0.5 0.4
Urbanized 17.1 18.0 2.7 2.1 0.7 0.3
Less Urbanized 12.4 14.6 0.9 1.8 0.3 0.6
Completely Rural 12.7 9.8 1.0 0.4 0.3 0.0
POVERTY LEVEL1            
Less Than 100% 14.0 14.7 2.9 3.5 0.8 1.0
100-199% 15.1 14.9 2.4 2.6 0.7 0.6
200% or More 16.8 16.4 2.0 2.4 0.7 0.5
HEALTH INSURANCE2            
Private 15.8 15.3 2.1 2.4 0.6 0.6
Medicaid/CHIP 16.3 16.6 2.6 3.1 0.9 0.8
Other3 11.6 12.4 0.7 0.8 0.2 0.2
No Coverage 18.7 20.0 3.4 4.2 1.1 1.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.75A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2,142 2,390 743 683 1,399 1,707 577 507 822 1,200
GEOGRAPHIC REGION                    
Northeast 356 590 111 87 245 502 107 87 138 415
Midwest 412 492 153 166 260 326 108 93 151 233
South 729 726 292 259 437 468 188 147 248 321
West 645 582 187 171 458 410 173 179 285 231
COUNTY TYPE                    
Large Metro 1,354 1,621 392 362 962 1,259 376 361 586 899
Small Metro 578 533 254 211 324 321 139 86 184 236
Nonmetro 211 236 97 110 114 126 62 60 52 66
Urbanized 103 104 40 50 63 54 34 33 29 21
Less Urbanized 81 118 45 48 37 70 20 25 17 45
Completely Rural 27 15 12 * 14 2 8 2 6 *
POVERTY LEVEL1                    
Less Than 100% 408 467 162 140 246 327 143 174 103 153
100-199% 376 357 147 96 229 261 108 112 121 149
200% or More 1,326 1,565 434 447 892 1,118 294 220 599 898
HEALTH INSURANCE2                    
Private 1,342 1,251 418 394 923 857 388 273 535 583
Medicaid/CHIP 488 713 282 282 207 431 99 86 107 345
Other3 248 165 36 66 212 98 46 15 166 83
No Coverage 162 381 25 12 137 368 64 135 73 233
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.75B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.8 0.9 3.0 2.7 0.6 0.7 1.7 1.5 0.4 0.5
GEOGRAPHIC REGION                    
Northeast 0.7 1.2 2.8 2.2 0.6 1.1 1.9 1.5 0.4 1.1
Midwest 0.7 0.9 2.9 3.1 0.5 0.6 1.5 1.3 0.3 0.5
South 0.7 0.7 3.0 2.6 0.5 0.5 1.5 1.2 0.3 0.4
West 1.0 0.9 3.1 2.8 0.8 0.7 2.1 2.2 0.6 0.4
COUNTY TYPE                    
Large Metro 0.9 1.1 2.9 2.6 0.7 0.9 2.0 2.0 0.5 0.8
Small Metro 0.7 0.6 3.3 2.8 0.4 0.4 1.3 0.8 0.3 0.4
Nonmetro 0.6 0.6 2.7 3.4 0.3 0.3 1.4 1.3 0.2 0.2
Urbanized 0.6 0.6 2.6 3.8 0.4 0.4 1.7 1.5 0.2 0.2
Less Urbanized 0.5 0.6 2.7 3.0 0.2 0.4 1.0 1.1 0.1 0.3
Completely Rural 0.6 0.3 3.0 * 0.4 0.1 2.2 0.7 0.2 *
POVERTY LEVEL1                    
Less Than 100% 1.1 1.1 3.2 3.0 0.8 0.9 1.8 2.1 0.4 0.5
100-199% 0.7 0.7 2.8 2.1 0.5 0.6 1.4 1.5 0.3 0.4
200% or More 0.7 0.8 3.0 2.8 0.5 0.7 1.7 1.3 0.4 0.6
HEALTH INSURANCE2                    
Private 0.7 0.7 2.9 2.6 0.6 0.5 1.9 1.4 0.4 0.4
Medicaid/CHIP 1.1 1.5 3.0 3.4 0.6 1.1 1.4 1.1 0.4 1.1
Other3 0.4 0.2 2.9 4.0 0.3 0.1 1.8 0.6 0.3 0.1
No Coverage 0.6 1.3 2.1 0.8 0.5 1.4 1.3 2.6 0.3 1.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.76A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 807 904 216 106 591 797 157 160 434 637
GEOGRAPHIC REGION                    
Northeast 151 289 37 24 114 265 32 29 82 235
Midwest 155 129 49 28 106 101 31 14 76 87
South 259 294 78 43 180 251 37 77 143 174
West 242 192 52 11 190 181 57 40 133 141
COUNTY TYPE                    
Large Metro 592 672 125 68 467 604 111 95 356 508
Small Metro 162 153 70 27 92 126 36 38 56 88
Nonmetro 53 80 21 12 32 68 10 26 22 41
Urbanized 26 33 9 5 17 28 8 * 9 10
Less Urbanized 25 39 10 1 15 38 1 7 13 31
Completely Rural 2 7 2 * * 1 * * * *
POVERTY LEVEL1                    
Less Than 100% 106 102 40 20 66 82 38 50 29 32
100-199% 174 163 71 10 103 153 39 42 64 111
200% or More 522 639 106 76 417 562 76 67 341 495
HEALTH INSURANCE2                    
Private 488 512 116 73 372 439 108 94 264 345
Medicaid/CHIP 174 230 90 45 84 185 25 23 59 162
Other3 124 65 9 * 115 65 8 1 107 64
No Coverage 60 142 5 * 54 142 17 43 37 100
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.76B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.3 0.3 0.9 0.4 0.2 0.3 0.5 0.5 0.2 0.3
GEOGRAPHIC REGION                    
Northeast 0.3 0.6 0.9 0.6 0.3 0.6 0.6 0.5 0.2 0.6
Midwest 0.3 0.2 0.9 0.5 0.2 0.2 0.4 0.2 0.2 0.2
South 0.2 0.3 0.8 0.4 0.2 0.3 0.3 0.6 0.2 0.2
West 0.4 0.3 0.9 0.2 0.3 0.3 0.7 0.5 0.3 0.3
COUNTY TYPE                    
Large Metro 0.4 0.4 0.9 0.5 0.3 0.4 0.6 0.5 0.3 0.4
Small Metro 0.2 0.2 0.9 0.3 0.1 0.2 0.3 0.3 0.1 0.1
Nonmetro 0.1 0.2 0.6 0.4 0.1 0.2 0.2 0.6 0.1 0.1
Urbanized 0.2 0.2 0.6 0.4 0.1 0.2 0.4 * 0.1 0.1
Less Urbanized 0.1 0.2 0.6 0.1 0.1 0.2 0.1 0.3 0.1 0.2
Completely Rural 0.1 0.1 0.6 * * 0.0 * * * *
POVERTY LEVEL1                    
Less Than 100% 0.3 0.2 0.8 0.4 0.2 0.2 0.5 0.6 0.1 0.1
100-199% 0.3 0.3 1.3 0.2 0.2 0.3 0.5 0.5 0.2 0.3
200% or More 0.3 0.3 0.7 0.5 0.2 0.3 0.4 0.4 0.2 0.3
HEALTH INSURANCE2                    
Private 0.3 0.3 0.8 0.5 0.2 0.3 0.5 0.5 0.2 0.2
Medicaid/CHIP 0.4 0.5 1.0 0.5 0.2 0.5 0.3 0.3 0.2 0.5
Other3 0.2 0.1 0.7 * 0.2 0.1 0.3 0.1 0.2 0.1
No Coverage 0.2 0.5 0.5 * 0.2 0.5 0.4 0.8 0.2 0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.77A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,999 2,550 41 21 1,958 2,528 275 171 1,682 2,358
GEOGRAPHIC REGION                    
Northeast 145 139 7 * 138 139 28 22 110 117
Midwest 448 479 8 14 441 464 70 42 371 422
South 691 973 12 6 679 967 101 64 578 902
West 715 959 14 1 701 958 77 42 624 916
COUNTY TYPE                    
Large Metro 941 837 21 4 920 833 132 81 788 752
Small Metro 586 1,322 13 13 572 1,309 84 56 489 1,253
Nonmetro 473 391 8 4 465 386 60 33 405 353
Urbanized 226 139 6 * 220 134 29 6 191 128
Less Urbanized 205 238 1 * 204 238 26 24 178 214
Completely Rural 41 13 * * 41 13 5 * 36 11
POVERTY LEVEL1                    
Less Than 100% 599 912 7 2 592 911 69 41 523 870
100-199% 655 660 7 1 649 658 96 75 552 583
200% or More 744 975 27 19 717 956 109 52 607 904
HEALTH INSURANCE2                    
Private 553 704 27 14 526 690 119 84 407 606
Medicaid/CHIP 810 1,118 14 7 797 1,111 80 80 717 1,030
Other3 323 696 4 * 320 696 19 10 300 686
No Coverage 545 507 * * 545 507 67 19 478 488
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.77B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.9 0.2 0.1 0.8 1.0 0.8 0.5 0.8 1.1
GEOGRAPHIC REGION                    
Northeast 0.3 0.3 0.2 * 0.3 0.3 0.5 0.4 0.3 0.3
Midwest 0.8 0.8 0.1 0.3 0.8 0.9 1.0 0.6 0.8 0.9
South 0.7 0.9 0.1 0.1 0.7 1.0 0.8 0.5 0.7 1.1
West 1.1 1.5 0.2 0.0 1.2 1.6 1.0 0.5 1.2 1.8
COUNTY TYPE                    
Large Metro 0.6 0.6 0.2 0.0 0.7 0.6 0.7 0.5 0.6 0.6
Small Metro 0.7 1.6 0.2 0.2 0.8 1.7 0.8 0.5 0.8 1.9
Nonmetro 1.2 0.9 0.2 0.1 1.3 1.0 1.4 0.7 1.3 1.1
Urbanized 1.4 0.8 0.4 * 1.5 0.9 1.4 0.3 1.5 1.0
Less Urbanized 1.2 1.2 0.1 * 1.3 1.3 1.4 1.1 1.2 1.3
Completely Rural 0.9 0.3 * * 1.0 0.3 1.3 * 1.0 0.2
POVERTY LEVEL1                    
Less Than 100% 1.6 2.2 0.1 0.0 1.8 2.4 0.9 0.5 2.1 3.0
100-199% 1.2 1.3 0.1 0.0 1.4 1.4 1.2 1.0 1.4 1.5
200% or More 0.4 0.5 0.2 0.1 0.4 0.6 0.6 0.3 0.4 0.6
HEALTH INSURANCE2                    
Private 0.3 0.4 0.2 0.1 0.3 0.4 0.6 0.4 0.3 0.4
Medicaid/CHIP 1.8 2.3 0.1 0.1 2.2 2.8 1.1 1.0 2.5 3.2
Other3 0.5 0.9 0.3 * 0.5 0.9 0.8 0.4 0.5 0.9
No Coverage 2.0 1.8 * * 2.1 1.9 1.4 0.4 2.3 2.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.78A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,173 1,722 11 7 1,161 1,715 110 74 1,051 1,641
GEOGRAPHIC REGION                    
Northeast 53 57 3 * 50 57 6 9 44 48
Midwest 276 316 3 * 274 316 33 16 240 299
South 363 654 5 6 359 649 46 38 313 611
West 480 695 1 1 479 694 25 11 454 683
COUNTY TYPE                    
Large Metro 633 623 7 * 626 623 48 33 578 590
Small Metro 311 852 4 3 306 849 38 27 268 822
Nonmetro 229 248 0 4 229 243 24 14 205 229
Urbanized 132 90 0 * 132 85 12 6 120 79
Less Urbanized 91 147 * * 91 147 12 8 79 140
Completely Rural 6 11 * * 6 11 * * 6 11
POVERTY LEVEL1                    
Less Than 100% 379 688 4 2 376 687 31 4 345 682
100-199% 378 418 * 1 378 417 51 31 328 386
200% or More 414 615 7 4 406 611 28 37 378 573
HEALTH INSURANCE2                    
Private 246 505 8 * 238 505 41 46 197 459
Medicaid/CHIP 495 712 3 7 491 705 38 21 453 684
Other3 177 381 0 * 177 381 12 6 164 375
No Coverage 351 391 * * 351 391 27 15 324 376
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.78B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.4 0.6 0.0 0.0 0.5 0.7 0.3 0.2 0.5 0.8
GEOGRAPHIC REGION                    
Northeast 0.1 0.1 0.1 * 0.1 0.1 0.1 0.2 0.1 0.1
Midwest 0.5 0.5 0.1 * 0.5 0.6 0.5 0.2 0.5 0.7
South 0.3 0.6 0.0 0.1 0.4 0.7 0.4 0.3 0.4 0.7
West 0.7 1.1 0.0 0.0 0.8 1.2 0.3 0.1 0.9 1.3
COUNTY TYPE                    
Large Metro 0.4 0.4 0.0 * 0.4 0.5 0.3 0.2 0.5 0.5
Small Metro 0.4 1.0 0.1 0.0 0.4 1.1 0.4 0.2 0.4 1.2
Nonmetro 0.6 0.6 0.0 0.1 0.7 0.6 0.6 0.3 0.7 0.7
Urbanized 0.8 0.5 0.0 * 0.9 0.6 0.6 0.3 1.0 0.6
Less Urbanized 0.5 0.7 * * 0.6 0.8 0.6 0.3 0.6 0.9
Completely Rural 0.1 0.2 * * 0.1 0.2 * * 0.2 0.2
POVERTY LEVEL1                    
Less Than 100% 1.0 1.6 0.1 0.0 1.2 1.8 0.4 0.1 1.4 2.3
100-199% 0.7 0.8 * 0.0 0.8 0.9 0.7 0.4 0.8 1.0
200% or More 0.2 0.3 0.1 0.0 0.2 0.4 0.2 0.2 0.2 0.4
HEALTH INSURANCE2                    
Private 0.1 0.3 0.1 * 0.1 0.3 0.2 0.2 0.1 0.3
Medicaid/CHIP 1.1 1.5 0.0 0.1 1.4 1.7 0.5 0.3 1.6 2.1
Other3 0.3 0.5 0.0 * 0.3 0.5 0.5 0.3 0.2 0.5
No Coverage 1.3 1.4 * * 1.4 1.4 0.6 0.3 1.5 1.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.79A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 82,559 75,198 3,980 3,079 78,579 72,118 8,357 6,858 70,222 65,261
GEOGRAPHIC REGION                    
Northeast 12,396 11,685 552 357 11,844 11,328 1,238 1,094 10,606 10,235
Midwest 17,550 15,012 795 666 16,755 14,347 1,822 1,316 14,933 13,030
South 32,479 30,506 1,612 1,403 30,867 29,103 3,209 2,801 27,658 26,302
West 20,134 17,994 1,021 653 19,112 17,341 2,087 1,647 17,025 15,693
COUNTY TYPE                    
Large Metro 43,623 38,079 2,052 1,521 41,571 36,558 4,543 3,409 37,028 33,149
Small Metro 26,925 25,231 1,324 1,127 25,600 24,104 2,691 2,324 22,909 21,780
Nonmetro 12,011 11,888 604 431 11,408 11,456 1,123 1,124 10,285 10,332
Urbanized 5,037 4,966 255 178 4,783 4,789 558 550 4,225 4,239
Less Urbanized 5,560 5,433 275 193 5,285 5,240 467 538 4,817 4,702
Completely Rural 1,414 1,488 74 * 1,340 1,428 98 37 1,242 1,391
POVERTY LEVEL1                    
Less Than 100% 11,567 13,045 907 636 10,660 12,408 1,883 1,586 8,777 10,822
100-199% 16,296 14,097 882 545 15,414 13,552 1,944 1,701 13,470 11,851
200% or More 54,407 47,937 2,191 1,898 52,216 46,039 4,241 3,451 47,975 42,588
HEALTH INSURANCE2                    
Private 52,152 44,978 2,161 1,729 49,991 43,249 4,988 3,956 45,003 39,294
Medicaid/CHIP 15,284 15,295 1,629 1,061 13,655 14,233 1,909 1,854 11,746 12,380
Other3 26,242 26,624 245 186 25,998 26,438 625 554 25,373 25,884
No Coverage 6,636 6,925 143 285 6,494 6,640 1,189 929 5,305 5,711
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.79B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 30.0 27.2 16.0 12.3 31.4 28.6 24.8 20.5 32.4 29.9
GEOGRAPHIC REGION                    
Northeast 26.0 24.5 13.9 9.1 27.0 25.9 21.5 19.3 27.9 26.9
Midwest 30.6 26.2 15.1 12.6 32.2 27.5 25.4 18.6 33.3 28.9
South 31.1 28.8 16.7 14.4 32.5 30.3 25.2 22.0 33.6 31.6
West 30.7 27.2 17.0 10.8 32.1 28.9 25.8 20.5 33.1 30.2
COUNTY TYPE                    
Large Metro 28.4 25.2 15.1 10.8 29.7 26.7 24.2 19.2 30.5 27.8
Small Metro 32.3 29.8 17.1 14.7 33.8 31.3 25.4 21.1 35.2 33.0
Nonmetro 31.6 28.8 16.8 13.4 33.1 30.1 25.9 23.6 34.1 31.0
Urbanized 31.7 30.1 16.6 13.4 33.3 31.5 27.5 25.0 34.3 32.7
Less Urbanized 31.2 27.6 16.6 12.0 32.7 29.0 24.2 24.3 33.8 29.6
Completely Rural 32.5 29.3 18.0 * 34.1 29.7 26.1 10.4 34.9 31.2
POVERTY LEVEL1                    
Less Than 100% 30.9 31.1 17.8 13.8 33.0 33.3 23.9 19.5 35.9 37.1
100-199% 30.8 27.9 16.5 12.1 32.4 29.5 25.1 22.1 33.8 31.0
200% or More 29.6 26.0 15.1 12.0 30.9 27.4 25.0 20.0 31.5 28.2
HEALTH INSURANCE2                    
Private 29.0 25.9 15.2 11.5 30.2 27.2 24.4 20.2 31.0 28.2
Medicaid/CHIP 33.8 31.4 17.3 12.7 38.2 35.3 26.3 23.8 41.2 38.1
Other3 37.4 34.9 20.0 11.2 37.7 35.4 24.6 22.8 38.2 35.8
No Coverage 24.5 24.3 12.3 19.5 25.1 24.6 24.7 17.6 25.2 26.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.80A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9,724 9,254 567 396 9,158 8,858 1,754 1,361 7,404 7,498
GEOGRAPHIC REGION                    
Northeast 1,352 1,631 57 65 1,295 1,566 234 206 1,062 1,360
Midwest 2,072 1,686 126 84 1,945 1,602 408 313 1,537 1,290
South 3,703 3,307 232 126 3,472 3,181 655 501 2,817 2,680
West 2,597 2,630 152 121 2,445 2,509 457 341 1,988 2,167
COUNTY TYPE                    
Large Metro 5,240 4,684 286 190 4,954 4,494 969 679 3,985 3,815
Small Metro 3,326 3,198 215 148 3,110 3,050 579 419 2,532 2,631
Nonmetro 1,159 1,372 66 58 1,093 1,314 206 262 887 1,051
Urbanized 537 584 28 24 509 560 121 120 388 440
Less Urbanized 495 754 24 33 471 721 64 132 407 589
Completely Rural 127 34 14 1 113 33 22 11 92 22
POVERTY LEVEL1                    
Less Than 100% 1,926 2,436 129 141 1,797 2,296 434 344 1,363 1,952
100-199% 2,171 1,775 144 55 2,028 1,721 419 336 1,609 1,385
200% or More 5,597 5,003 294 201 5,303 4,803 871 642 4,432 4,161
HEALTH INSURANCE2                    
Private 5,055 4,578 288 170 4,767 4,408 973 748 3,794 3,660
Medicaid/CHIP 2,429 2,724 240 173 2,189 2,551 401 352 1,788 2,199
Other3 1,741 1,927 43 20 1,698 1,906 114 106 1,584 1,800
No Coverage 1,605 1,494 10 * 1,595 1,437 333 233 1,262 1,203
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.80B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.5 3.3 2.3 1.6 3.7 3.5 5.2 4.1 3.4 3.4
GEOGRAPHIC REGION                    
Northeast 2.8 3.4 1.4 1.7 3.0 3.6 4.1 3.6 2.8 3.6
Midwest 3.6 2.9 2.4 1.6 3.7 3.1 5.7 4.4 3.4 2.9
South 3.5 3.1 2.4 1.3 3.7 3.3 5.2 3.9 3.4 3.2
West 4.0 4.0 2.5 2.0 4.1 4.2 5.7 4.3 3.9 4.2
COUNTY TYPE                    
Large Metro 3.4 3.1 2.1 1.3 3.5 3.3 5.2 3.8 3.3 3.2
Small Metro 4.0 3.8 2.8 1.9 4.1 4.0 5.5 3.8 3.9 4.0
Nonmetro 3.0 3.3 1.8 1.8 3.2 3.4 4.8 5.5 2.9 3.2
Urbanized 3.4 3.5 1.8 1.8 3.5 3.7 6.0 5.4 3.1 3.4
Less Urbanized 2.8 3.8 1.5 2.0 2.9 4.0 3.3 6.0 2.9 3.7
Completely Rural 2.9 0.7 3.4 0.6 2.9 0.7 5.8 3.0 2.6 0.5
POVERTY LEVEL1                    
Less Than 100% 5.1 5.8 2.5 3.1 5.6 6.2 5.5 4.2 5.6 6.7
100-199% 4.1 3.5 2.7 1.2 4.3 3.7 5.4 4.4 4.0 3.6
200% or More 3.0 2.7 2.0 1.3 3.1 2.9 5.1 3.7 2.9 2.8
HEALTH INSURANCE2                    
Private 2.8 2.6 2.0 1.1 2.9 2.8 4.8 3.8 2.6 2.6
Medicaid/CHIP 5.4 5.6 2.6 2.1 6.1 6.3 5.5 4.5 6.3 6.8
Other3 2.5 2.5 3.5 1.2 2.5 2.6 4.5 4.4 2.4 2.5
No Coverage 5.9 5.3 0.8 * 6.2 5.3 6.9 4.4 6.0 5.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.81A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2,819 2,536 165 96 2,654 2,440 420 288 2,234 2,152
GEOGRAPHIC REGION                    
Northeast 409 386 13 19 395 368 58 54 337 313
Midwest 626 459 44 27 581 432 95 69 486 362
South 1,045 877 63 36 982 841 154 111 828 730
West 739 814 44 14 695 800 112 54 583 746
COUNTY TYPE                    
Large Metro 1,541 1,253 79 51 1,462 1,203 225 143 1,237 1,060
Small Metro 922 969 65 34 857 935 127 79 730 855
Nonmetro 355 313 21 11 334 303 67 66 267 237
Urbanized 133 118 7 * 125 113 38 * 87 100
Less Urbanized 181 195 8 6 172 190 24 53 148 137
Completely Rural 42 * 5 * 37 * 5 * 31 *
POVERTY LEVEL1                    
Less Than 100% 538 794 32 16 505 778 98 105 407 673
100-199% 584 479 41 12 543 467 101 58 442 409
200% or More 1,685 1,244 91 68 1,594 1,176 208 106 1,385 1,070
HEALTH INSURANCE2                    
Private 1,354 988 95 50 1,259 938 221 135 1,038 803
Medicaid/CHIP 766 911 62 38 705 872 120 117 584 756
Other3 474 562 7 7 467 555 12 16 455 539
No Coverage 565 459 2 2 563 457 80 41 484 416
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.81B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.0 0.9 0.7 0.4 1.1 1.0 1.2 0.9 1.0 1.0
GEOGRAPHIC REGION                    
Northeast 0.9 0.8 0.3 0.5 0.9 0.8 1.0 1.0 0.9 0.8
Midwest 1.1 0.8 0.8 0.5 1.1 0.8 1.3 1.0 1.1 0.8
South 1.0 0.8 0.7 0.4 1.0 0.9 1.2 0.9 1.0 0.9
West 1.1 1.2 0.7 0.2 1.2 1.3 1.4 0.7 1.1 1.4
COUNTY TYPE                    
Large Metro 1.0 0.8 0.6 0.4 1.0 0.9 1.2 0.8 1.0 0.9
Small Metro 1.1 1.1 0.8 0.4 1.1 1.2 1.2 0.7 1.1 1.3
Nonmetro 0.9 0.8 0.6 0.3 1.0 0.8 1.6 1.4 0.9 0.7
Urbanized 0.8 0.7 0.5 * 0.9 0.7 1.9 * 0.7 0.8
Less Urbanized 1.0 1.0 0.5 0.3 1.1 1.0 1.2 2.4 1.0 0.9
Completely Rural 1.0 * 1.3 * 0.9 * 1.4 * 0.9 *
POVERTY LEVEL1                    
Less Than 100% 1.4 1.9 0.6 0.4 1.6 2.1 1.2 1.3 1.7 2.3
100-199% 1.1 0.9 0.8 0.3 1.1 1.0 1.3 0.8 1.1 1.1
200% or More 0.9 0.7 0.6 0.4 0.9 0.7 1.2 0.6 0.9 0.7
HEALTH INSURANCE2                    
Private 0.8 0.6 0.7 0.3 0.8 0.6 1.1 0.7 0.7 0.6
Medicaid/CHIP 1.7 1.9 0.7 0.5 2.0 2.2 1.7 1.5 2.0 2.3
Other3 0.7 0.7 0.5 0.4 0.7 0.7 0.5 0.7 0.7 0.7
No Coverage 2.1 1.6 0.2 0.1 2.2 1.7 1.6 0.8 2.3 1.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.82A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 18,290 18,332 1,837 1,593 16,453 16,739 4,320 3,773 12,133 12,966
GEOGRAPHIC REGION                    
Northeast 2,900 3,061 251 215 2,649 2,846 823 687 1,826 2,159
Midwest 4,246 4,077 434 367 3,812 3,710 1,109 1,008 2,704 2,702
South 7,368 7,194 758 740 6,610 6,455 1,554 1,268 5,056 5,187
West 3,776 4,000 394 272 3,382 3,728 835 810 2,547 2,918
COUNTY TYPE                    
Large Metro 10,377 10,232 1,015 924 9,363 9,308 2,459 1,957 6,904 7,351
Small Metro 5,658 5,811 578 507 5,080 5,304 1,368 1,320 3,713 3,984
Nonmetro 2,254 2,289 244 163 2,010 2,126 494 496 1,516 1,631
Urbanized 1,038 1,075 102 54 936 1,021 270 301 666 721
Less Urbanized 1,020 1,058 111 73 909 986 192 183 717 803
Completely Rural 197 156 32 * 165 119 32 12 133 107
POVERTY LEVEL1                    
Less Than 100% 2,546 2,916 302 229 2,244 2,687 941 730 1,303 1,957
100-199% 3,107 3,286 345 180 2,762 3,106 754 893 2,008 2,213
200% or More 12,480 12,074 1,189 1,184 11,291 10,890 2,470 2,095 8,821 8,795
HEALTH INSURANCE2                    
Private 12,481 11,455 1,098 1,073 11,383 10,382 3,226 2,708 8,157 7,674
Medicaid/CHIP 3,118 3,668 654 468 2,464 3,200 617 566 1,847 2,633
Other3 2,825 3,283 131 158 2,694 3,124 290 204 2,404 2,920
No Coverage 1,600 1,885 53 23 1,547 1,862 350 446 1,197 1,416
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.82B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 6.6 6.6 7.4 6.4 6.6 6.6 12.8 11.3 5.6 5.9
GEOGRAPHIC REGION                    
Northeast 6.1 6.4 6.3 5.5 6.0 6.5 14.3 12.1 4.8 5.7
Midwest 7.4 7.1 8.2 7.0 7.3 7.1 15.5 14.2 6.0 6.0
South 7.0 6.8 7.8 7.6 7.0 6.7 12.2 10.0 6.2 6.2
West 5.8 6.1 6.6 4.5 5.7 6.2 10.3 10.1 4.9 5.6
COUNTY TYPE                    
Large Metro 6.7 6.8 7.5 6.6 6.7 6.8 13.1 11.0 5.7 6.2
Small Metro 6.8 6.9 7.5 6.6 6.7 6.9 12.9 12.0 5.7 6.0
Nonmetro 5.9 5.5 6.8 5.1 5.8 5.6 11.4 10.4 5.0 4.9
Urbanized 6.5 6.5 6.7 4.1 6.5 6.7 13.3 13.6 5.4 5.6
Less Urbanized 5.7 5.4 6.7 4.5 5.6 5.4 9.9 8.3 5.0 5.1
Completely Rural 4.5 3.1 7.7 * 4.2 2.5 8.6 3.3 3.7 2.4
POVERTY LEVEL1                    
Less Than 100% 6.8 7.0 5.9 5.0 6.9 7.2 11.9 9.0 5.3 6.7
100-199% 5.9 6.5 6.5 4.0 5.8 6.8 9.7 11.6 5.0 5.8
200% or More 6.8 6.6 8.2 7.5 6.7 6.5 14.6 12.1 5.8 5.8
HEALTH INSURANCE2                    
Private 6.9 6.6 7.7 7.2 6.9 6.5 15.8 13.8 5.6 5.5
Medicaid/CHIP 6.9 7.5 6.9 5.6 6.9 7.9 8.5 7.3 6.5 8.1
Other3 4.0 4.3 10.7 9.6 3.9 4.2 11.4 8.4 3.6 4.0
No Coverage 5.9 6.6 4.6 1.6 6.0 6.9 7.3 8.5 5.7 6.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.83A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,929 5,092 430 288 4,499 4,804 1,951 1,616 2,548 3,188
GEOGRAPHIC REGION                    
Northeast 881 1,032 51 41 830 991 402 251 428 740
Midwest 1,254 1,133 93 72 1,161 1,061 547 436 614 625
South 1,712 1,855 186 87 1,525 1,768 629 536 896 1,232
West 1,082 1,073 99 89 982 984 373 392 609 592
COUNTY TYPE                    
Large Metro 2,915 3,053 256 163 2,659 2,890 1,197 909 1,462 1,981
Small Metro 1,510 1,654 126 99 1,384 1,555 567 590 817 965
Nonmetro 504 385 48 27 456 358 187 116 270 242
Urbanized 232 162 29 13 203 148 97 33 106 115
Less Urbanized 238 216 15 13 223 204 72 78 151 125
Completely Rural 34 7 4 0 30 7 17 5 13 2
POVERTY LEVEL1                    
Less Than 100% 844 862 60 34 784 828 483 333 301 495
100-199% 783 832 81 32 702 799 328 353 374 447
200% or More 3,231 3,355 289 222 2,942 3,133 1,069 886 1,873 2,247
HEALTH INSURANCE2                    
Private 3,360 3,417 284 193 3,075 3,224 1,498 1,215 1,578 2,009
Medicaid/CHIP 853 914 135 101 718 813 235 157 483 656
Other3 348 254 26 6 322 248 105 69 218 179
No Coverage 605 814 10 9 595 805 158 233 437 572
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.83B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.8 1.8 1.7 1.2 1.8 1.9 5.8 4.8 1.2 1.5
GEOGRAPHIC REGION                    
Northeast 1.8 2.2 1.3 1.0 1.9 2.3 7.0 4.4 1.1 1.9
Midwest 2.2 2.0 1.8 1.4 2.2 2.0 7.6 6.1 1.4 1.4
South 1.6 1.8 1.9 0.9 1.6 1.8 4.9 4.2 1.1 1.5
West 1.6 1.6 1.7 1.5 1.6 1.6 4.6 4.9 1.2 1.1
COUNTY TYPE                    
Large Metro 1.9 2.0 1.9 1.2 1.9 2.1 6.4 5.1 1.2 1.7
Small Metro 1.8 2.0 1.6 1.3 1.8 2.0 5.3 5.4 1.3 1.5
Nonmetro 1.3 0.9 1.3 0.8 1.3 0.9 4.3 2.4 0.9 0.7
Urbanized 1.5 1.0 1.9 1.0 1.4 1.0 4.8 1.5 0.9 0.9
Less Urbanized 1.3 1.1 0.9 0.8 1.4 1.1 3.7 3.5 1.1 0.8
Completely Rural 0.8 0.1 0.9 0.2 0.8 0.1 4.6 1.3 0.4 0.0
POVERTY LEVEL1                    
Less Than 100% 2.3 2.1 1.2 0.7 2.4 2.2 6.1 4.1 1.2 1.7
100-199% 1.5 1.6 1.5 0.7 1.5 1.7 4.2 4.6 0.9 1.2
200% or More 1.8 1.8 2.0 1.4 1.7 1.9 6.3 5.1 1.2 1.5
HEALTH INSURANCE2                    
Private 1.9 2.0 2.0 1.3 1.9 2.0 7.3 6.2 1.1 1.4
Medicaid/CHIP 1.9 1.9 1.4 1.2 2.0 2.0 3.2 2.0 1.7 2.0
Other3 0.5 0.3 2.1 0.4 0.5 0.3 4.1 2.8 0.3 0.2
No Coverage 2.2 2.9 0.9 0.6 2.3 3.0 3.3 4.4 2.1 2.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.84A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,566 1,493 123 72 1,443 1,421 587 267 856 1,154
GEOGRAPHIC REGION                    
Northeast 261 392 13 18 248 374 118 40 130 334
Midwest 348 370 27 12 321 358 153 87 167 270
South 556 520 55 34 502 486 219 73 283 413
West 401 211 28 8 373 203 96 67 277 136
COUNTY TYPE                    
Large Metro 1,006 945 80 35 926 910 384 174 542 736
Small Metro 413 431 30 35 384 397 152 59 231 338
Nonmetro 147 117 14 2 133 114 50 34 83 81
Urbanized 73 43 11 1 62 42 29 2 33 40
Less Urbanized 64 72 2 2 62 70 19 29 44 41
Completely Rural 10 2 1 * 9 2 * * 6 *
POVERTY LEVEL1                    
Less Than 100% 300 218 12 4 288 214 169 45 120 170
100-199% 171 175 13 * 159 175 79 63 80 112
200% or More 1,067 1,098 99 69 969 1,030 312 157 657 873
HEALTH INSURANCE2                    
Private 1,082 960 91 58 991 903 446 186 545 717
Medicaid/CHIP 209 324 29 10 180 313 63 43 116 270
Other3 104 45 9 2 96 43 43 20 52 23
No Coverage 230 241 0 2 230 239 48 38 182 201
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.84B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.6 0.5 0.5 0.3 0.6 0.6 1.7 0.8 0.4 0.5
GEOGRAPHIC REGION                    
Northeast 0.5 0.8 0.3 0.4 0.6 0.9 2.0 0.7 0.3 0.9
Midwest 0.6 0.6 0.5 0.2 0.6 0.7 2.1 1.2 0.4 0.6
South 0.5 0.5 0.6 0.3 0.5 0.5 1.7 0.6 0.3 0.5
West 0.6 0.3 0.5 0.1 0.6 0.3 1.2 0.8 0.5 0.3
COUNTY TYPE                    
Large Metro 0.7 0.6 0.6 0.3 0.7 0.7 2.0 1.0 0.4 0.6
Small Metro 0.5 0.5 0.4 0.4 0.5 0.5 1.4 0.5 0.4 0.5
Nonmetro 0.4 0.3 0.4 0.1 0.4 0.3 1.2 0.7 0.3 0.2
Urbanized 0.5 0.3 0.7 0.0 0.4 0.3 1.4 0.1 0.3 0.3
Less Urbanized 0.4 0.4 0.1 0.1 0.4 0.4 1.0 1.3 0.3 0.3
Completely Rural 0.2 0.0 0.2 * 0.2 0.0 * * 0.2 *
POVERTY LEVEL1                    
Less Than 100% 0.8 0.5 0.2 0.1 0.9 0.6 2.1 0.5 0.5 0.6
100-199% 0.3 0.3 0.2 * 0.3 0.4 1.0 0.8 0.2 0.3
200% or More 0.6 0.6 0.7 0.4 0.6 0.6 1.8 0.9 0.4 0.6
HEALTH INSURANCE2                    
Private 0.6 0.6 0.6 0.4 0.6 0.6 2.2 0.9 0.4 0.5
Medicaid/CHIP 0.5 0.7 0.3 0.1 0.5 0.8 0.9 0.6 0.4 0.8
Other3 0.1 0.1 0.7 0.1 0.1 0.1 1.7 0.8 0.1 0.0
No Coverage 0.9 0.8 0.0 0.1 0.9 0.9 1.0 0.7 0.9 0.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.85A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 44,051 43,001 1,370 936 42,682 42,065 3,995 3,805 38,687 38,261
GEOGRAPHIC REGION                    
Northeast 7,664 7,711 195 149 7,469 7,562 662 586 6,807 6,976
Midwest 9,214 9,045 278 190 8,936 8,855 956 854 7,980 8,001
South 17,162 16,867 571 354 16,591 16,513 1,417 1,512 15,174 15,002
West 10,012 9,378 326 243 9,685 9,135 961 852 8,724 8,282
COUNTY TYPE                    
Large Metro 24,203 22,653 751 422 23,452 22,231 2,280 1,827 21,172 20,404
Small Metro 13,588 14,053 419 375 13,169 13,678 1,203 1,341 11,966 12,337
Nonmetro 6,260 6,295 200 139 6,060 6,156 512 637 5,548 5,520
Urbanized 2,479 2,686 83 39 2,396 2,646 280 343 2,116 2,303
Less Urbanized 3,065 3,015 85 96 2,980 2,920 189 282 2,790 2,638
Completely Rural 716 594 31 * 685 590 43 12 642 578
POVERTY LEVEL1                    
Less Than 100% 5,402 5,993 353 223 5,049 5,770 867 884 4,182 4,886
100-199% 8,061 7,691 281 142 7,781 7,549 856 919 6,925 6,629
200% or More 30,482 29,285 736 571 29,746 28,714 2,166 1,968 27,579 26,746
HEALTH INSURANCE2                    
Private 28,892 26,611 704 537 28,188 26,075 2,541 2,414 25,647 23,661
Medicaid/CHIP 7,742 8,551 574 378 7,169 8,173 847 852 6,322 7,321
Other3 14,865 14,964 90 39 14,775 14,925 304 177 14,471 14,748
No Coverage 2,846 3,206 65 35 2,781 3,171 464 513 2,317 2,658
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.85B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 16.0 15.5 5.5 3.7 17.1 16.7 11.8 11.4 17.9 17.5
GEOGRAPHIC REGION                    
Northeast 16.0 16.2 4.9 3.8 17.1 17.3 11.5 10.4 17.9 18.3
Midwest 16.1 15.8 5.3 3.6 17.2 17.0 13.3 12.0 17.8 17.8
South 16.4 16.0 5.9 3.6 17.5 17.2 11.1 11.9 18.5 18.0
West 15.3 14.2 5.4 4.0 16.3 15.2 11.9 10.6 16.9 15.9
COUNTY TYPE                    
Large Metro 15.7 15.0 5.5 3.0 16.7 16.2 12.1 10.3 17.4 17.1
Small Metro 16.3 16.6 5.4 4.9 17.4 17.8 11.3 12.2 18.4 18.7
Nonmetro 16.4 15.2 5.5 4.3 17.6 16.2 11.8 13.3 18.4 16.6
Urbanized 15.6 16.3 5.4 3.0 16.7 17.4 13.8 15.6 17.2 17.7
Less Urbanized 17.2 15.3 5.2 5.9 18.4 16.1 9.8 12.7 19.6 16.6
Completely Rural 16.5 11.7 7.6 * 17.4 12.3 11.4 3.3 18.0 13.0
POVERTY LEVEL1                    
Less Than 100% 14.4 14.3 6.9 4.8 15.6 15.5 11.0 10.9 17.1 16.7
100-199% 15.2 15.2 5.3 3.2 16.3 16.4 11.1 11.9 17.4 17.3
200% or More 16.6 15.9 5.1 3.6 17.6 17.1 12.8 11.4 18.1 17.7
HEALTH INSURANCE2                    
Private 16.1 15.3 4.9 3.6 17.0 16.4 12.4 12.3 17.7 17.0
Medicaid/CHIP 17.1 17.6 6.1 4.5 20.0 20.3 11.7 10.9 22.2 22.5
Other3 21.2 19.6 7.3 2.4 21.4 20.0 12.0 7.3 21.8 20.4
No Coverage 10.5 11.3 5.6 2.4 10.7 11.7 9.6 9.7 11.0 12.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.86A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,895 6,205 436 226 5,459 5,979 1,409 1,237 4,050 4,742
GEOGRAPHIC REGION                    
Northeast 1,057 824 31 41 1,025 784 227 133 798 650
Midwest 1,116 1,334 103 36 1,014 1,298 307 311 707 987
South 2,213 2,472 154 73 2,059 2,399 536 483 1,523 1,917
West 1,509 1,574 148 76 1,361 1,498 339 310 1,022 1,188
COUNTY TYPE                    
Large Metro 3,551 2,981 224 98 3,328 2,883 797 665 2,531 2,218
Small Metro 1,754 2,365 166 112 1,588 2,253 423 408 1,165 1,845
Nonmetro 589 859 46 16 543 843 189 164 354 680
Urbanized 285 288 24 3 261 285 129 85 132 201
Less Urbanized 259 551 20 12 240 539 49 77 190 461
Completely Rural 45 20 3 0 42 19 10 1 32 18
POVERTY LEVEL1                    
Less Than 100% 1,038 1,206 95 69 943 1,138 327 314 616 824
100-199% 1,066 1,070 103 14 963 1,056 278 322 685 734
200% or More 3,752 3,919 238 143 3,514 3,776 765 592 2,749 3,184
HEALTH INSURANCE2                    
Private 3,370 3,551 214 111 3,156 3,440 914 720 2,242 2,720
Medicaid/CHIP 1,447 1,425 195 107 1,252 1,317 256 293 996 1,024
Other3 793 1,122 25 2 768 1,120 73 60 695 1,060
No Coverage 792 938 17 15 775 923 216 218 560 705
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.86B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 2.1 2.2 1.8 0.9 2.2 2.4 4.2 3.7 1.9 2.2
GEOGRAPHIC REGION                    
Northeast 2.2 1.7 0.8 1.0 2.3 1.8 3.9 2.4 2.1 1.7
Midwest 1.9 2.3 1.9 0.7 1.9 2.5 4.3 4.4 1.6 2.2
South 2.1 2.3 1.6 0.7 2.2 2.5 4.2 3.8 1.9 2.3
West 2.3 2.4 2.5 1.3 2.3 2.5 4.2 3.9 2.0 2.3
COUNTY TYPE                    
Large Metro 2.3 2.0 1.6 0.7 2.4 2.1 4.2 3.8 2.1 1.9
Small Metro 2.1 2.8 2.1 1.5 2.1 2.9 4.0 3.7 1.8 2.8
Nonmetro 1.5 2.1 1.3 0.5 1.6 2.2 4.4 3.4 1.2 2.0
Urbanized 1.8 1.7 1.5 0.2 1.8 1.9 6.4 3.9 1.1 1.5
Less Urbanized 1.5 2.8 1.2 0.8 1.5 3.0 2.6 3.5 1.3 2.9
Completely Rural 1.0 0.4 0.7 0.2 1.1 0.4 2.8 0.4 0.9 0.4
POVERTY LEVEL1                    
Less Than 100% 2.8 2.9 1.9 1.5 2.9 3.0 4.1 3.9 2.5 2.8
100-199% 2.0 2.1 1.9 0.3 2.0 2.3 3.6 4.2 1.7 1.9
200% or More 2.0 2.1 1.6 0.9 2.1 2.2 4.5 3.4 1.8 2.1
HEALTH INSURANCE2                    
Private 1.9 2.0 1.5 0.7 1.9 2.2 4.5 3.7 1.5 2.0
Medicaid/CHIP 3.2 2.9 2.1 1.3 3.5 3.3 3.5 3.8 3.5 3.1
Other3 1.1 1.5 2.0 0.1 1.1 1.5 2.9 2.5 1.0 1.5
No Coverage 2.9 3.3 1.4 1.0 3.0 3.4 4.5 4.1 2.7 3.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.87A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,958 2,196 121 26 1,837 2,170 365 371 1,472 1,799
GEOGRAPHIC REGION                    
Northeast 329 306 8 9 321 297 67 36 254 261
Midwest 382 382 29 1 353 380 85 69 268 311
South 667 936 41 2 626 935 113 151 513 783
West 581 572 44 14 537 558 100 114 437 444
COUNTY TYPE                    
Large Metro 1,171 947 59 21 1,112 926 216 181 896 746
Small Metro 576 1,003 56 5 519 998 104 132 416 866
Nonmetro 211 246 5 0 206 246 45 58 161 187
Urbanized 88 72 5 0 83 72 31 33 52 39
Less Urbanized 104 174 1 * 103 174 14 25 89 148
Completely Rural 20 * * * 20 * * * 20 *
POVERTY LEVEL1                    
Less Than 100% 360 572 13 2 348 570 67 96 281 474
100-199% 289 335 31 1 259 334 66 125 193 209
200% or More 1,300 1,289 78 23 1,222 1,266 223 150 999 1,116
HEALTH INSURANCE2                    
Private 1,017 1,132 75 19 942 1,113 242 189 700 924
Medicaid/CHIP 498 508 47 8 451 500 68 102 383 398
Other3 295 453 4 * 291 453 14 9 277 444
No Coverage 292 404 1 * 292 404 58 83 233 321
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.87B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.7 0.8 0.5 0.1 0.7 0.9 1.1 1.1 0.7 0.8
GEOGRAPHIC REGION                    
Northeast 0.7 0.6 0.2 0.2 0.7 0.7 1.2 0.6 0.7 0.7
Midwest 0.7 0.7 0.5 0.0 0.7 0.7 1.2 1.0 0.6 0.7
South 0.6 0.9 0.4 0.0 0.7 1.0 0.9 1.2 0.6 0.9
West 0.9 0.9 0.7 0.2 0.9 0.9 1.2 1.4 0.8 0.9
COUNTY TYPE                    
Large Metro 0.8 0.6 0.4 0.1 0.8 0.7 1.1 1.0 0.7 0.6
Small Metro 0.7 1.2 0.7 0.1 0.7 1.3 1.0 1.2 0.6 1.3
Nonmetro 0.6 0.6 0.2 0.0 0.6 0.6 1.0 1.2 0.5 0.6
Urbanized 0.6 0.4 0.3 0.0 0.6 0.5 1.5 1.5 0.4 0.3
Less Urbanized 0.6 0.9 0.1 * 0.6 1.0 0.7 1.1 0.6 0.9
Completely Rural 0.5 * * * 0.5 * * * 0.6 *
POVERTY LEVEL1                    
Less Than 100% 1.0 1.4 0.2 0.0 1.1 1.5 0.8 1.2 1.1 1.6
100-199% 0.5 0.7 0.6 0.0 0.5 0.7 0.9 1.6 0.5 0.5
200% or More 0.7 0.7 0.5 0.1 0.7 0.8 1.3 0.9 0.7 0.7
HEALTH INSURANCE2                    
Private 0.6 0.7 0.5 0.1 0.6 0.7 1.2 1.0 0.5 0.7
Medicaid/CHIP 1.1 1.0 0.5 0.1 1.3 1.2 0.9 1.3 1.3 1.2
Other3 0.4 0.6 0.3 * 0.4 0.6 0.5 0.4 0.4 0.6
No Coverage 1.1 1.4 0.1 * 1.1 1.5 1.2 1.6 1.1 1.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.88A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 35,601 35,018 1,010 588 34,591 34,430 3,419 3,338 31,172 31,092
GEOGRAPHIC REGION                    
Northeast 6,387 6,519 125 87 6,262 6,432 578 546 5,685 5,886
Midwest 7,460 7,376 221 131 7,239 7,245 819 735 6,421 6,510
South 13,851 13,784 422 197 13,429 13,586 1,219 1,282 12,209 12,304
West 7,903 7,339 243 172 7,660 7,167 803 775 6,857 6,392
COUNTY TYPE                    
Large Metro 19,449 18,548 557 267 18,892 18,280 1,931 1,605 16,961 16,675
Small Metro 11,120 11,471 324 239 10,796 11,232 1,035 1,198 9,762 10,033
Nonmetro 5,032 4,999 129 81 4,903 4,918 453 535 4,450 4,384
Urbanized 2,047 1,945 63 25 1,984 1,920 265 279 1,719 1,640
Less Urbanized 2,415 2,492 52 52 2,363 2,440 153 244 2,210 2,196
Completely Rural 570 563 14 * 556 559 36 11 520 547
POVERTY LEVEL1                    
Less Than 100% 4,575 5,135 251 165 4,324 4,970 755 823 3,568 4,147
100-199% 6,614 6,595 204 86 6,410 6,510 739 831 5,671 5,679
200% or More 24,338 23,267 555 337 23,783 22,931 1,850 1,664 21,933 21,266
HEALTH INSURANCE2                    
Private 23,204 21,294 518 318 22,686 20,975 2,196 2,094 20,490 18,882
Medicaid/CHIP 6,494 7,176 415 263 6,079 6,914 740 751 5,339 6,162
Other3 11,372 11,727 66 31 11,306 11,696 235 164 11,072 11,532
No Coverage 2,441 2,827 49 19 2,392 2,808 394 461 1,997 2,347
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.88B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 12.9 12.6 4.1 2.4 13.8 13.7 10.1 10.0 14.4 14.2
GEOGRAPHIC REGION                    
Northeast 13.4 13.7 3.2 2.2 14.3 14.7 10.0 9.6 14.9 15.4
Midwest 13.0 12.8 4.2 2.5 13.9 13.9 11.4 10.4 14.3 14.5
South 13.2 13.0 4.4 2.0 14.1 14.2 9.6 10.1 14.9 14.8
West 12.1 11.1 4.0 2.9 12.9 11.9 9.9 9.7 13.3 12.3
COUNTY TYPE                    
Large Metro 12.6 12.3 4.1 1.9 13.5 13.4 10.3 9.1 14.0 14.0
Small Metro 13.3 13.5 4.2 3.1 14.3 14.6 9.8 10.9 15.0 15.2
Nonmetro 13.2 12.1 3.6 2.5 14.2 12.9 10.5 11.2 14.8 13.2
Urbanized 12.9 11.8 4.1 1.9 13.8 12.6 13.1 12.7 13.9 12.6
Less Urbanized 13.5 12.6 3.1 3.2 14.6 13.5 7.9 11.0 15.5 13.8
Completely Rural 13.1 11.1 3.5 * 14.1 11.6 9.5 3.2 14.6 12.3
POVERTY LEVEL1                    
Less Than 100% 12.2 12.3 4.9 3.6 13.4 13.3 9.6 10.1 14.6 14.2
100-199% 12.5 13.1 3.8 1.9 13.5 14.2 9.6 10.8 14.2 14.9
200% or More 13.2 12.6 3.8 2.1 14.1 13.6 10.9 9.6 14.4 14.1
HEALTH INSURANCE2                    
Private 12.9 12.2 3.6 2.1 13.7 13.2 10.8 10.7 14.1 13.6
Medicaid/CHIP 14.4 14.7 4.4 3.1 17.0 17.1 10.2 9.6 18.7 18.9
Other3 16.2 15.4 5.4 1.9 16.4 15.7 9.2 6.8 16.7 16.0
No Coverage 9.0 9.9 4.2 1.3 9.2 10.4 8.2 8.8 9.5 10.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.89A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5,220 5,460 392 196 4,829 5,264 1,313 1,108 3,516 4,156
GEOGRAPHIC REGION                    
Northeast 978 734 21 33 957 701 227 130 730 571
Midwest 971 1,182 93 30 878 1,152 291 303 588 849
South 2,005 2,097 138 57 1,867 2,040 494 402 1,373 1,638
West 1,267 1,446 140 75 1,127 1,371 301 274 826 1,097
COUNTY TYPE                    
Large Metro 3,109 2,635 198 77 2,911 2,557 736 594 2,175 1,963
Small Metro 1,567 2,059 152 106 1,415 1,953 392 374 1,023 1,579
Nonmetro 545 766 41 12 503 754 185 140 318 613
Urbanized 266 250 23 3 243 247 127 67 116 180
Less Urbanized 237 496 16 9 221 487 48 72 173 415
Completely Rural 42 20 3 0 39 19 10 1 28 18
POVERTY LEVEL1                    
Less Than 100% 930 1,089 79 64 851 1,025 319 292 532 732
100-199% 949 959 91 13 858 946 261 277 597 669
200% or More 3,313 3,403 222 119 3,091 3,285 705 530 2,387 2,755
HEALTH INSURANCE2                    
Private 2,916 3,016 200 93 2,716 2,923 843 648 1,873 2,275
Medicaid/CHIP 1,317 1,281 170 101 1,146 1,179 238 248 909 931
Other3 672 949 22 2 650 947 59 57 592 890
No Coverage 748 866 12 9 736 857 213 209 523 648
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.89B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.9 2.0 1.6 0.8 1.9 2.1 3.9 3.3 1.6 1.9
GEOGRAPHIC REGION                    
Northeast 2.0 1.5 0.5 0.8 2.2 1.6 3.9 2.3 1.9 1.5
Midwest 1.7 2.1 1.8 0.6 1.7 2.2 4.1 4.3 1.3 1.9
South 1.9 2.0 1.4 0.6 2.0 2.1 3.9 3.2 1.7 2.0
West 1.9 2.2 2.3 1.2 1.9 2.3 3.7 3.4 1.6 2.1
COUNTY TYPE                    
Large Metro 2.0 1.7 1.5 0.5 2.1 1.9 3.9 3.4 1.8 1.6
Small Metro 1.9 2.4 2.0 1.4 1.9 2.5 3.7 3.4 1.6 2.4
Nonmetro 1.4 1.9 1.1 0.4 1.5 2.0 4.3 2.9 1.1 1.8
Urbanized 1.7 1.5 1.5 0.2 1.7 1.6 6.3 3.0 0.9 1.4
Less Urbanized 1.3 2.5 0.9 0.6 1.4 2.7 2.5 3.2 1.2 2.6
Completely Rural 1.0 0.4 0.7 0.2 1.0 0.4 2.7 0.4 0.8 0.4
POVERTY LEVEL1                    
Less Than 100% 2.5 2.6 1.6 1.4 2.6 2.7 4.0 3.6 2.2 2.5
100-199% 1.8 1.9 1.7 0.3 1.8 2.1 3.4 3.6 1.5 1.7
200% or More 1.8 1.8 1.5 0.7 1.8 2.0 4.2 3.1 1.6 1.8
HEALTH INSURANCE2                    
Private 1.6 1.7 1.4 0.6 1.6 1.8 4.1 3.3 1.3 1.6
Medicaid/CHIP 2.9 2.6 1.8 1.2 3.2 2.9 3.3 3.2 3.2 2.9
Other3 1.0 1.2 1.8 0.1 0.9 1.3 2.3 2.3 0.9 1.2
No Coverage 2.8 3.0 1.0 0.6 2.8 3.2 4.4 4.0 2.5 3.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.90A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,781 1,891 112 25 1,669 1,866 337 357 1,332 1,509
GEOGRAPHIC REGION                    
Northeast 315 261 6 9 308 252 67 33 241 219
Midwest 357 339 27 * 329 339 85 66 245 273
South 608 755 36 2 571 753 97 145 474 608
West 502 537 43 14 460 522 88 113 372 409
COUNTY TYPE                    
Large Metro 1,056 827 54 21 1,002 806 195 176 807 630
Small Metro 521 837 53 4 468 833 98 127 370 706
Nonmetro 204 227 5 0 199 227 44 53 154 174
Urbanized 85 67 5 0 81 67 30 28 50 39
Less Urbanized 99 160 1 * 98 160 14 25 84 135
Completely Rural 20 * * * 20 * * * 20 *
POVERTY LEVEL1                    
Less Than 100% 325 517 13 2 312 515 66 94 246 421
100-199% 249 309 27 1 221 308 60 116 162 191
200% or More 1,200 1,065 72 21 1,128 1,044 203 147 924 897
HEALTH INSURANCE2                    
Private 920 932 71 17 849 915 227 182 622 732
Medicaid/CHIP 444 467 42 8 402 459 59 100 343 359
Other3 238 338 4 * 233 338 11 9 222 329
No Coverage 289 342 1 * 288 342 58 78 230 264
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.90B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.6 0.7 0.5 0.1 0.7 0.7 1.0 1.1 0.6 0.7
GEOGRAPHIC REGION                    
Northeast 0.7 0.5 0.2 0.2 0.7 0.6 1.2 0.6 0.6 0.6
Midwest 0.6 0.6 0.5 * 0.6 0.6 1.2 0.9 0.5 0.6
South 0.6 0.7 0.4 0.0 0.6 0.8 0.8 1.1 0.6 0.7
West 0.8 0.8 0.7 0.2 0.8 0.9 1.1 1.4 0.7 0.8
COUNTY TYPE                    
Large Metro 0.7 0.5 0.4 0.1 0.7 0.6 1.0 1.0 0.7 0.5
Small Metro 0.6 1.0 0.7 0.1 0.6 1.1 0.9 1.2 0.6 1.1
Nonmetro 0.5 0.5 0.2 0.0 0.6 0.6 1.0 1.1 0.5 0.5
Urbanized 0.5 0.4 0.3 0.0 0.6 0.4 1.5 1.3 0.4 0.3
Less Urbanized 0.6 0.8 0.1 * 0.6 0.9 0.7 1.1 0.6 0.8
Completely Rural 0.5 * * * 0.5 * * * 0.6 *
POVERTY LEVEL1                    
Less Than 100% 0.9 1.2 0.2 0.0 1.0 1.4 0.8 1.2 1.0 1.4
100-199% 0.5 0.6 0.5 0.0 0.5 0.7 0.8 1.5 0.4 0.5
200% or More 0.7 0.6 0.5 0.1 0.7 0.6 1.2 0.8 0.6 0.6
HEALTH INSURANCE2                    
Private 0.5 0.5 0.5 0.1 0.5 0.6 1.1 0.9 0.4 0.5
Medicaid/CHIP 1.0 1.0 0.4 0.1 1.1 1.1 0.8 1.3 1.2 1.1
Other3 0.3 0.4 0.3 * 0.3 0.5 0.4 0.4 0.3 0.5
No Coverage 1.1 1.2 0.1 * 1.1 1.3 1.2 1.5 1.1 1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.91A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 15,636 15,364 545 429 15,091 14,935 1,051 1,066 14,040 13,869
GEOGRAPHIC REGION                    
Northeast 2,434 2,586 83 75 2,351 2,511 157 122 2,194 2,389
Midwest 3,226 3,304 109 87 3,117 3,217 247 233 2,870 2,983
South 6,254 5,810 233 185 6,021 5,625 366 489 5,655 5,136
West 3,720 3,664 119 82 3,602 3,582 281 222 3,320 3,360
COUNTY TYPE                    
Large Metro 8,651 7,670 284 182 8,368 7,488 616 477 7,751 7,011
Small Metro 4,691 5,085 165 175 4,526 4,909 303 428 4,222 4,481
Nonmetro 2,294 2,610 96 72 2,198 2,538 131 161 2,067 2,378
Urbanized 930 1,055 30 25 900 1,030 60 93 840 937
Less Urbanized 1,109 1,294 49 47 1,060 1,247 55 65 1,005 1,182
Completely Rural 255 261 17 * 238 261 16 3 222 258
POVERTY LEVEL1                    
Less Than 100% 1,860 2,315 155 90 1,705 2,225 242 247 1,463 1,978
100-199% 2,715 2,554 105 63 2,610 2,492 216 253 2,394 2,239
200% or More 11,022 10,474 284 276 10,738 10,198 554 545 10,183 9,653
HEALTH INSURANCE2                    
Private 10,202 9,457 297 270 9,904 9,187 658 702 9,247 8,484
Medicaid/CHIP 2,720 3,212 225 150 2,495 3,061 244 239 2,251 2,822
Other3 6,373 6,104 39 8 6,334 6,097 93 58 6,241 6,039
No Coverage 719 895 19 18 700 877 117 114 583 763
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.91B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 5.7 5.5 2.2 1.7 6.0 5.9 3.1 3.2 6.5 6.3
GEOGRAPHIC REGION                    
Northeast 5.1 5.4 2.1 1.9 5.4 5.7 2.7 2.2 5.8 6.3
Midwest 5.6 5.8 2.1 1.7 6.0 6.2 3.4 3.3 6.4 6.6
South 6.0 5.5 2.4 1.9 6.3 5.9 2.9 3.8 6.9 6.2
West 5.7 5.5 2.0 1.4 6.0 6.0 3.5 2.8 6.4 6.5
COUNTY TYPE                    
Large Metro 5.6 5.1 2.1 1.3 6.0 5.5 3.3 2.7 6.4 5.9
Small Metro 5.6 6.0 2.1 2.3 6.0 6.4 2.9 3.9 6.5 6.8
Nonmetro 6.0 6.3 2.7 2.2 6.4 6.7 3.0 3.4 6.9 7.1
Urbanized 5.9 6.4 1.9 1.9 6.3 6.8 3.0 4.2 6.8 7.2
Less Urbanized 6.2 6.6 3.0 2.9 6.6 6.9 2.8 2.9 7.1 7.4
Completely Rural 5.9 5.1 4.3 * 6.0 5.4 4.2 0.9 6.2 5.8
POVERTY LEVEL1                    
Less Than 100% 5.0 5.5 3.1 2.0 5.3 6.0 3.1 3.0 6.0 6.8
100-199% 5.1 5.1 2.0 1.4 5.5 5.4 2.8 3.3 6.0 5.9
200% or More 6.0 5.7 2.0 1.7 6.3 6.1 3.3 3.2 6.7 6.4
HEALTH INSURANCE2                    
Private 5.7 5.4 2.1 1.8 6.0 5.8 3.2 3.6 6.4 6.1
Medicaid/CHIP 6.0 6.6 2.4 1.8 7.0 7.6 3.4 3.1 7.9 8.7
Other3 9.1 8.0 3.1 0.5 9.2 8.2 3.7 2.4 9.4 8.4
No Coverage 2.7 3.1 1.7 1.2 2.7 3.2 2.4 2.2 2.8 3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.92A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1,098 1,240 82 35 1,016 1,205 175 251 841 954
GEOGRAPHIC REGION                    
Northeast 202 180 11 12 191 168 15 7 176 160
Midwest 191 281 25 6 167 275 32 26 135 249
South 374 541 33 16 341 526 75 140 266 385
West 330 238 13 1 317 237 53 77 264 160
COUNTY TYPE                    
Large Metro 673 586 43 21 630 565 104 104 526 461
Small Metro 338 509 32 11 307 498 53 111 254 387
Nonmetro 87 145 8 3 79 142 18 35 62 107
Urbanized 44 64 4 * 40 64 12 23 28 41
Less Urbanized 36 81 4 3 32 78 5 12 27 66
Completely Rural 7 * * * 7 * 0 * 7 *
POVERTY LEVEL1                    
Less Than 100% 201 229 20 5 182 224 28 56 154 168
100-199% 193 228 18 1 174 227 42 94 132 133
200% or More 692 781 44 29 648 752 93 99 555 653
HEALTH INSURANCE2                    
Private 630 756 45 23 586 733 123 142 463 591
Medicaid/CHIP 235 268 32 6 203 262 33 64 170 198
Other3 224 297 3 * 220 296 22 8 198 288
No Coverage 108 155 5 6 103 149 17 44 86 105
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.92B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.4 0.4 0.3 0.1 0.4 0.5 0.5 0.7 0.4 0.4
GEOGRAPHIC REGION                    
Northeast 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.5 0.4
Midwest 0.3 0.5 0.5 0.1 0.3 0.5 0.4 0.4 0.3 0.6
South 0.4 0.5 0.3 0.2 0.4 0.5 0.6 1.1 0.3 0.5
West 0.5 0.4 0.2 0.0 0.5 0.4 0.7 1.0 0.5 0.3
COUNTY TYPE                    
Large Metro 0.4 0.4 0.3 0.1 0.4 0.4 0.6 0.6 0.4 0.4
Small Metro 0.4 0.6 0.4 0.1 0.4 0.6 0.5 1.0 0.4 0.6
Nonmetro 0.2 0.4 0.2 0.1 0.2 0.4 0.4 0.7 0.2 0.3
Urbanized 0.3 0.4 0.3 * 0.3 0.4 0.6 1.1 0.2 0.3
Less Urbanized 0.2 0.4 0.2 0.2 0.2 0.4 0.3 0.5 0.2 0.4
Completely Rural 0.2 * * * 0.2 * 0.0 * 0.2 *
POVERTY LEVEL1                    
Less Than 100% 0.5 0.5 0.4 0.1 0.6 0.6 0.4 0.7 0.6 0.6
100-199% 0.4 0.5 0.3 0.0 0.4 0.5 0.5 1.2 0.3 0.3
200% or More 0.4 0.4 0.3 0.2 0.4 0.4 0.6 0.6 0.4 0.4
HEALTH INSURANCE2                    
Private 0.4 0.4 0.3 0.2 0.4 0.5 0.6 0.7 0.3 0.4
Medicaid/CHIP 0.5 0.6 0.3 0.1 0.6 0.7 0.5 0.8 0.6 0.6
Other3 0.3 0.4 0.3 * 0.3 0.4 0.9 0.3 0.3 0.4
No Coverage 0.4 0.5 0.4 0.4 0.4 0.6 0.4 0.8 0.4 0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.93A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 304 481 29 1 275 480 44 78 231 402
GEOGRAPHIC REGION                    
Northeast 74 86 2 * 72 86 4 4 69 82
Midwest 48 93 11 1 38 92 6 8 32 84
South 92 251 15 * 76 251 22 52 54 199
West 90 51 1 * 89 51 12 14 77 37
COUNTY TYPE                    
Large Metro 205 189 11 * 194 189 32 21 163 167
Small Metro 84 248 18 1 66 247 12 51 54 195
Nonmetro 15 44 * * 15 44 1 5 14 39
Urbanized 10 21 * * 10 21 1 5 10 16
Less Urbanized 5 23 * * 5 23 * * 5 23
Completely Rural * * * * * * * * * *
POVERTY LEVEL1                    
Less Than 100% 55 136 2 * 53 136 1 31 53 105
100-199% 48 101 6 * 43 101 12 43 31 58
200% or More 199 244 21 1 178 242 31 4 148 238
HEALTH INSURANCE2                    
Private 159 256 22 1 138 255 31 38 107 217
Medicaid/CHIP 68 102 7 * 61 102 11 11 51 92
Other3 93 166 * * 93 166 8 5 86 161
No Coverage 23 110 * * 23 110 * 29 23 81
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.93B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.2
GEOGRAPHIC REGION                    
Northeast 0.2 0.2 0.0 * 0.2 0.2 0.1 0.1 0.2 0.2
Midwest 0.1 0.2 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.2
South 0.1 0.2 0.2 * 0.1 0.3 0.2 0.4 0.1 0.2
West 0.1 0.1 0.0 * 0.1 0.1 0.1 0.2 0.1 0.1
COUNTY TYPE                    
Large Metro 0.1 0.1 0.1 * 0.1 0.1 0.2 0.1 0.1 0.1
Small Metro 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.1 0.3
Nonmetro 0.0 0.1 * * 0.0 0.1 0.0 0.1 0.0 0.1
Urbanized 0.1 0.1 * * 0.1 0.1 0.0 0.2 0.1 0.1
Less Urbanized 0.0 0.1 * * 0.0 0.1 * * 0.0 0.1
Completely Rural * * * * * * * * * *
POVERTY LEVEL1                    
Less Than 100% 0.1 0.3 0.0 * 0.2 0.4 0.0 0.4 0.2 0.4
100-199% 0.1 0.2 0.1 * 0.1 0.2 0.2 0.6 0.1 0.2
200% or More 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.2
HEALTH INSURANCE2                    
Private 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.2 0.1 0.2
Medicaid/CHIP 0.2 0.2 0.1 * 0.2 0.3 0.2 0.1 0.2 0.3
Other3 0.1 0.2 * * 0.1 0.2 0.3 0.2 0.1 0.2
No Coverage 0.1 0.4 * * 0.1 0.4 * 0.6 0.1 0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.94A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 29,408 27,026 749 418 28,659 26,607 2,983 2,861 25,676 23,747
GEOGRAPHIC REGION                    
Northeast 5,326 4,860 81 71 5,244 4,789 502 418 4,743 4,371
Midwest 6,182 5,577 168 84 6,014 5,492 716 615 5,298 4,877
South 11,368 10,566 292 139 11,076 10,427 1,042 1,127 10,033 9,300
West 6,532 6,022 207 124 6,325 5,899 723 700 5,602 5,198
COUNTY TYPE                    
Large Metro 16,415 14,685 404 195 16,011 14,490 1,699 1,430 14,312 13,060
Small Metro 8,906 8,886 249 166 8,657 8,720 894 1,013 7,763 7,707
Nonmetro 4,086 3,455 96 58 3,991 3,397 389 417 3,602 2,980
Urbanized 1,666 1,322 45 19 1,620 1,303 224 240 1,397 1,063
Less Urbanized 1,949 1,656 40 34 1,909 1,622 132 169 1,777 1,453
Completely Rural 472 477 11 * 462 473 34 8 428 464
POVERTY LEVEL1                    
Less Than 100% 3,619 4,096 176 131 3,443 3,965 665 733 2,778 3,232
100-199% 5,535 4,905 171 50 5,364 4,854 607 734 4,757 4,120
200% or More 20,199 18,011 402 236 19,797 17,775 1,656 1,380 18,142 16,395
HEALTH INSURANCE2                    
Private 19,000 16,418 360 218 18,640 16,200 1,911 1,735 16,729 14,464
Medicaid/CHIP 5,306 5,567 324 184 4,982 5,383 637 661 4,345 4,722
Other3 9,345 9,066 52 16 9,293 9,050 224 122 9,069 8,927
No Coverage 2,109 2,218 36 17 2,073 2,200 343 452 1,730 1,748
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.94B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10.7 9.8 3.0 1.7 11.4 10.6 8.8 8.5 11.9 10.9
GEOGRAPHIC REGION                    
Northeast 11.2 10.2 2.1 1.8 12.0 10.9 8.7 7.4 12.5 11.5
Midwest 10.8 9.7 3.2 1.6 11.6 10.5 10.0 8.7 11.8 10.8
South 10.9 10.0 3.0 1.4 11.7 10.9 8.2 8.9 12.2 11.2
West 10.0 9.1 3.4 2.0 10.6 9.8 8.9 8.7 10.9 10.0
COUNTY TYPE                    
Large Metro 10.7 9.7 3.0 1.4 11.4 10.6 9.0 8.1 11.8 11.0
Small Metro 10.7 10.5 3.2 2.2 11.4 11.3 8.4 9.2 11.9 11.7
Nonmetro 10.7 8.4 2.7 1.8 11.6 8.9 9.0 8.7 12.0 8.9
Urbanized 10.5 8.0 2.9 1.5 11.3 8.6 11.0 10.9 11.3 8.2
Less Urbanized 10.9 8.4 2.4 2.1 11.8 9.0 6.8 7.6 12.5 9.2
Completely Rural 10.9 9.4 2.6 * 11.7 9.8 8.9 2.3 12.0 10.4
POVERTY LEVEL1                    
Less Than 100% 9.7 9.8 3.5 2.9 10.7 10.6 8.4 9.0 11.4 11.1
100-199% 10.5 9.7 3.2 1.1 11.3 10.6 7.8 9.5 11.9 10.8
200% or More 11.0 9.8 2.8 1.5 11.7 10.6 9.8 8.0 11.9 10.9
HEALTH INSURANCE2                    
Private 10.6 9.4 2.5 1.5 11.3 10.2 9.4 8.9 11.5 10.4
Medicaid/CHIP 11.7 11.4 3.4 2.2 13.9 13.3 8.8 8.5 15.2 14.5
Other3 13.3 11.9 4.3 1.0 13.5 12.1 8.8 5.0 13.6 12.4
No Coverage 7.8 7.8 3.1 1.2 8.0 8.2 7.1 8.6 8.2 8.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.95A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,841 4,779 381 157 4,460 4,622 1,266 1,097 3,194 3,526
GEOGRAPHIC REGION                    
Northeast 912 639 24 33 888 606 212 130 676 476
Midwest 918 1,058 90 17 828 1,041 285 292 543 749
South 1,866 1,772 127 51 1,739 1,721 484 397 1,255 1,324
West 1,144 1,310 139 56 1,005 1,254 284 278 720 976
COUNTY TYPE                    
Large Metro 2,902 2,376 197 72 2,705 2,304 711 590 1,994 1,714
Small Metro 1,417 1,804 145 72 1,271 1,731 377 366 894 1,365
Nonmetro 522 599 39 12 484 587 178 140 306 447
Urbanized 258 246 20 3 238 243 121 67 117 176
Less Urbanized 226 343 16 9 210 334 46 72 164 262
Completely Rural 38 10 3 0 35 10 10 1 25 8
POVERTY LEVEL1                    
Less Than 100% 827 1,054 77 58 750 996 305 290 445 706
100-199% 898 806 96 11 803 795 256 277 546 518
200% or More 3,091 2,911 209 88 2,882 2,822 678 521 2,204 2,302
HEALTH INSURANCE2                    
Private 2,724 2,621 189 71 2,535 2,551 811 638 1,723 1,912
Medicaid/CHIP 1,170 1,123 170 78 1,000 1,045 224 248 776 798
Other3 620 820 24 2 596 818 60 55 536 763
No Coverage 697 803 12 9 685 794 213 209 472 585
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.95B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.8 1.7 1.5 0.6 1.8 1.8 3.8 3.3 1.5 1.6
GEOGRAPHIC REGION                    
Northeast 1.9 1.3 0.6 0.8 2.0 1.4 3.7 2.3 1.8 1.3
Midwest 1.6 1.8 1.7 0.3 1.6 2.0 4.0 4.1 1.2 1.7
South 1.8 1.7 1.3 0.5 1.8 1.8 3.8 3.1 1.5 1.6
West 1.7 2.0 2.3 0.9 1.7 2.1 3.5 3.5 1.4 1.9
COUNTY TYPE                    
Large Metro 1.9 1.6 1.5 0.5 1.9 1.7 3.8 3.3 1.6 1.4
Small Metro 1.7 2.1 1.9 0.9 1.7 2.2 3.6 3.3 1.4 2.1
Nonmetro 1.4 1.5 1.1 0.4 1.4 1.5 4.1 2.9 1.0 1.3
Urbanized 1.6 1.5 1.3 0.2 1.7 1.6 6.0 3.0 0.9 1.4
Less Urbanized 1.3 1.7 0.9 0.6 1.3 1.8 2.4 3.2 1.2 1.7
Completely Rural 0.9 0.2 0.7 0.2 0.9 0.2 2.7 0.4 0.7 0.2
POVERTY LEVEL1                    
Less Than 100% 2.2 2.5 1.5 1.3 2.3 2.7 3.9 3.6 1.8 2.4
100-199% 1.7 1.6 1.8 0.2 1.7 1.7 3.3 3.6 1.4 1.4
200% or More 1.7 1.6 1.4 0.6 1.7 1.7 4.0 3.0 1.4 1.5
HEALTH INSURANCE2                    
Private 1.5 1.5 1.3 0.5 1.5 1.6 4.0 3.3 1.2 1.4
Medicaid/CHIP 2.6 2.3 1.8 0.9 2.8 2.6 3.1 3.2 2.7 2.5
Other3 0.9 1.1 2.0 0.1 0.9 1.1 2.4 2.3 0.8 1.1
No Coverage 2.6 2.8 1.0 0.6 2.6 2.9 4.4 4.0 2.2 2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.96A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10,065 9,490 567 396 9,499 9,094 1,776 1,376 7,723 7,717
GEOGRAPHIC REGION                    
Northeast 1,398 1,655 57 65 1,342 1,590 239 206 1,102 1,384
Midwest 2,191 1,749 126 84 2,065 1,665 408 321 1,656 1,344
South 3,757 3,401 232 126 3,526 3,275 660 505 2,866 2,770
West 2,718 2,685 152 121 2,567 2,564 468 344 2,098 2,219
COUNTY TYPE                    
Large Metro 5,418 4,804 286 190 5,133 4,614 981 690 4,151 3,924
Small Metro 3,472 3,257 215 148 3,257 3,109 588 423 2,669 2,686
Nonmetro 1,174 1,428 66 58 1,109 1,370 206 263 902 1,107
Urbanized 541 584 28 24 514 560 121 120 393 440
Less Urbanized 500 810 24 33 476 777 64 132 412 645
Completely Rural 133 34 14 1 119 33 22 11 97 22
POVERTY LEVEL1                    
Less Than 100% 2,056 2,527 129 141 1,927 2,386 434 346 1,493 2,041
100-199% 2,278 1,830 144 55 2,134 1,776 427 340 1,708 1,436
200% or More 5,701 5,093 294 201 5,407 4,893 885 652 4,523 4,241
HEALTH INSURANCE2                    
Private 5,120 4,607 288 170 4,831 4,437 988 756 3,844 3,681
Medicaid/CHIP 2,619 2,856 240 173 2,379 2,683 404 353 1,976 2,330
Other3 1,862 1,995 43 20 1,819 1,974 114 108 1,706 1,866
No Coverage 1,643 1,559 10 * 1,633 1,501 339 238 1,294 1,263
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.96B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.7 3.4 2.3 1.6 3.8 3.6 5.3 4.1 3.6 3.5
GEOGRAPHIC REGION                    
Northeast 2.9 3.5 1.4 1.7 3.1 3.6 4.2 3.6 2.9 3.6
Midwest 3.8 3.0 2.4 1.6 4.0 3.2 5.7 4.5 3.7 3.0
South 3.6 3.2 2.4 1.3 3.7 3.4 5.2 4.0 3.5 3.3
West 4.1 4.1 2.5 2.0 4.3 4.3 5.8 4.3 4.1 4.3
COUNTY TYPE                    
Large Metro 3.5 3.2 2.1 1.3 3.7 3.4 5.2 3.9 3.4 3.3
Small Metro 4.2 3.8 2.8 1.9 4.3 4.0 5.5 3.8 4.1 4.1
Nonmetro 3.1 3.5 1.8 1.8 3.2 3.6 4.8 5.5 3.0 3.3
Urbanized 3.4 3.5 1.8 1.8 3.6 3.7 6.0 5.4 3.2 3.4
Less Urbanized 2.8 4.1 1.5 2.0 2.9 4.3 3.3 6.0 2.9 4.1
Completely Rural 3.1 0.7 3.4 0.6 3.0 0.7 5.8 3.1 2.7 0.5
POVERTY LEVEL1                    
Less Than 100% 5.5 6.0 2.5 3.1 6.0 6.4 5.5 4.2 6.1 7.0
100-199% 4.3 3.6 2.7 1.2 4.5 3.9 5.5 4.4 4.3 3.8
200% or More 3.1 2.8 2.0 1.3 3.2 2.9 5.2 3.8 3.0 2.8
HEALTH INSURANCE2                    
Private 2.8 2.6 2.0 1.1 2.9 2.8 4.8 3.9 2.6 2.6
Medicaid/CHIP 5.8 5.9 2.6 2.1 6.7 6.7 5.6 4.5 6.9 7.2
Other3 2.7 2.6 3.5 1.2 2.6 2.6 4.5 4.5 2.6 2.6
No Coverage 6.1 5.5 0.8 * 6.3 5.6 7.0 4.5 6.1 5.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.97A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3,101 2,885 165 96 2,936 2,789 439 296 2,497 2,493
GEOGRAPHIC REGION                    
Northeast 451 537 13 19 438 519 69 55 369 464
Midwest 742 480 44 27 698 453 101 69 598 384
South 1,085 960 63 36 1,022 924 154 115 867 809
West 823 906 44 14 778 893 115 57 663 836
COUNTY TYPE                    
Large Metro 1,680 1,438 79 51 1,601 1,388 235 144 1,366 1,244
Small Metro 1,055 1,127 65 34 990 1,093 136 86 853 1,007
Nonmetro 366 319 21 11 345 308 68 66 278 242
Urbanized 134 123 7 * 126 118 38 * 88 105
Less Urbanized 185 196 8 6 177 191 24 53 153 138
Completely Rural 47 * 5 * 42 * 5 * 37 *
POVERTY LEVEL1                    
Less Than 100% 653 969 32 16 620 953 98 107 522 847
100-199% 701 585 41 12 659 573 112 64 548 509
200% or More 1,735 1,312 91 68 1,644 1,244 217 106 1,427 1,138
HEALTH INSURANCE2                    
Private 1,394 1,012 95 50 1,299 962 233 136 1,066 826
Medicaid/CHIP 962 1,128 62 38 900 1,090 127 118 773 971
Other3 577 593 7 7 571 587 12 16 559 570
No Coverage 576 554 2 2 574 552 84 45 490 507
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.97B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.1 1.0 0.7 0.4 1.2 1.1 1.3 0.9 1.2 1.1
GEOGRAPHIC REGION                    
Northeast 0.9 1.1 0.3 0.5 1.0 1.2 1.2 1.0 1.0 1.2
Midwest 1.3 0.8 0.8 0.5 1.3 0.9 1.4 1.0 1.3 0.9
South 1.0 0.9 0.7 0.4 1.1 1.0 1.2 0.9 1.1 1.0
West 1.3 1.4 0.7 0.2 1.3 1.5 1.4 0.7 1.3 1.6
COUNTY TYPE                    
Large Metro 1.1 1.0 0.6 0.4 1.1 1.0 1.3 0.8 1.1 1.0
Small Metro 1.3 1.3 0.8 0.4 1.3 1.4 1.3 0.8 1.3 1.5
Nonmetro 1.0 0.8 0.6 0.3 1.0 0.8 1.6 1.4 0.9 0.7
Urbanized 0.8 0.7 0.5 * 0.9 0.8 1.9 * 0.7 0.8
Less Urbanized 1.0 1.0 0.5 0.3 1.1 1.1 1.3 2.4 1.1 0.9
Completely Rural 1.1 * 1.3 * 1.1 * 1.4 * 1.0 *
POVERTY LEVEL1                    
Less Than 100% 1.7 2.3 0.6 0.4 1.9 2.6 1.2 1.3 2.1 2.9
100-199% 1.3 1.2 0.8 0.3 1.4 1.2 1.4 0.8 1.4 1.3
200% or More 0.9 0.7 0.6 0.4 1.0 0.7 1.3 0.6 0.9 0.8
HEALTH INSURANCE2                    
Private 0.8 0.6 0.7 0.3 0.8 0.6 1.1 0.7 0.7 0.6
Medicaid/CHIP 2.1 2.3 0.7 0.5 2.5 2.7 1.8 1.5 2.7 3.0
Other3 0.8 0.8 0.5 0.4 0.8 0.8 0.5 0.7 0.8 0.8
No Coverage 2.1 1.9 0.2 0.1 2.2 2.0 1.7 0.9 2.3 2.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.98A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 10,136 10,306 499 346 9,638 9,960 3,205 2,567 6,433 7,393
GEOGRAPHIC REGION                    
Northeast 1,612 1,934 56 45 1,556 1,890 606 427 950 1,463
Midwest 2,137 2,039 100 72 2,037 1,968 740 584 1,297 1,384
South 3,437 3,615 211 116 3,226 3,499 1,005 852 2,220 2,647
West 2,950 2,717 130 114 2,819 2,603 854 704 1,965 1,899
COUNTY TYPE                    
Large Metro 6,011 5,794 292 196 5,719 5,598 1,941 1,447 3,778 4,151
Small Metro 2,965 3,516 157 111 2,808 3,405 947 884 1,862 2,522
Nonmetro 1,160 996 50 39 1,110 957 318 237 793 720
Urbanized 612 431 31 18 580 413 182 99 398 314
Less Urbanized 458 535 15 21 443 514 113 125 330 388
Completely Rural 91 31 4 0 87 30 22 * 65 18
POVERTY LEVEL1                    
Less Than 100% 2,037 2,197 78 47 1,959 2,149 729 558 1,229 1,592
100-199% 2,054 1,979 100 34 1,954 1,945 598 575 1,356 1,370
200% or More 5,952 6,082 321 265 5,631 5,817 1,784 1,386 3,847 4,431
HEALTH INSURANCE2                    
Private 5,821 5,645 320 216 5,502 5,429 2,315 1,837 3,187 3,592
Medicaid/CHIP 2,482 2,523 166 134 2,317 2,389 490 322 1,826 2,066
Other3 968 1,148 29 7 940 1,142 185 119 755 1,022
No Coverage 1,620 1,806 14 13 1,606 1,793 325 361 1,281 1,432
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.98B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.7 3.7 2.0 1.4 3.9 4.0 9.5 7.7 3.0 3.4
GEOGRAPHIC REGION                    
Northeast 3.4 4.1 1.4 1.1 3.6 4.3 10.5 7.5 2.5 3.8
Midwest 3.7 3.6 1.9 1.4 3.9 3.8 10.3 8.2 2.9 3.1
South 3.3 3.4 2.2 1.2 3.4 3.6 7.9 6.7 2.7 3.2
West 4.5 4.1 2.2 1.9 4.7 4.3 10.6 8.8 3.8 3.7
COUNTY TYPE                    
Large Metro 3.9 3.8 2.2 1.4 4.1 4.1 10.3 8.2 3.1 3.5
Small Metro 3.6 4.2 2.0 1.4 3.7 4.4 8.9 8.0 2.9 3.8
Nonmetro 3.0 2.4 1.4 1.2 3.2 2.5 7.3 5.0 2.6 2.2
Urbanized 3.8 2.6 2.0 1.3 4.0 2.7 9.0 4.5 3.2 2.4
Less Urbanized 2.6 2.7 0.9 1.3 2.7 2.8 5.8 5.7 2.3 2.4
Completely Rural 2.1 0.6 0.9 0.2 2.2 0.6 5.9 * 1.8 0.4
POVERTY LEVEL1                    
Less Than 100% 5.4 5.2 1.5 1.0 6.1 5.8 9.2 6.9 5.0 5.5
100-199% 3.9 3.9 1.9 0.7 4.1 4.2 7.7 7.5 3.4 3.6
200% or More 3.2 3.3 2.2 1.7 3.3 3.5 10.5 8.0 2.5 2.9
HEALTH INSURANCE2                    
Private 3.2 3.2 2.2 1.4 3.3 3.4 11.3 9.4 2.2 2.6
Medicaid/CHIP 5.5 5.2 1.8 1.6 6.5 5.9 6.8 4.1 6.4 6.4
Other3 1.4 1.5 2.3 0.4 1.4 1.5 7.3 4.9 1.1 1.4
No Coverage 6.0 6.3 1.2 0.9 6.2 6.6 6.7 6.9 6.1 6.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.99A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 4,264 4,483 160 87 4,103 4,396 1,127 682 2,976 3,714
GEOGRAPHIC REGION                    
Northeast 639 855 18 18 622 837 200 110 421 728
Midwest 853 841 30 12 822 829 268 144 555 684
South 1,471 1,574 72 38 1,398 1,536 376 275 1,022 1,261
West 1,301 1,213 40 19 1,261 1,194 283 153 978 1,041
COUNTY TYPE                    
Large Metro 2,717 2,508 96 44 2,620 2,464 695 409 1,925 2,056
Small Metro 1,110 1,569 49 36 1,061 1,533 329 229 732 1,303
Nonmetro 437 406 15 7 422 399 103 44 319 355
Urbanized 247 152 12 5 234 147 59 9 175 138
Less Urbanized 161 241 2 2 159 239 39 33 119 206
Completely Rural 29 13 1 * 29 13 5 * 24 11
POVERTY LEVEL1                    
Less Than 100% 1,000 1,148 25 4 975 1,144 299 139 676 1,005
100-199% 829 819 22 1 807 818 214 162 593 656
200% or More 2,401 2,510 114 82 2,287 2,428 581 375 1,706 2,052
HEALTH INSURANCE2                    
Private 2,257 2,196 108 66 2,150 2,130 794 455 1,356 1,675
Medicaid/CHIP 1,059 1,221 49 17 1,010 1,204 156 86 854 1,118
Other3 377 496 9 2 368 494 82 46 286 448
No Coverage 808 906 0 2 808 904 133 128 674 775
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.99B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 1.5 1.6 0.6 0.3 1.6 1.7 3.3 2.0 1.4 1.7
GEOGRAPHIC REGION                    
Northeast 1.3 1.8 0.5 0.4 1.4 1.9 3.5 1.9 1.1 1.9
Midwest 1.5 1.5 0.6 0.2 1.6 1.6 3.7 2.0 1.2 1.5
South 1.4 1.5 0.7 0.4 1.5 1.6 3.0 2.2 1.2 1.5
West 2.0 1.8 0.7 0.3 2.1 2.0 3.5 1.9 1.9 2.0
COUNTY TYPE                    
Large Metro 1.8 1.7 0.7 0.3 1.9 1.8 3.7 2.3 1.6 1.7
Small Metro 1.3 1.9 0.6 0.5 1.4 2.0 3.1 2.1 1.1 2.0
Nonmetro 1.1 1.0 0.4 0.2 1.2 1.0 2.4 0.9 1.1 1.1
Urbanized 1.6 0.9 0.8 0.4 1.6 1.0 2.9 0.4 1.4 1.1
Less Urbanized 0.9 1.2 0.1 0.1 1.0 1.3 2.0 1.5 0.8 1.3
Completely Rural 0.7 0.3 0.2 * 0.7 0.3 1.3 * 0.7 0.2
POVERTY LEVEL1                    
Less Than 100% 2.7 2.7 0.5 0.1 3.0 3.1 3.8 1.7 2.8 3.4
100-199% 1.6 1.6 0.4 0.0 1.7 1.8 2.8 2.1 1.5 1.7
200% or More 1.3 1.4 0.8 0.5 1.4 1.4 3.4 2.2 1.1 1.4
HEALTH INSURANCE2                    
Private 1.3 1.3 0.8 0.4 1.3 1.3 3.9 2.3 0.9 1.2
Medicaid/CHIP 2.3 2.5 0.5 0.2 2.8 3.0 2.2 1.1 3.0 3.4
Other3 0.5 0.7 0.7 0.1 0.5 0.7 3.2 1.9 0.4 0.6
No Coverage 3.0 3.2 0.0 0.1 3.1 3.3 2.8 2.4 3.2 3.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.100A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 23,588 23,962 1,862 1,507 21,727 22,455 5,791 5,169 15,936 17,286
GEOGRAPHIC REGION                    
Northeast 3,722 4,224 222 232 3,500 3,992 991 826 2,509 3,165
Midwest 4,830 4,752 415 346 4,415 4,407 1,257 1,155 3,157 3,252
South 8,207 8,510 724 505 7,483 8,005 1,913 1,840 5,570 6,165
West 6,830 6,476 501 424 6,329 6,052 1,630 1,347 4,699 4,705
COUNTY TYPE                    
Large Metro 13,560 13,153 975 765 12,585 12,388 3,374 2,893 9,211 9,495
Small Metro 7,430 7,822 661 506 6,769 7,317 1,782 1,613 4,987 5,704
Nonmetro 2,599 2,987 226 236 2,373 2,751 635 664 1,738 2,087
Urbanized 1,325 1,356 106 105 1,218 1,250 352 370 867 880
Less Urbanized 1,026 1,525 88 111 938 1,413 222 264 716 1,149
Completely Rural 248 107 32 20 216 87 61 29 156 58
POVERTY LEVEL1                    
Less Than 100% 4,417 4,884 430 352 3,987 4,532 1,379 1,242 2,608 3,290
100-199% 4,945 4,508 382 198 4,563 4,310 1,199 1,199 3,364 3,111
200% or More 14,049 14,477 1,050 957 12,999 13,520 3,036 2,635 9,964 10,886
HEALTH INSURANCE2                    
Private 13,516 13,400 1,007 818 12,509 12,583 3,764 3,454 8,745 9,129
Medicaid/CHIP 5,583 5,847 767 566 4,816 5,282 1,076 814 3,740 4,467
Other3 3,259 3,901 106 107 3,153 3,794 374 290 2,779 3,504
No Coverage 3,373 3,597 61 117 3,312 3,480 790 780 2,521 2,701
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.100B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 8.6 8.7 7.5 6.0 8.7 8.9 17.2 15.4 7.4 7.9
GEOGRAPHIC REGION                    
Northeast 7.8 8.9 5.6 5.9 8.0 9.1 17.2 14.6 6.6 8.3
Midwest 8.4 8.3 7.9 6.6 8.5 8.5 17.5 16.3 7.0 7.2
South 7.8 8.0 7.5 5.2 7.9 8.3 15.1 14.5 6.8 7.4
West 10.4 9.8 8.3 7.0 10.6 10.1 20.1 16.8 9.1 9.0
COUNTY TYPE                    
Large Metro 8.8 8.7 7.2 5.4 9.0 9.1 18.0 16.3 7.6 8.0
Small Metro 8.9 9.2 8.6 6.6 8.9 9.5 16.8 14.7 7.7 8.6
Nonmetro 6.8 7.2 6.3 7.4 6.9 7.2 14.6 13.9 5.8 6.3
Urbanized 8.3 8.2 6.9 7.9 8.5 8.2 17.4 16.8 7.0 6.8
Less Urbanized 5.8 7.7 5.3 6.9 5.8 7.8 11.5 11.9 5.0 7.2
Completely Rural 5.7 2.1 7.8 7.4 5.5 1.8 16.2 8.2 4.4 1.3
POVERTY LEVEL1                    
Less Than 100% 11.8 11.7 8.4 7.7 12.3 12.1 17.5 15.3 10.7 11.3
100-199% 9.3 8.9 7.2 4.4 9.6 9.4 15.5 15.6 8.4 8.1
200% or More 7.6 7.9 7.2 6.0 7.7 8.0 17.9 15.2 6.5 7.2
HEALTH INSURANCE2                    
Private 7.5 7.7 7.1 5.5 7.6 7.9 18.4 17.6 6.0 6.6
Medicaid/CHIP 12.4 12.0 8.2 6.8 13.5 13.1 14.8 10.4 13.1 13.7
Other3 4.6 5.1 8.7 6.4 4.6 5.1 14.7 11.9 4.2 4.8
No Coverage 12.5 12.6 5.3 8.0 12.8 12.9 16.4 14.8 12.0 12.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.101A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 9,333 9,305 598 305 8,735 9,000 2,059 1,600 6,676 7,400
GEOGRAPHIC REGION                    
Northeast 1,387 1,762 66 51 1,320 1,711 347 242 973 1,468
Midwest 1,974 1,738 129 83 1,845 1,656 453 347 1,392 1,308
South 3,078 3,232 237 111 2,841 3,121 656 600 2,185 2,522
West 2,893 2,573 166 60 2,728 2,513 602 411 2,126 2,102
COUNTY TYPE                    
Large Metro 5,558 5,083 312 163 5,246 4,920 1,224 917 4,022 4,003
Small Metro 2,828 3,237 228 105 2,600 3,132 612 512 1,987 2,619
Nonmetro 947 986 58 37 889 948 223 171 666 777
Urbanized 454 356 27 18 428 338 122 66 306 272
Less Urbanized 398 610 20 15 377 595 84 101 293 494
Completely Rural 96 21 11 * 85 15 17 4 68 11
POVERTY LEVEL1                    
Less Than 100% 1,850 2,199 117 53 1,733 2,146 509 428 1,224 1,718
100-199% 1,830 1,814 159 26 1,670 1,787 414 386 1,256 1,401
200% or More 5,594 5,247 322 225 5,272 5,021 1,075 740 4,196 4,281
HEALTH INSURANCE2                    
Private 4,971 4,615 326 199 4,645 4,416 1,315 1,004 3,330 3,412
Medicaid/CHIP 2,367 2,642 248 102 2,119 2,540 411 278 1,708 2,262
Other3 1,274 1,458 30 11 1,244 1,447 140 84 1,105 1,363
No Coverage 1,518 1,599 15 8 1,503 1,592 271 306 1,232 1,285
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.101B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic Aged 12+
(2019)
Aged 12+
(2020)
Aged
12-17
(2019)
Aged
12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged
18-25
(2019)
Aged
18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
TOTAL 3.4 3.4 2.4 1.2 3.5 3.6 6.1 4.8 3.1 3.4
GEOGRAPHIC REGION                    
Northeast 2.9 3.7 1.7 1.3 3.0 3.9 6.0 4.3 2.6 3.9
Midwest 3.4 3.0 2.4 1.6 3.5 3.2 6.3 4.9 3.1 2.9
South 2.9 3.1 2.4 1.1 3.0 3.3 5.2 4.7 2.7 3.0
West 4.4 3.9 2.8 1.0 4.6 4.2 7.4 5.1 4.1 4.0
COUNTY TYPE                    
Large Metro 3.6 3.4 2.3 1.2 3.7 3.6 6.5 5.2 3.3 3.4
Small Metro 3.4 3.8 3.0 1.4 3.4 4.1 5.8 4.7 3.1 4.0
Nonmetro 2.5 2.4 1.6 1.2 2.6 2.5 5.1 3.6 2.2 2.3
Urbanized 2.9 2.2 1.7 1.3 3.0 2.2 6.0 3.0 2.5 2.1
Less Urbanized 2.2 3.1 1.2 0.9 2.3 3.3 4.4 4.6 2.1 3.1
Completely Rural 2.2 0.4 2.7 * 2.2 0.3 4.5 1.2 1.9 0.2
POVERTY LEVEL1                    
Less Than 100% 4.9 5.2 2.3 1.2 5.4 5.8 6.4 5.3 5.0 5.9
100-199% 3.5 3.6 3.0 0.6 3.5 3.9 5.4 5.0 3.2 3.7
200% or More 3.0 2.8 2.2 1.4 3.1 3.0 6.3 4.3 2.8 2.8
HEALTH INSURANCE2                    
Private 2.8 2.7 2.3 1.3 2.8 2.8 6.4 5.1 2.3 2.4
Medicaid/CHIP 5.2 5.4 2.6 1.2 5.9 6.3 5.7 3.6 6.0 7.0
Other3 1.8 1.9 2.5 0.6 1.8 1.9 5.5 3.5 1.7 1.9
No Coverage 5.6 5.6 1.3 0.5 5.8 5.9 5.6 5.8 5.9 5.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.102A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2019 and 2020
Drug or Method of Administration Aged 12+
(2019)
Aged 12+
(2020)
Aged 12-17
(2019)
Aged 12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged 18-25
(2019)
Aged 18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
HALLUCINOGENS 44,087 43,949 615 563 43,472 43,386 5,597 5,269 37,876 38,117
PCP 5,516 6,141 41 7 5,475 6,134 249 167 5,226 5,967
LSD 27,528 28,123 392 317 27,137 27,806 3,368 3,284 23,769 24,521
Peyote 5,670 5,040 49 24 5,621 5,016 208 111 5,413 4,905
Mescaline 7,571 6,913 21 3 7,550 6,911 176 98 7,373 6,813
Psilocybin/Mushrooms 25,254 26,111 285 204 24,968 25,908 2,990 2,936 21,979 22,971
Ecstasy 20,097 20,478 225 183 19,872 20,295 3,500 2,946 16,372 17,348
Ketamine 3,833 3,955 32 38 3,801 3,917 539 600 3,262 3,317
DMT, AMT, or 5-MeO-DIPT/Foxy 3,345 3,192 51 42 3,294 3,150 697 552 2,597 2,598
Salvia divinorum 5,188 5,106 52 28 5,136 5,079 699 423 4,437 4,655
INHALANTS 25,090 26,749 2,202 2,327 22,889 24,422 3,099 2,929 19,790 21,493
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 7,122 8,168 126 155 6,995 8,013 541 549 6,454 7,464
Correction Fluid, Degreaser, or Cleaning Fluid 1,298 1,685 163 217 1,135 1,467 184 63 950 1,405
Gasoline or Lighter Fluid 2,814 3,132 436 472 2,378 2,660 321 334 2,057 2,326
Glue, Shoe Polish, or Toluene 2,723 3,489 525 692 2,198 2,797 297 330 1,901 2,467
Halothane, Ether, or Other Anesthetics 609 1,230 29 12 581 1,218 54 81 527 1,137
Lacquer Thinner or Other Paint Solvents 1,452 1,557 130 185 1,322 1,372 170 125 1,152 1,247
Lighter Gases 806 733 149 135 656 598 99 68 557 529
Nitrous Oxide or Whippits 12,640 12,891 139 125 12,500 12,766 1,138 1,031 11,363 11,735
Felt-Tip Pens or Felt-Tip/Magic Markers 6,595 7,640 1,599 1,875 4,996 5,765 1,412 1,336 3,584 4,428
Spray Paints 1,800 1,864 407 439 1,394 1,425 268 282 1,126 1,143
Computer Cleaner/Air Duster 2,885 2,685 188 116 2,697 2,569 551 285 2,146 2,283
Other Aerosol Sprays 1,368 1,372 131 112 1,237 1,260 193 134 1,044 1,126
NEEDLE USE1 4,592 5,417 19 2 4,572 5,415 280 187 4,292 5,228
Heroin Needle Use1 2,710 2,896 5 * 2,705 2,896 172 133 2,533 2,763
Cocaine Needle Use1 2,380 2,698 2 * 2,378 2,698 89 21 2,289 2,677
Methamphetamine Needle Use1 2,141 2,724 * * 2,141 2,724 142 75 1,999 2,649
HEROIN 5,696 6,252 21 * 5,675 6,251 389 226 5,287 6,024
Smoke Heroin1 2,567 3,028 13 * 2,554 3,027 193 154 2,361 2,873
Sniff or Snort Heroin1 3,746 4,378 4 * 3,741 4,378 285 170 3,457 4,208
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210614
Table 1.102B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2019 and 2020
Drug or Method of Administration Aged 12+
(2019)
Aged 12+
(2020)
Aged 12-17
(2019)
Aged 12-17
(2020)
Aged 18+
(2019)
Aged 18+
(2020)
Aged 18-25
(2019)
Aged 18-25
(2020)
Aged 26+
(2019)
Aged 26+
(2020)
HALLUCINOGENS 16.0 15.9 2.5 2.3 17.4 17.2 16.6 15.7 17.5 17.5
PCP 2.0 2.2 0.2 0.0 2.2 2.4 0.7 0.5 2.4 2.7
LSD 10.0 10.2 1.6 1.3 10.8 11.0 10.0 9.8 11.0 11.2
Peyote 2.1 1.8 0.2 0.1 2.2 2.0 0.6 0.3 2.5 2.2
Mescaline 2.8 2.5 0.1 0.0 3.0 2.7 0.5 0.3 3.4 3.1
Psilocybin/Mushrooms 9.2 9.4 1.1 0.8 10.0 10.3 8.9 8.8 10.1 10.5
Ecstasy 7.3 7.4 0.9 0.7 7.9 8.1 10.4 8.8 7.6 7.9
Ketamine 1.4 1.4 0.1 0.2 1.5 1.6 1.6 1.8 1.5 1.5
DMT, AMT, or 5-MeO-DIPT/Foxy 1.2 1.2 0.2 0.2 1.3 1.3 2.1 1.6 1.2 1.2
Salvia divinorum 1.9 1.8 0.2 0.1 2.1 2.0 2.1 1.3 2.0 2.1
INHALANTS 9.1 9.7 8.8 9.3 9.1 9.7 9.2 8.7 9.1 9.8
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 2.6 2.9 0.5 0.6 2.8 3.2 1.6 1.6 3.0 3.4
Correction Fluid, Degreaser, or Cleaning Fluid 0.5 0.6 0.7 0.9 0.5 0.6 0.5 0.2 0.4 0.6
Gasoline or Lighter Fluid 1.0 1.1 1.7 1.9 1.0 1.1 1.0 1.0 0.9 1.1
Glue, Shoe Polish, or Toluene 1.0 1.3 2.1 2.8 0.9 1.1 0.9 1.0 0.9 1.1
Halothane, Ether, or Other Anesthetics 0.2 0.4 0.1 0.0 0.2 0.5 0.2 0.2 0.2 0.5
Lacquer Thinner or Other Paint Solvents 0.5 0.6 0.5 0.7 0.5 0.5 0.5 0.4 0.5 0.6
Lighter Gases 0.3 0.3 0.6 0.5 0.3 0.2 0.3 0.2 0.3 0.2
Nitrous Oxide or Whippits 4.6 4.7 0.6 0.5 5.0 5.1 3.4 3.1 5.2 5.4
Felt-Tip Pens or Felt-Tip/Magic Markers 2.4 2.8 6.4 7.5 2.0 2.3 4.2 4.0 1.7 2.0
Spray Paints 0.7 0.7 1.6 1.8 0.6 0.6 0.8 0.8 0.5 0.5
Computer Cleaner/Air Duster 1.0 1.0 0.8 0.5 1.1 1.0 1.6 0.9 1.0 1.0
Other Aerosol Sprays 0.5 0.5 0.5 0.4 0.5 0.5 0.6 0.4 0.5 0.5
NEEDLE USE1 1.7 2.0 0.1 0.0 1.8 2.1 0.8 0.6 2.0 2.4
Heroin Needle Use1 1.0 1.0 0.0 * 1.1 1.1 0.5 0.4 1.2 1.3
Cocaine Needle Use1 0.9 1.0 0.0 * 1.0 1.1 0.3 0.1 1.1 1.2
Methamphetamine Needle Use1 0.8 1.0 * * 0.9 1.1 0.4 0.2 0.9 1.2
HEROIN 2.1 2.3 0.1 * 2.3 2.5 1.2 0.7 2.4 2.8
Smoke Heroin1 0.9 1.1 0.1 * 1.0 1.2 0.6 0.5 1.1 1.3
Sniff or Snort Heroin1 1.4 1.6 0.0 * 1.5 1.7 0.8 0.5 1.6 1.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.103A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 82,559 75,198 9,724 9,254 9,724 9,254
Hydrocodone Products 43,571 37,657 5,068 4,729 5,068 4,729
Zohydro®ER 338 401 35 30 * *
Oxycodone Products 24,372 21,756 3,185 3,153 3,185 3,153
OxyContin® 8,799 7,136 1,207 1,317 1,207 1,317
Tramadol Products 17,183 16,718 1,340 1,513 1,340 1,513
Codeine Products 24,106 19,998 2,380 2,447 2,380 2,447
Morphine Products 5,838 5,541 455 492 455 492
Fentanyl Products 2,530 2,403 269 356 269 356
Buprenorphine Products 2,469 2,605 686 690 686 690
Oxymorphone Products 856 925 234 159 234 *
Demerol® 918 394 51 31 51 *
Hydromorphone Products 1,614 1,314 179 219 179 219
Methadone 1,064 1,422 240 229 240 *
Any Other Prescription Pain Reliever1 22,829 20,878 930 1,117 930 1,117
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.103B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 30.0 27.2 3.5 3.3 11.8 12.3
Hydrocodone Products 15.8 13.6 1.8 1.7 11.6 12.6
Zohydro®ER 0.1 0.1 0.0 0.0 * *
Oxycodone Products 8.9 7.9 1.2 1.1 13.1 14.5
OxyContin® 3.2 2.6 0.4 0.5 13.7 18.5
Tramadol Products 6.2 6.0 0.5 0.5 7.8 9.0
Codeine Products 8.8 7.2 0.9 0.9 9.9 12.2
Morphine Products 2.1 2.0 0.2 0.2 7.8 8.9
Fentanyl Products 0.9 0.9 0.1 0.1 10.6 14.8
Buprenorphine Products 0.9 0.9 0.2 0.2 27.8 26.5
Oxymorphone Products 0.3 0.3 0.1 0.1 27.3 *
Demerol® 0.3 0.1 0.0 0.0 5.6 *
Hydromorphone Products 0.6 0.5 0.1 0.1 11.1 16.6
Methadone 0.4 0.5 0.1 0.1 22.5 *
Any Other Prescription Pain Reliever1 8.3 7.5 0.3 0.4 4.1 5.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.104A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 3,980 3,079 567 396 567 396
Hydrocodone Products 767 676 160 107 160 107
Zohydro®ER 28 18 7 * * *
Oxycodone Products 703 552 164 94 164 94
OxyContin® 288 274 69 68 69 *
Tramadol Products 335 190 52 35 52 *
Codeine Products 1,386 1,148 215 128 215 128
Morphine Products 318 181 40 20 40 *
Fentanyl Products 68 33 5 * * *
Buprenorphine Products 72 50 10 8 * *
Oxymorphone Products 47 34 5 13 * *
Demerol® 34 7 4 * * *
Hydromorphone Products 12 31 6 5 * *
Methadone 42 12 16 * * *
Any Other Prescription Pain Reliever1 1,912 1,313 124 149 124 149
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.104B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 16.0 12.3 2.3 1.6 14.2 12.9
Hydrocodone Products 3.1 2.7 0.6 0.4 20.9 15.8
Zohydro®ER 0.1 0.1 0.0 * * *
Oxycodone Products 2.8 2.2 0.7 0.4 23.3 17.1
OxyContin® 1.2 1.1 0.3 0.3 23.8 *
Tramadol Products 1.3 0.8 0.2 0.1 15.6 *
Codeine Products 5.6 4.6 0.9 0.5 15.5 11.2
Morphine Products 1.3 0.7 0.2 0.1 12.5 *
Fentanyl Products 0.3 0.1 0.0 * * *
Buprenorphine Products 0.3 0.2 0.0 0.0 * *
Oxymorphone Products 0.2 0.1 0.0 0.1 * *
Demerol® 0.1 0.0 0.0 * * *
Hydromorphone Products 0.0 0.1 0.0 0.0 * *
Methadone 0.2 0.0 0.1 * * *
Any Other Prescription Pain Reliever1 7.7 5.3 0.5 0.6 6.5 11.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.105A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 78,579 72,118 9,158 8,858 9,158 8,858
Hydrocodone Products 42,804 36,981 4,908 4,623 4,908 4,623
Zohydro®ER 310 382 28 30 * *
Oxycodone Products 23,669 21,204 3,020 3,059 3,020 3,059
OxyContin® 8,510 6,862 1,138 1,250 1,138 1,250
Tramadol Products 16,848 16,528 1,287 1,478 1,287 1,478
Codeine Products 22,720 18,850 2,165 2,319 2,165 2,319
Morphine Products 5,520 5,360 415 472 415 472
Fentanyl Products 2,462 2,370 264 356 264 356
Buprenorphine Products 2,397 2,555 676 682 676 682
Oxymorphone Products 808 891 228 146 228 *
Demerol® 884 386 48 31 48 *
Hydromorphone Products 1,602 1,283 173 213 173 *
Methadone 1,022 1,410 223 229 223 *
Any Other Prescription Pain Reliever1 20,916 19,565 807 968 807 968
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.105B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 31.4 28.6 3.7 3.5 11.7 12.3
Hydrocodone Products 17.1 14.7 2.0 1.8 11.5 12.5
Zohydro®ER 0.1 0.2 0.0 0.0 * *
Oxycodone Products 9.5 8.4 1.2 1.2 12.8 14.4
OxyContin® 3.4 2.7 0.5 0.5 13.4 18.2
Tramadol Products 6.7 6.6 0.5 0.6 7.6 8.9
Codeine Products 9.1 7.5 0.9 0.9 9.5 12.3
Morphine Products 2.2 2.1 0.2 0.2 7.5 8.8
Fentanyl Products 1.0 0.9 0.1 0.1 10.7 15.0
Buprenorphine Products 1.0 1.0 0.3 0.3 28.2 26.7
Oxymorphone Products 0.3 0.4 0.1 0.1 28.3 *
Demerol® 0.4 0.2 0.0 0.0 5.4 *
Hydromorphone Products 0.6 0.5 0.1 0.1 10.8 *
Methadone 0.4 0.6 0.1 0.1 21.8 *
Any Other Prescription Pain Reliever1 8.4 7.8 0.3 0.4 3.9 4.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.106A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 8,357 6,858 1,754 1,361 1,754 1,361
Hydrocodone Products 3,607 3,069 855 703 855 703
Zohydro®ER 45 29 3 * * *
Oxycodone Products 2,497 2,059 615 622 615 622
OxyContin® 922 683 266 180 266 180
Tramadol Products 1,220 1,180 228 242 228 242
Codeine Products 2,600 2,086 434 291 434 291
Morphine Products 726 426 96 48 96 *
Fentanyl Products 252 285 49 34 49 *
Buprenorphine Products 286 257 124 49 124 *
Oxymorphone Products 141 142 55 33 * *
Demerol® 50 14 11 3 * *
Hydromorphone Products 96 48 30 3 * *
Methadone 79 138 29 10 * *
Any Other Prescription Pain Reliever1 2,794 2,081 207 133 207 133
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.106B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 24.8 20.5 5.2 4.1 21.0 19.8
Hydrocodone Products 10.7 9.2 2.5 2.1 23.7 22.9
Zohydro®ER 0.1 0.1 0.0 * * *
Oxycodone Products 7.4 6.1 1.8 1.9 24.6 30.2
OxyContin® 2.7 2.0 0.8 0.5 28.8 26.3
Tramadol Products 3.6 3.5 0.7 0.7 18.7 20.5
Codeine Products 7.7 6.2 1.3 0.9 16.7 13.9
Morphine Products 2.2 1.3 0.3 0.1 13.2 *
Fentanyl Products 0.7 0.9 0.1 0.1 19.5 *
Buprenorphine Products 0.8 0.8 0.4 0.1 43.2 *
Oxymorphone Products 0.4 0.4 0.2 0.1 * *
Demerol® 0.1 0.0 0.0 0.0 * *
Hydromorphone Products 0.3 0.1 0.1 0.0 * *
Methadone 0.2 0.4 0.1 0.0 * *
Any Other Prescription Pain Reliever1 8.3 6.2 0.6 0.4 7.4 6.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.107A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 70,222 65,261 7,404 7,498 7,404 7,498
Hydrocodone Products 39,197 33,912 4,053 3,920 4,053 3,920
Zohydro®ER 265 353 25 30 * *
Oxycodone Products 21,172 19,146 2,405 2,437 2,405 2,437
OxyContin® 7,588 6,179 872 1,070 872 1,070
Tramadol Products 15,627 15,349 1,059 1,236 1,059 1,236
Codeine Products 20,121 16,763 1,731 2,028 1,731 2,028
Morphine Products 4,794 4,934 319 424 319 424
Fentanyl Products 2,210 2,084 215 322 215 322
Buprenorphine Products 2,110 2,298 552 633 552 633
Oxymorphone Products 667 749 173 113 * *
Demerol® 834 372 37 28 37 *
Hydromorphone Products 1,506 1,236 143 210 143 *
Methadone 944 1,272 194 219 194 *
Any Other Prescription Pain Reliever1 18,122 17,484 600 835 600 835
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.107B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Pain Reliever
Subtypes
(2020)
ANY PRESCRIPTION PAIN RELIEVER 32.4 29.9 3.4 3.4 10.5 11.5
Hydrocodone Products 18.1 15.5 1.9 1.8 10.3 11.6
Zohydro®ER 0.1 0.2 0.0 0.0 * *
Oxycodone Products 9.8 8.8 1.1 1.1 11.4 12.7
OxyContin® 3.5 2.8 0.4 0.5 11.5 17.3
Tramadol Products 7.2 7.0 0.5 0.6 6.8 8.0
Codeine Products 9.3 7.7 0.8 0.9 8.6 12.1
Morphine Products 2.2 2.3 0.1 0.2 6.7 8.6
Fentanyl Products 1.0 1.0 0.1 0.1 9.7 15.4
Buprenorphine Products 1.0 1.1 0.3 0.3 26.2 27.5
Oxymorphone Products 0.3 0.3 0.1 0.1 * *
Demerol® 0.4 0.2 0.0 0.0 4.4 *
Hydromorphone Products 0.7 0.6 0.1 0.1 9.5 *
Methadone 0.4 0.6 0.1 0.1 20.5 *
Any Other Prescription Pain Reliever1 8.4 8.0 0.3 0.4 3.3 4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.108A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 18,290 18,332 4,929 5,092 4,929 5,092
Amphetamine or Methylphenidate Products 14,294 13,863 4,711 4,699 4,711 4,699
Amphetamine Products 12,647 11,853 4,486 4,435 4,486 4,435
Methylphenidate Products 3,383 3,812 704 661 704 661
Anorectic (Weight-Loss) Stimulants 2,220 2,790 207 231 207 231
Provigil® 536 536 87 119 * *
Any Other Prescription Stimulant1 2,594 2,763 31 97 31 97
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.108B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 6.6 6.6 1.8 1.8 26.9 27.8
Amphetamine or Methylphenidate Products 5.2 5.0 1.7 1.7 33.0 33.9
Amphetamine Products 4.6 4.3 1.6 1.6 35.5 37.4
Methylphenidate Products 1.2 1.4 0.3 0.2 20.8 17.3
Anorectic (Weight-Loss) Stimulants 0.8 1.0 0.1 0.1 9.3 8.3
Provigil® 0.2 0.2 0.0 0.0 * *
Any Other Prescription Stimulant1 0.9 1.0 0.0 0.0 1.2 3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.109A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 1,837 1,593 430 288 430 288
Amphetamine or Methylphenidate Products 1,643 1,409 407 253 407 253
Amphetamine Products 1,301 964 373 235 373 235
Methylphenidate Products 590 625 80 61 80 61
Anorectic (Weight-Loss) Stimulants 72 32 15 5 * *
Provigil® 9 12 2 * * *
Any Other Prescription Stimulant1 360 272 17 22 17 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.109B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 7.4 6.4 1.7 1.2 23.4 18.1
Amphetamine or Methylphenidate Products 6.6 5.6 1.6 1.0 24.8 18.0
Amphetamine Products 5.2 3.9 1.5 0.9 28.6 24.3
Methylphenidate Products 2.4 2.5 0.3 0.2 13.6 9.8
Anorectic (Weight-Loss) Stimulants 0.3 0.1 0.1 0.0 * *
Provigil® 0.0 0.0 0.0 * * *
Any Other Prescription Stimulant1 1.4 1.1 0.1 0.1 4.7 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.110A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 16,453 16,739 4,499 4,804 4,499 4,804
Amphetamine or Methylphenidate Products 12,650 12,454 4,304 4,446 4,304 4,446
Amphetamine Products 11,346 10,890 4,114 4,200 4,114 4,200
Methylphenidate Products 2,792 3,187 623 600 623 600
Anorectic (Weight-Loss) Stimulants 2,148 2,758 193 226 193 226
Provigil® 527 524 85 119 * *
Any Other Prescription Stimulant1 2,235 2,491 14 76 14 76
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.110B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 6.6 6.6 1.8 1.9 27.3 28.7
Amphetamine or Methylphenidate Products 5.1 4.9 1.7 1.8 34.0 35.7
Amphetamine Products 4.5 4.3 1.6 1.7 36.3 38.6
Methylphenidate Products 1.1 1.3 0.2 0.2 22.3 18.8
Anorectic (Weight-Loss) Stimulants 0.9 1.1 0.1 0.1 9.0 8.2
Provigil® 0.2 0.2 0.0 0.0 * *
Any Other Prescription Stimulant1 0.9 1.0 0.0 0.0 0.6 3.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.111A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 4,320 3,773 1,951 1,616 1,951 1,616
Amphetamine or Methylphenidate Products 3,998 3,536 1,926 1,603 1,926 1,603
Amphetamine Products 3,615 3,168 1,845 1,529 1,845 1,529
Methylphenidate Products 1,011 887 300 216 300 216
Anorectic (Weight-Loss) Stimulants 189 192 27 19 * *
Provigil® 47 21 10 6 * *
Any Other Prescription Stimulant1 361 247 14 15 14 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.111B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 12.8 11.3 5.8 4.8 45.2 42.8
Amphetamine or Methylphenidate Products 11.9 10.6 5.7 4.8 48.2 45.3
Amphetamine Products 10.7 9.5 5.5 4.6 51.0 48.3
Methylphenidate Products 3.0 2.6 0.9 0.6 29.7 24.4
Anorectic (Weight-Loss) Stimulants 0.6 0.6 0.1 0.1 * *
Provigil® 0.1 0.1 0.0 0.0 * *
Any Other Prescription Stimulant1 1.1 0.7 0.0 0.0 4.0 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.112A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 12,133 12,966 2,548 3,188 2,548 3,188
Amphetamine or Methylphenidate Products 8,652 8,918 2,378 2,843 2,378 2,843
Amphetamine Products 7,732 7,721 2,269 2,671 2,269 2,671
Methylphenidate Products 1,781 2,300 323 383 323 383
Anorectic (Weight-Loss) Stimulants 1,959 2,566 165 207 165 207
Provigil® 480 503 76 113 * *
Any Other Prescription Stimulant1 1,874 2,244 * 60 * 60
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.112B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Stimulant Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Stimulant
Subtypes
(2020)
ANY PRESCRIPTION STIMULANT 5.6 5.9 1.2 1.5 21.0 24.6
Amphetamine or Methylphenidate Products 4.0 4.1 1.1 1.3 27.5 31.9
Amphetamine Products 3.6 3.5 1.0 1.2 29.3 34.6
Methylphenidate Products 0.8 1.1 0.1 0.2 18.1 16.7
Anorectic (Weight-Loss) Stimulants 0.9 1.2 0.1 0.1 8.4 8.1
Provigil® 0.2 0.2 0.0 0.1 * *
Any Other Prescription Stimulant1 0.9 1.0 * 0.0 * 2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.113A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 35,601 35,018 5,220 5,460 5,220 5,460
Benzodiazepine Tranquilizers 28,316 26,095 4,819 4,739 4,819 4,739
Alprazolam Products 16,748 14,507 3,668 3,419 3,668 3,419
Lorazepam Products 7,787 7,189 795 723 795 723
Clonazepam Products 5,998 6,357 1,029 1,234 1,029 1,234
Diazepam Products 5,672 5,706 758 971 758 971
Muscle Relaxants 6,049 8,127 552 845 552 845
Cyclobenzaprine 4,955 7,289 361 738 361 738
Soma® 1,182 1,215 223 206 223 *
Any Other Prescription Tranquilizer1 5,738 5,428 97 228 97 228
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.113B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 12.9 12.6 1.9 2.0 14.7 15.6
Benzodiazepine Tranquilizers 10.3 9.4 1.8 1.7 17.0 18.2
Alprazolam Products 6.1 5.2 1.3 1.2 21.9 23.6
Lorazepam Products 2.8 2.6 0.3 0.3 10.2 10.1
Clonazepam Products 2.2 2.3 0.4 0.4 17.2 19.4
Diazepam Products 2.1 2.1 0.3 0.4 13.4 17.0
Muscle Relaxants 2.2 2.9 0.2 0.3 9.1 10.4
Cyclobenzaprine 1.8 2.6 0.1 0.3 7.3 10.1
Soma® 0.4 0.4 0.1 0.1 18.8 *
Any Other Prescription Tranquilizer1 2.1 2.0 0.0 0.1 1.7 4.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.114A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 1,010 588 392 196 392 196
Benzodiazepine Tranquilizers 700 398 371 152 371 *
Alprazolam Products 613 308 359 151 359 *
Lorazepam Products 84 48 9 9 * *
Clonazepam Products 83 41 33 2 * *
Diazepam Products 80 44 16 7 * *
Muscle Relaxants 45 27 15 7 * *
Cyclobenzaprine 32 27 4 7 * *
Soma® 11 * 10 * * *
Any Other Prescription Tranquilizer1 367 184 16 23 16 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.114B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 4.1 2.4 1.6 0.8 38.8 33.3
Benzodiazepine Tranquilizers 2.8 1.6 1.5 0.6 52.9 *
Alprazolam Products 2.5 1.2 1.4 0.6 58.6 *
Lorazepam Products 0.3 0.2 0.0 0.0 * *
Clonazepam Products 0.3 0.2 0.1 0.0 * *
Diazepam Products 0.3 0.2 0.1 0.0 * *
Muscle Relaxants 0.2 0.1 0.1 0.0 * *
Cyclobenzaprine 0.1 0.1 0.0 0.0 * *
Soma® 0.0 * 0.0 * * *
Any Other Prescription Tranquilizer1 1.5 0.7 0.1 0.1 4.3 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.115A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 34,591 34,430 4,829 5,264 4,829 5,264
Benzodiazepine Tranquilizers 27,615 25,697 4,448 4,587 4,448 4,587
Alprazolam Products 16,134 14,199 3,308 3,269 3,308 3,269
Lorazepam Products 7,703 7,140 786 714 786 714
Clonazepam Products 5,916 6,316 996 1,232 996 1,232
Diazepam Products 5,592 5,662 742 965 742 965
Muscle Relaxants 6,005 8,099 537 838 537 838
Cyclobenzaprine 4,923 7,262 358 731 358 731
Soma® 1,170 1,214 213 206 213 *
Any Other Prescription Tranquilizer1 5,371 5,244 81 205 81 205
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.115B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 13.8 13.7 1.9 2.1 14.0 15.3
Benzodiazepine Tranquilizers 11.0 10.2 1.8 1.8 16.1 17.9
Alprazolam Products 6.4 5.6 1.3 1.3 20.5 23.0
Lorazepam Products 3.1 2.8 0.3 0.3 10.2 10.0
Clonazepam Products 2.4 2.5 0.4 0.5 16.8 19.5
Diazepam Products 2.2 2.2 0.3 0.4 13.3 17.0
Muscle Relaxants 2.4 3.2 0.2 0.3 8.9 10.3
Cyclobenzaprine 2.0 2.9 0.1 0.3 7.3 10.1
Soma® 0.5 0.5 0.1 0.1 18.2 *
Any Other Prescription Tranquilizer1 2.1 2.1 0.0 0.1 1.5 3.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.116A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 3,419 3,338 1,313 1,108 1,313 1,108
Benzodiazepine Tranquilizers 2,922 2,822 1,260 1,087 1,260 1,087
Alprazolam Products 2,229 1,992 1,091 932 1,091 932
Lorazepam Products 630 701 132 169 132 169
Clonazepam Products 599 641 214 216 214 *
Diazepam Products 451 561 138 117 138 *
Muscle Relaxants 314 396 59 64 59 *
Cyclobenzaprine 258 351 35 41 35 *
Soma® 70 73 33 42 * *
Any Other Prescription Tranquilizer1 515 466 33 3 33 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.116B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 10.1 10.0 3.9 3.3 38.4 33.2
Benzodiazepine Tranquilizers 8.7 8.4 3.7 3.2 43.1 38.5
Alprazolam Products 6.6 5.9 3.2 2.8 49.0 46.8
Lorazepam Products 1.9 2.1 0.4 0.5 21.0 24.1
Clonazepam Products 1.8 1.9 0.6 0.6 35.7 *
Diazepam Products 1.3 1.7 0.4 0.4 30.6 *
Muscle Relaxants 0.9 1.2 0.2 0.2 18.9 *
Cyclobenzaprine 0.8 1.0 0.1 0.1 13.5 *
Soma® 0.2 0.2 0.1 0.1 * *
Any Other Prescription Tranquilizer1 1.5 1.4 0.1 0.0 6.4 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.117A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 31,172 31,092 3,516 4,156 3,516 4,156
Benzodiazepine Tranquilizers 24,693 22,875 3,188 3,500 3,188 3,500
Alprazolam Products 13,906 12,207 2,217 2,336 2,217 2,336
Lorazepam Products 7,074 6,439 654 545 654 545
Clonazepam Products 5,317 5,675 782 1,016 782 1,016
Diazepam Products 5,141 5,101 604 847 604 847
Muscle Relaxants 5,690 7,703 477 774 477 774
Cyclobenzaprine 4,665 6,911 323 690 323 690
Soma® 1,100 1,141 179 164 179 *
Any Other Prescription Tranquilizer1 4,856 4,778 48 202 48 202
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.117B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Tranquilizer
Subtypes
(2020)
ANY PRESCRIPTION TRANQUILIZER 14.4 14.2 1.6 1.9 11.3 13.4
Benzodiazepine Tranquilizers 11.4 10.5 1.5 1.6 12.9 15.3
Alprazolam Products 6.4 5.6 1.0 1.1 15.9 19.1
Lorazepam Products 3.3 2.9 0.3 0.2 9.2 8.5
Clonazepam Products 2.5 2.6 0.4 0.5 14.7 17.9
Diazepam Products 2.4 2.3 0.3 0.4 11.7 16.6
Muscle Relaxants 2.6 3.5 0.2 0.4 8.4 10.0
Cyclobenzaprine 2.2 3.2 0.1 0.3 6.9 10.0
Soma® 0.5 0.5 0.1 0.1 16.3 *
Any Other Prescription Tranquilizer1 2.2 2.2 0.0 0.1 1.0 4.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.118A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 15,636 15,364 1,098 1,240 1,098 1,240
Zolpidem Products 8,816 8,050 774 807 774 807
Eszopiclone Products 932 991 21 54 21 54
Zaleplon Products 414 252 25 * * *
Benzodiazepine Sedatives 1,729 1,675 68 101 68 101
Flurazepam 140 113 * 16 * *
Temazepam Products 1,038 898 42 83 42 *
Triazolam Products 580 689 26 27 26 *
Barbiturates 510 597 44 50 * *
Any Other Prescription Sedative1 5,441 5,946 237 291 237 291
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.118B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 5.7 5.5 0.4 0.4 7.0 8.1
Zolpidem Products 3.2 2.9 0.3 0.3 8.8 10.0
Eszopiclone Products 0.3 0.4 0.0 0.0 2.2 5.4
Zaleplon Products 0.2 0.1 0.0 * * *
Benzodiazepine Sedatives 0.6 0.6 0.0 0.0 3.9 6.0
Flurazepam 0.1 0.0 * 0.0 * *
Temazepam Products 0.4 0.3 0.0 0.0 4.1 *
Triazolam Products 0.2 0.2 0.0 0.0 4.4 *
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative1 2.0 2.1 0.1 0.1 4.3 4.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.119A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 545 429 82 35 82 35
Zolpidem Products 143 66 38 4 * *
Eszopiclone Products 17 4 4 1 * *
Zaleplon Products 30 6 7 * * *
Benzodiazepine Sedatives 69 25 11 5 * *
Flurazepam 10 9 3 5 * *
Temazepam Products 23 * 2 * * *
Triazolam Products 39 16 6 * * *
Barbiturates 47 15 11 * * *
Any Other Prescription Sedative1 358 324 24 20 24 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.119B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 2.2 1.7 0.3 0.1 15.1 8.1
Zolpidem Products 0.6 0.3 0.2 0.0 * *
Eszopiclone Products 0.1 0.0 0.0 0.0 * *
Zaleplon Products 0.1 0.0 0.0 * * *
Benzodiazepine Sedatives 0.3 0.1 0.0 0.0 * *
Flurazepam 0.0 0.0 0.0 0.0 * *
Temazepam Products 0.1 * 0.0 * * *
Triazolam Products 0.2 0.1 0.0 * * *
Barbiturates 0.2 0.1 0.0 * * *
Any Other Prescription Sedative1 1.4 1.3 0.1 0.1 6.8 *
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.120A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 15,091 14,935 1,016 1,205 1,016 1,205
Zolpidem Products 8,673 7,984 736 803 736 803
Eszopiclone Products 915 987 17 52 17 52
Zaleplon Products 384 246 19 * * *
Benzodiazepine Sedatives 1,660 1,650 57 96 57 96
Flurazepam 130 104 * * * *
Temazepam Products 1,015 898 41 83 41 *
Triazolam Products 541 673 19 27 19 *
Barbiturates 463 582 33 50 * *
Any Other Prescription Sedative1 5,083 5,622 212 271 212 271
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.120B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 6.0 5.9 0.4 0.5 6.7 8.1
Zolpidem Products 3.5 3.2 0.3 0.3 8.5 10.1
Eszopiclone Products 0.4 0.4 0.0 0.0 1.8 5.3
Zaleplon Products 0.2 0.1 0.0 * * *
Benzodiazepine Sedatives 0.7 0.7 0.0 0.0 3.4 5.8
Flurazepam 0.1 0.0 * * * *
Temazepam Products 0.4 0.4 0.0 0.0 4.0 *
Triazolam Products 0.2 0.3 0.0 0.0 3.6 *
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative1 2.0 2.2 0.1 0.1 4.2 4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.121A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 1,051 1,066 175 251 175 251
Zolpidem Products 436 428 120 189 120 *
Eszopiclone Products 35 70 4 5 * *
Zaleplon Products 10 13 2 * * *
Benzodiazepine Sedatives 113 146 28 16 * *
Flurazepam 12 16 3 * * *
Temazepam Products 38 22 20 9 * *
Triazolam Products 75 108 12 7 * *
Barbiturates 29 57 4 5 * *
Any Other Prescription Sedative1 572 500 26 40 26 40
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.121B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 3.1 3.2 0.5 0.7 16.6 23.5
Zolpidem Products 1.3 1.3 0.4 0.6 27.5 *
Eszopiclone Products 0.1 0.2 0.0 0.0 * *
Zaleplon Products 0.0 0.0 0.0 * * *
Benzodiazepine Sedatives 0.3 0.4 0.1 0.0 * *
Flurazepam 0.0 0.0 0.0 * * *
Temazepam Products 0.1 0.1 0.1 0.0 * *
Triazolam Products 0.2 0.3 0.0 0.0 * *
Barbiturates 0.1 0.2 0.0 0.0 * *
Any Other Prescription Sedative1 1.7 1.5 0.1 0.1 4.6 8.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.122A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 14,040 13,869 841 954 841 954
Zolpidem Products 8,236 7,556 616 613 616 613
Eszopiclone Products 880 917 12 47 12 *
Zaleplon Products 374 233 16 * * *
Benzodiazepine Sedatives 1,547 1,503 29 80 29 80
Flurazepam 118 88 * 12 * *
Temazepam Products 977 875 21 74 21 *
Triazolam Products 466 565 * 20 * *
Barbiturates 434 525 29 45 * *
Any Other Prescription Sedative1 4,510 5,122 186 230 186 230
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.122B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Sedative Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Sedative
Subtypes
(2020)
ANY PRESCRIPTION SEDATIVE 6.5 6.3 0.4 0.4 6.0 6.9
Zolpidem Products 3.8 3.5 0.3 0.3 7.5 8.1
Eszopiclone Products 0.4 0.4 0.0 0.0 1.4 *
Zaleplon Products 0.2 0.1 0.0 * * *
Benzodiazepine Sedatives 0.7 0.7 0.0 0.0 1.9 5.3
Flurazepam 0.1 0.0 * 0.0 * *
Temazepam Products 0.5 0.4 0.0 0.0 2.2 *
Triazolam Products 0.2 0.3 * 0.0 * *
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative1 2.1 2.3 0.1 0.1 4.1 4.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.123A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 29,408 27,026 4,841 4,779 4,841 4,779
Benzodiazepine Tranquilizers 28,316 26,095 4,819 4,739 4,819 4,739
Alprazolam Products 16,748 14,507 3,668 3,419 3,668 3,419
Lorazepam Products 7,787 7,189 795 723 795 723
Clonazepam Products 5,998 6,357 1,029 1,234 1,029 1,234
Diazepam Products 5,672 5,706 758 971 758 971
Benzodiazepine Sedatives 1,729 1,675 68 101 68 101
Flurazepam 140 113 * 16 * *
Temazepam Products 1,038 898 42 83 42 *
Triazolam Products 580 689 26 27 26 *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 58 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.123B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 10.7 9.8 1.8 1.7 16.5 17.7
Benzodiazepine Tranquilizers 10.3 9.4 1.8 1.7 17.0 18.2
Alprazolam Products 6.1 5.2 1.3 1.2 21.9 23.6
Lorazepam Products 2.8 2.6 0.3 0.3 10.2 10.1
Clonazepam Products 2.2 2.3 0.4 0.4 17.2 19.4
Diazepam Products 2.1 2.1 0.3 0.4 13.4 17.0
Benzodiazepine Sedatives 0.6 0.6 0.0 0.0 3.9 6.0
Flurazepam 0.1 0.0 * 0.0 * *
Temazepam Products 0.4 0.3 0.0 0.0 4.1 *
Triazolam Products 0.2 0.2 0.0 0.0 4.4 *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 0.0 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.124A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 749 418 381 157 381 *
Benzodiazepine Tranquilizers 700 398 371 152 371 *
Alprazolam Products 613 308 359 151 359 *
Lorazepam Products 84 48 9 9 * *
Clonazepam Products 83 41 33 2 * *
Diazepam Products 80 44 16 7 * *
Benzodiazepine Sedatives 69 25 11 5 * *
Flurazepam 10 9 3 5 * *
Temazepam Products 23 * 2 * * *
Triazolam Products 39 16 6 * * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * * da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.124B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 3.0 1.7 1.5 0.6 50.9 *
Benzodiazepine Tranquilizers 2.8 1.6 1.5 0.6 52.9 *
Alprazolam Products 2.5 1.2 1.4 0.6 58.6 *
Lorazepam Products 0.3 0.2 0.0 0.0 * *
Clonazepam Products 0.3 0.2 0.1 0.0 * *
Diazepam Products 0.3 0.2 0.1 0.0 * *
Benzodiazepine Sedatives 0.3 0.1 0.0 0.0 * *
Flurazepam 0.0 0.0 0.0 0.0 * *
Temazepam Products 0.1 * 0.0 * * *
Triazolam Products 0.2 0.1 0.0 * * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * * da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.125A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 28,659 26,607 4,460 4,622 4,460 4,622
Benzodiazepine Tranquilizers 27,615 25,697 4,448 4,587 4,448 4,587
Alprazolam Products 16,134 14,199 3,308 3,269 3,308 3,269
Lorazepam Products 7,703 7,140 786 714 786 714
Clonazepam Products 5,916 6,316 996 1,232 996 1,232
Diazepam Products 5,592 5,662 742 965 742 965
Benzodiazepine Sedatives 1,660 1,650 57 96 57 96
Flurazepam 130 104 * * * *
Temazepam Products 1,015 898 41 83 41 *
Triazolam Products 541 673 19 27 19 *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 58 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.125B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 11.4 10.6 1.8 1.8 15.6 17.4
Benzodiazepine Tranquilizers 11.0 10.2 1.8 1.8 16.1 17.9
Alprazolam Products 6.4 5.6 1.3 1.3 20.5 23.0
Lorazepam Products 3.1 2.8 0.3 0.3 10.2 10.0
Clonazepam Products 2.4 2.5 0.4 0.5 16.8 19.5
Diazepam Products 2.2 2.2 0.3 0.4 13.3 17.0
Benzodiazepine Sedatives 0.7 0.7 0.0 0.0 3.4 5.8
Flurazepam 0.1 0.0 * * * *
Temazepam Products 0.4 0.4 0.0 0.0 4.0 *
Triazolam Products 0.2 0.3 0.0 0.0 3.6 *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 0.0 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.126A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 2,983 2,861 1,266 1,097 1,266 1,097
Benzodiazepine Tranquilizers 2,922 2,822 1,260 1,087 1,260 1,087
Alprazolam Products 2,229 1,992 1,091 932 1,091 932
Lorazepam Products 630 701 132 169 132 169
Clonazepam Products 599 641 214 216 214 *
Diazepam Products 451 561 138 117 138 *
Benzodiazepine Sedatives 113 146 28 16 * *
Flurazepam 12 16 3 * * *
Temazepam Products 38 22 20 9 * *
Triazolam Products 75 108 12 7 * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 4 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.126B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 8.8 8.5 3.8 3.3 42.4 38.3
Benzodiazepine Tranquilizers 8.7 8.4 3.7 3.2 43.1 38.5
Alprazolam Products 6.6 5.9 3.2 2.8 49.0 46.8
Lorazepam Products 1.9 2.1 0.4 0.5 21.0 24.1
Clonazepam Products 1.8 1.9 0.6 0.6 35.7 *
Diazepam Products 1.3 1.7 0.4 0.4 30.6 *
Benzodiazepine Sedatives 0.3 0.4 0.1 0.0 * *
Flurazepam 0.0 0.0 0.0 * * *
Temazepam Products 0.1 0.1 0.1 0.0 * *
Triazolam Products 0.2 0.3 0.0 0.0 * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 0.0 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.127A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 25,676 23,747 3,194 3,526 3,194 3,526
Benzodiazepine Tranquilizers 24,693 22,875 3,188 3,500 3,188 3,500
Alprazolam Products 13,906 12,207 2,217 2,336 2,217 2,336
Lorazepam Products 7,074 6,439 654 545 654 545
Clonazepam Products 5,317 5,675 782 1,016 782 1,016
Diazepam Products 5,141 5,101 604 847 604 847
Benzodiazepine Sedatives 1,547 1,503 29 80 29 80
Flurazepam 118 88 * 12 * *
Temazepam Products 977 875 21 74 21 *
Triazolam Products 466 565 * 20 * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 54 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.
210616
Table 1.127B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype Any Use
in Past Year
(2019)
Any Use
in Past Year
(2020)
Misuse
in Past Year
among
Total Population
(2019)
Misuse
in Past Year
among
Total Population
(2020)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2019)
Misuse
in Past Year
among
Past Year
Any Users of
Benzodiazepine
Subtypes
(2020)
ANY PRESCRIPTION BENZODIAZEPINE 11.9 10.9 1.5 1.6 12.4 14.8
Benzodiazepine Tranquilizers 11.4 10.5 1.5 1.6 12.9 15.3
Alprazolam Products 6.4 5.6 1.0 1.1 15.9 19.1
Lorazepam Products 3.3 2.9 0.3 0.2 9.2 8.5
Clonazepam Products 2.5 2.6 0.4 0.5 14.7 17.9
Diazepam Products 2.4 2.3 0.3 0.4 11.7 16.6
Benzodiazepine Sedatives 0.7 0.7 0.0 0.0 1.9 5.3
Flurazepam 0.1 0.0 * 0.0 * *
Temazepam Products 0.5 0.4 0.0 0.0 2.2 *
Triazolam Products 0.2 0.3 * 0.0 * *
Any Miscellaneous Prescription Benzodiazepine
   Tranquilizers or Sedatives1
da da * 0.0 da da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
1 Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

Go to Top of PageGo to the Table of Contents